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RESUMO
Os fibroblastos cardíacos desempenham um papel crucial na
remodelação do coração assim como nas alterações electrofisiológicas e
hemodinâmicas após enfarte do miocárdio. Contudo, a sua participação na
homeostasia cardíaca na saúde e na doença tem sido preterida em favor do papel
central dos cardiomiócitos enquanto responsáveis pela contratilidade e
sinalização elétrica do miocárdio. Durante a isquemia e reperfusão do miocárdio,
são libertadas grandes quantidades de ATP e UTP para o meio extracelular,
ativando múltiplos subtipos de recetores purinérgicos P2. Uma vez no meio
extracelular, estes nucleótidos podem ser rapidamente desfosforilados em
nucleósidos difosfato, por NTPDases ligadas à membrana plasmática, permitindo
a ativação subsequente de recetores P2Y sensíveis ao ADP ou UDP. Os
fibroblastos cardíacos expressam ainda uma variedade de transportadores e
canais permeáveis ao cálcio, tais como canais TRP e o trocador Na+/Ca2+, que
podem regular os efeitos produzidos na sinalização mediada pelo Ca2+ operada
por recetores purinérgicos. Este sistema dinâmico que abrange os locais de
libertação dos nucleótidos, enzimas membranares, recetores purinérgicos e
canais iónicos deve funcionar de forma muito coordenada para regular várias das
funções celulares. Neste contexto, o presente estudo contribuiu para explorar o
papel da sinalização purinérgica sobre os aumentos transitórios de Ca2+ e sobre a
proliferação / diferenciação de fibroblastos ventriculares isolados do coração de
ratazanas adultas.
Demonstrámos que os fibroblastos ventriculares em cultura co-
expressam o recetor do domínio discoide 2 e actina-α do músculo liso e, por isso,
possuem um fenótipo ativado semelhante aos miofibroblastos encontrados no
coração após fenómenos de isquemia/reperfusão, inflamação e sobrecarga de
pressão ou volume. Tanto os nucleótidos de adenina como os de uracilo
causaram a elevação dos níveis intracelulares de cálcio ([Ca2+]i) de forma bifásica.
i.e. observou-se numa primeira fase um aumento rápido dos níveis de [Ca2+]i
através do seu recrutamento a partir de reservatórios intracelulares sensíveis à
tapsigargina, cujos níveis diminuiram parcialmente para um patamar que foi
mantido através da entrada de Ca2+ do meio extracelular. O UTP e o ATP foram
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os nucleótidos mais potentes, seguidos do ADP e UDP por essa ordem. O recetor
responsável pela resposta rápida de [Ca2+]i nos fibroblastos cardíacos é
provavelmente do subtipo P2Y4. Esta conclusão foi retirada (1) pela presença
deste recetor nestas células verificada por microscopia confocal, (2) pela
reprodução do efeito do UTP pelo agonista seletivo dos recetores P2Y4,
MRS4062, e (3) pelo antagonismo da resposta aos nucleótidos tanto pelo reactive
blue-2 (RB-2) como pela suramina. A demonstração do envolvimento da via de
transdução de sinal intracelular associada à fosfolipase C com libertação de IP3 e
DAG a partir dos fosfolípidos de membrana reforça a ideia do envolvimento de um
recetor acoplado à proteína Gq/11, tal como o recetor P2Y4
Os resultados deste estudo mostram pela primeira vez que a ativação de
recetores P2Y4 pelo UTP facilita a libertação de ATP para o meio extracelular
através de hemicanais contendo Cx43. Este processo promove a ativação de
recetores P2Y11 sensíveis ao ATP. O sinergismo entre a ativação de recetores
P2Y4 e P2Y11 acoplados a proteínas Gq/11 e Gs, respetivamente, favorece a
manutenção dos níveis de [Ca2+]i na segunda fase da resposta ao UTP. Esta
conclusão foi retirada a partir do bloqueio da fase de planalto da resposta ao UTP
(1) na presença do antagonista seletivo dos recetores P2Y11, NF340, e (2) após o
tratamento das células com inibidores da ciclase do adenilato, SQ22536 ou
MDL12,3303a.
Apesar de se ter detetado a presença de recetores sensíveis ao ADP,
P2Y1, P2Y12 e P2Y13, nos fibroblastos ventriculares, o efeito deste nucleótido
sobre a acumulação de [Ca2+]i nestas células possui uma farmacologia compatível
com a ativação preferencial de recetores do subtipo P2Y4 mas, neste caso, sem
um envolvimento significativo do recetor P2Y11 na fase de planalto da resposta.
Mostra-se pela primeira vez neste trabalho que a entrada capacitativa de Ca2+
responsável pela segunda fase da resposta ao ADP depende da abertura de
canais TRP (sensíveis ao 2-APB e ao ácido flufenâmico) aglomerados junto aos
recetores P2Y4 e à fosfolipase C em microdomínios membranares ricos em
colesterol e caveolina-1 – jangadas lipídicas (lipid rafts). A disrupção das jangadas
lipídicas motivada pela depleção de colesterol com metil-β-ciclodextrina eliminou
a segunda fase do sinal de [Ca2+]i causado pelo ADP
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O efeito a longo prazo dos nucleótidos de adenina e uracilo sobre a
proliferação e diferenciação dos fibroblastos ventriculares em cultura mostrou o
envolvimento preferencial de recetores dos subtipos P2Y2 e P2Y1, consoante a
ativação se produza por nucleósidos trifosfatados (ATP e UTP) e difosfatados
(ADP), ou pelos seus análogos estáveis MRS2768 e ADPβS, respetivamente.
Qualquer um destes recetores possui um potencial efeito pró-fibrótico na
remodelação miocárdica, sendo de destacar que a ativação tónica do recetor
P2Y1, mas não de qualquer outro recetor sensível ao ADP (e.g. P2Y12 ou P2Y13)
promove a síntese de colagénio de tipo I em maior escala do que a ativação do
recetor P2Y2. Por se tratar de um recetor facilmente dessensibilizável através da
ação repetida ou prolongada dos seus agonistas, o recetor P2Y4 não exerce
qualquer efeito significativo na proliferação dos fibroblastos cardíacos em cultura.
O efeito do UTP sobre a proliferação de fibroblastos cardíacos em cultura parece
ser em parte contrabalançado pela ativação tónica do recetor P2Y11, já que o
mesmo foi prevenido pelo antagonista seletivo destes recetores, NF340. O efeito
anti-fibrótico do recetor P2Y11 foi confirmado porque o seu agonista seletivo,
NF546, reduziu a proliferação dos fibroblastos por um mecanismo dependente da
via de transdução de sinal envolvendo a ciclase do adenilato / AMP cíclico / EPAC.
Em conclusão, os fibroblastos ventriculares de ratazanas adultas
expressam diversos subtipos de recetores purinérgicos funcionais, tais como
P2Y1, P2Y2, P2Y4 e P2Y11. Os nucleótidos de adenina e uracilo provocam
oscilações de [Ca2+]i através da ativação preferencial dos recetores P2Y4. Para
além do recrutamento rápido de Ca2+ a partir de reservatórios intracelulares, os
níveis intracelulares de Ca2+ são mantidos em níveis elevados através da entrada
Ca2+ do meio extracelular por intermédio de canais TRP localizados junto aos
recetores em microdomínios (lipid rafts) da membrana plasmática. A ativação
seletiva do recetor P2Y4 conduz, ainda, à libertação de ATP e, subsequente,
ativação de recetores P2Y11 que também contribui para a segunda fase da
sinalização mediada pelo Ca2+. Os nucleótidos de adenina e uracilo possuem uma
atividade pró-fibrótica favorecida pela ativação de recetores P2Y1 e P2Y2. Este
efeito promotor da proliferação fibroblástica pode ser contrariado pela ativação de
recetores do subtipo P2Y11, cujo potencial anti-fibrótico pode ser aproveitado
clinicamente usando novos ativadores específicos.
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ABSTRACT
Cardiac fibroblasts play crucial roles in heart remodeling, electrophysiology
and hemodynamic alterations following myocardial infarction. Notwithstanding this,
research has been focused predominantly on the pathophysiological role of
cardiomyocytes, which can be explained because these cells were considered,
until recently, the main determinants of contractility and electrical integration of the
myocardium. During myocardial ischemia and reperfusion, both ATP and UTP are
released in huge amounts into the extracellular milieu, leading to the activation of
many subtypes of P2 purinoceptors. Once in the extracellular milieu, these
nucleotides can be rapidly dephosphorylated into diphosphate nucleosides by
membrane-bound NTPDases, which facilitate the activation of ADP- or UDP-
sensitive P2Y receptors. Besides that, cardiac fibroblasts are also endowed with a
variety of calcium channels and transporters, like transient receptor channels (TRP)
and the Na+/Ca2+ exchanger, which may modulate Ca2+ signals operated by P2
purinoceptors activation. This dynamic system covering nucleotide release sites,
membrane-bound enzymes, purinoceptors and ion channels must function
coordinately in order to regulate various cell functions. In this context, this study
was designed to explore the role of purinergic signaling on Ca2+ transients and
proliferation / differentiation of fibroblasts isolated from adult rat ventricles.
Cultured ventricular fibroblasts co-express discoidin domain receptor 2 and
alpha-smooth muscle actin, suggesting a myofibroblast (activated) phenotype.
Both adenine and uracil nucleotides caused a biphasic intracellular calcium ([Ca2+]i)
response consisting of a fast [Ca2+]i rise originated from thapsigargin-sensitive
internal stores, which partially declined to a plateau providing that Ca2+ was
present in the extracellular fluid. [Ca2+]i responses caused by UTP and ATP were
more exuberant than those produced by ADP and UDP, in that order. The receptor
responsible for the fast [Ca2+]i response in ventricular myofibroblasts is of the P2Y4
subtype. This conclusion was drawn from the presence of this receptor
demonstrated by confocal microscopy, and because the effect of UTP was
reproduced by the P2Y4 selective agonist, MRS4062, and antagonized by both
reactive blue-2 (RB-2) and suramin. The P2Y4 receptor is usually coupled to Gq/11
protein and to phospholipase C resulting in the release of IP3 and DAG from
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membrane phospholipids, and this mechanism was proved to be involved in
ventricular fibroblasts in culture.
Results from this study show for the first time that activation of the P2Y4
receptor by UTP facilitates the release of ATP to the extracellular milieu through
hemichannels containing Cx43. Extracellular ATP accumulation favors activation
of the P2Y11 receptor that is co-expressed with the P2Y4 in ventricular
myofibroblasts. Synergism between P2Y4 and P2Y11 receptors coupling to Gq/11
and Gs proteins, respectively, contributes to maintain high [Ca2+]i levels during the
plateau phase of the Ca2+ response to UTP. This was concluded because
blockage of UTP-induced [Ca2+]i plateau was verified (1) in the presence of a
selective P2Y11 receptor antagonist, NF340, and (2) after treating the cells with
adenylate cyclase inhibitors, such as SQ22536 or MDL12,3303a.
Besides the fact that ventricular fibroblasts are endowed with ADP-
sensitive receptors, namely P2Y1, P2Y12 and P2Y13, the pharmacology of ADP-
mediated effects in these cells is compatible with a preferential activation of the
P2Y4 receptor subtype, without a significant involvement of the P2Y11 receptor in
the plateau phase of the [Ca2+]i response. We show here for the first time that the
capacitative Ca2+ entry responsible for the second phase of the ADP response
depends on 2-APB- and flufenamic acid-sensitive TRP channels opening. These
channels are compartmentalized with the P2Y4 receptor and phospholipase C
within lipid rafts microdomains enriched in cholesterol and caveolin-1. Disruption of
lipid rafts microdomains by depletion of cholesterol with methyl-β-cyclodextrin
abrogated the second plateau phase of ADP-induced [Ca2+]i response.
Long-term effects of adenine and uracil nucleotides on proliferation and/or
differentiation of cultured ventricular fibroblasts are mediated preferentially via
P2Y2 and P2Y1 receptor subtypes depending whether native ligands are
nucleoside triphosphates (both ATP and UTP) or diphosphates (ADP), or their
stable analogs MRS2768 and ADPβS, respectively. Both receptors have a pro-
fibrotic potential on cardiac remodeling, but it is worth to note that tonic activation
of the P2Y1 receptor, but no any other receptor sensitive to ADP activation (e.g.
P2Y12 or P2Y13) favors type I collagen synthesis more effectively than the P2Y2
receptor subtype. Given that the P2Y4 receptor is fast desensitizing by repeated or
prolonged application of its agonists, this receptor subtype had no effect on
cardiac fibroblast cells growth in culture. Interestingly, the proliferative effect of
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UTP may be partially counteracted by tonic activation of the P2Y11 receptor, which
can be blocked selectively by NF340 or by inhibiting the adenylate cyclase / cyclic
AMP / EPAC transduction pathway.
In conclusion, ventricular fibroblasts from adult rats are endowed with
several P2Y receptor subtypes, namely P2Y1, P2Y2, P2Y4 and P2Y11. Adenine and
uracil nucleotides cause [Ca2+]i transients through the preferential activation of
P2Y4 receptors. Besides the fast [Ca2+]i rise originated by Ca2+ recruitment from
internal stores, capacitative Ca2+ entry from the extracellular milieu sustains
elevated [Ca2+]i levels through opening of TRP channels compartmentalized with
the P2Y4 receptor within lipid rafts membrane microdomains. In addition, selective
activation of the P2Y4 facilitates the outflow of ATP, which accumulation in the
extracellular milieu favors activation of P2Y11 receptors also contributing to the
second (plateau) phase of UTP-induced [Ca2+]i response. Adenine and uracil
nucleotides display an overall pro-fibrotic activity that is predominantly mediated
by P2Y1 and P2Y2 receptors activation. Fibroblast growth promotion can be, at
least partially, counteracted by P2Y11 activation and we propose here that the anti-
fibrotic effect of P2Y11 receptors might be used as a novel therapeutic target to
prevent cardiac fibrosis.
PhD THESIS – MARIANA DE SOUSA CERTAL GOMES 13
CHAPTER 1. INTRODUCTION
14 PhD THESIS – MARIANA DE SOUSA CERTAL GOMES
1.1. Cardiac remodeling
1.1.1. Cardiac remodeling: an introduction
Heart diseases are a major cause of morbidity and mortality in economically
developed countries. These disease conditions are associated with pathological
remodeling of the heart, an event that is characterized by changes in gene
expression leading to structural alterations at molecular, cellular and interstitial
levels that are manifested clinically as changes in size, shape and activity of the
heart (Cohn et al., 2000). These remodeling events may be secondary to
myocardial infarction (MI), pressure/volume overload and inflammatory insults, or
may be idiopathic as observed in dilated cardiomyopathy. Although there are
several different heart diseases with various pathophysiological mechanisms, they
share common molecular, biochemical, and cellular mechanisms to collectively
change the shape and function of the myocardium (Kehat et al., 2010). In what
concerns the clinical diagnosis, usually heart remodeling is based on the detection
of morphological changes, such as modifications in the diameter of the cavities,
cardiac mass (hypertrophy and atrophy), geometry (heart wall thickness and
shape), areas of scar after MI, fibrosis and inflammatory infiltrates (Cohn et al.,
2000). Collectively, these features result in heart dysfunction leading to a poor
prognosis.
The remodeling process of the heart may be divided into different phases.
Despite the initial remodeling phase leading to reparation of the necrotic area and
to scar formation may be, in some extension, considered beneficial (Cohn et al.,
2000), when faced with increased workload or injury, the cardiac remodeling
begins to become pathological and cardiac functions decline often leading to heart
failure (Cohn et al., 2000; Kehat et al., 2010).
The macroscopic and functional modifications of the heart described above
result from processes that involve cellular and molecular cardiac changes, such as
cardiomyocyte hypertrophy, necrosis (Tan et al., 1991), apoptosis (Sharov et al.,
1996; Teiger et al., 1996; Olivetti et al., 1997), fibrosis (Anderson et al., 1979),
increased fibrillary collagen (Weber et al., 1990) and fibroblast transdifferentiation
and proliferation (Villareal et al., 1993). In general, the critical phases of this
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response consist in inflammation, proliferation of non-myocyte cells, and scarring
(Travers et al., 2016).
In what concerns the mechanisms underlying cardiac remodeling, as well
as cardiac function in healthy tissues, most of the studies rely on cardiomyocyte
function, whereas stromal cells, such as cardiac fibroblasts, tend not to be
considered. In fact, this is not surprising given that the heart pumping function
directly depends on the contractile activity of cardiomyocytes. However, to
effectively perform their functions, cardiomyocytes have to be embedded in an
appropriately configured extracellular matrix (ECM) and to coordinate their activity
with non-myocyte cardiac cells, mainly cardiac fibroblasts.
1.1.2. Cardiac remodeling: fibrosis
As mentioned earlier, myocardial fibrosis constitutes one of the cardiac
morphological changes detected during heart remodeling. In fact, myocardial
fibrosis is one of the most common histologic features of the failing heart and
constitutes a terminal event of various cardiac diseases. An important
consideration is that the term ‘fibrosis’ is often confused with ‘scar’ and these
terms are frequently used interchangeably. However, we must consider that
fibrosis is not a synonymous of an increased presence of interstitial cells but,
conversely, it is a measurable characteristic quantified through the presence of
collagen - a key component of the acellular fraction of connective tissue. Thus,
fibrotic scars, for instance commonly observed in the skin, are generally acellular
and predominantly composed of fibrillar collagen (Desmoulière et al., 1995). In the
heart, however, scar tissue assumes a more proactive role than simply preserving
ventricular integrity, facilitating force transmission, and preventing wall rupture.
This ability led some authors to designate cardiac scars as ‘very much alive’ scars
because of the heterocellular activity that contributes to the maintenance of
structural and mechanical integrity following heart injury (Rog-Zielinska et al.,
2016).
Adaptive cardiac fibrosis is a cellular and molecular process that aims at
maintaining the structural integrity and pressure-generating capacity of the heart.
This process can be categorized into 2 classical forms, namely reactive interstitial
fibrosis or replacement fibrosis, according to the underlying cardiomyopathic
process. The term ”reactive interstitial fibrosis” is used to describe expansion of
16 PhD THESIS – MARIANA DE SOUSA CERTAL GOMES
the cardiac interstitial space in the absence of significant loss of cardiomyocytes.
This type of fibrosis presents a diffuse distribution within the interstitium that is
more often perivascular (Weber et al., 1988). In addition, this process has a
progressive onset and follows the increase in collagen synthesis by myofibroblasts
under the influence of several stimuli. Thus, interstitial fibrosis is an intermediate
marker of disease severity, as it has been shown in hypertensive cardiomyopathy,
and it precedes irreversible replacement fibrosis (Webber et al., 1991; Martos et
al., 2007). In contrast, ”reparative or replacement fibrosis” refers to the substitution
of cardiomyocytes after cell damage or necrosis by plexiform fibrosis, mainly type I
collagen (Sutton et al., 2000). Replacement fibrosis appears as soon as the
cardiomyocytes integrity is affected and it may have a localized or a diffuse
distribution according to the etiology (Mahrholdt et al., 2005; Bohl et al., 2008;
Karamitsos et al., 2009). In addition, it has been also described a third subtype of
fibrosis designated ”infiltrative interstitial fibrosis” that is induced by the
progressive deposition of insoluble proteins (amyloidosis) or glycosphingolipids
(Anderson Fabry’s disease) (Shah et al., 2006; Zarate et al., 2008) in the cardiac
interstitium.
As mentioned above, despite different pathophysiological events can lead
to a common process designated cardiac remodeling, it can assume distinctive
forms. For example, in the early stages of infarct healing, fibroblasts become pro-
inflammatory cells, producing cytokines, chemokines and proteases that delay
myofibroblast transformation until the wound is cleared from dead cells and matrix
debris. After the initial inflammatory phase of healing, fibroblasts undergo
phenotypic changes mounting the proliferative phase of healing. This stage is
characterized by the removal of pro-inflammatory signals, high proliferative activity,
migration through the provisional matrix network of the infarct, expression and
incorporation of contractile proteins in the cytoskeleton and synthesis of both
structural and matricellular ECM proteins (Shinde and Frangogiannis, 2014).
Formation of a collagen-based matrix marks the end of the proliferative phase and
sets the period for maturation, a poorly understood process that is characterized
by matrix cross-linking and progressive loss of the cellular elements. Conversely,
the non-infarcted myocardium is subjected to pressure and volume overload
causing chronic activation of the local fibroblast population. Pressure overload
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induces early activation of matrix synthetic pathways, associated with fibrosis and
diastolic dysfunction, followed by activation of matrix-degrading signals, chamber
dilatation and predominantly associated with matrix loss and cardiac dilatation.
In advanced phases of the fibrotic process, the tensile strength of collagen
increases within the site of injury (van den Borne et al., 2010). In this setting, a
subset of activated myofibroblasts acquire new phenotypic characteristics,
including the expression of the contractile protein α-smooth muscle actin (α-SMA),
and contribute to pathological cardiac remodeling (Tomasek et al., 2002;
Calderone et al., 2006). Although initially adaptive, these processes eventually
lead to the development of adverse changes in ventricular structure and
compliance, and a concurrent progression into overt heart failure.
1.1.3. Cardiac remodeling: the role of cardiac fibroblasts
Despite the pathophysiological importance of fibrosis in cardiovascular
disease, as well as the predominant functions of cardiac fibroblasts in the process,
these cells remain relatively mischaracterized and poorly understood. In fact,
cardiac fibroblasts have preponderant functions on the cardiac remodeling process,
particularly fibrosis, but also in the regulation of healthy cardiac physiology. For
instance, after an acute myocardial injury, the expression of various
proinflammatory cytokines and profibrotic factors is up-regulated in cardiac
fibroblasts, leading to increased proliferation of these cells and, ultimately, the
transition to the myofibroblast phenotype (Kawaguchi et al., 2011). During this
maturation phase, myofibroblasts, sometimes referred as hipersecretory cells,
begin to secrete increased levels of collagen (particularly, type I and III collagen)
and other ECM proteins, including fibronectin and laminin. This activated
phenotype of cardiac fibroblasts, which is not normally present in the adult heart, is
thought to derive primary from resident interstitial and adventitial fibroblasts
undergoing a phenotype switch, from bone marrow-derived circulating precursors
(fibrocytes), and from cells undergoing epithelial/endothelial-to-mesenchymal
transition (Hinz et al., 2007; Turner and Porter, 2013).
Pathological cardiac remodeling is characterized by fibroblasts
accumulation and excessive deposition of ECM proteins, which leads to distorted
organ architecture and has significant consequences on cardiac function (Weber,
2000). In addition, excess ECM and fibroblasts impair mechano-electric coupling
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of cardiomyocytes, thus reducing cardiac contraction and increasing the risk of
arrhythmogenesis and mortality (de Bakker et al., 1996; Spach and Boineau,
1997). In fact, the infiltration of myocardium with abundant myofibroblasts may
alter cardiac electrophysiology by creating a barrier that blocks propagation of the
electrical impulse, delaying conduction and promoting re-entry circuits. Thus, the
dynamic phenotypic alterations of the fibroblast population following an infarction
may profoundly influence arrhythmogenesis through several distinct mechanisms:
secretion of pro-inflammatory mediators that may exert paracrine effects on
cardiomyocytes, modifications of the expression of connexion-containing gap
junctions, and incorporation of α-SMA into the fibroblast cytoskeleton thus
contributing to arrhythmogenicity. Although fibrosis is strongly associated with an
elevated risk of arrhythmogenesis, it is not well understood how exactly it is
involved in either the active generation or the passive maintenance of abnormal
electrical conduction episodes. Usually, the effect of connective tissue on cardiac
electrophysiology is attributed to its non-excitability resulting in an electrical
insulation of some areas of the heart. However, some clinical observations
suggest that fibrotic tissue is not necessarily always and exclusively an electrical
insulator. In fact, all aged hearts develop some degree of fibrosis (Biernacka and
Frangogiannis, 2011), and one may wonder, therefore, why these do not appear to
be arrhythmogenic suggesting the possibility of trans-scar conduction of electrical
signals. These findings are in line with the concept of ‘very much alive’ scars of the
heart, previously discussed. Furthermore, inflammation and fibrosis within
perivascular regions may decrease tissue availability to oxygen and nutrients and,
thus, increase the pathological remodeling response (Kai et al., 2006).
Another consideration is the importance of cell-cell communications as an
integral feature of their behavior and function. In fact, cardiac fibroblasts do not
operate in isolation but, on the other hand, these cells are particularly responsive
to mechanical and chemical stimuli induced upon cardiac injury, which enhances
the production and secretion of various pro-inflammatory and pro-fibrotic cytokines,
growth factors, and chemokines (Kakkar and Lee, 2010). The released mediators
act in both autocrine and paracrine fashions to modulate local inflammatory cells,
cardiomyocytes, and cardiac fibroblasts themselves to exacerbate pathologic
remodeling. In fact, many studies show that fibroblasts actively modulate the
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structure and function of cardiomyocytes through different pathways: direct cell
contact, via ECM proteins, and by the release of soluble mediators (Camelliti et al.,
2005; Kakkar and Lee, 2010). On the other hand, cardiac fibroblasts activation and
ECM proteins deposition may be affected by a number of humoral factors
produced by other cell types including angiotensin II (AngII), endothelin-1 (ET-1),
transforming growth factor β (TGF-β), fibroblasts growth factor 2 (FGF-2), and
insulin-like growth factor 1 (IGF-1) (Bouzegrhane and Thibault, 2002; Manabe et
al., 2002; Bujak and Frangogiannis, 2007).
1.2. Cardiac fibroblasts
1.2.1. Cardiac fibroblasts: origin, characteristics and function
Fibroblasts are mesenchymal cells, abundantly distributed in connective
tissues of most organs that traditionally are viewed as matrix-producing cells which
become activated following injury and participate in fibrotic tissue formation.
Fibroblast cells are phenotypically diverse, and experimental evidence has
demonstrated the existence of considerable heterogeneity between fibroblasts
from different tissues (Camelliti et al., 2005). In what concerns cardiac fibroblast
characteristic morphology identifiers, we may emphasize the lack of basement
membrane and the presence of multiple elongated cytoplasmic processes or
sheet-like extensions (Rog-Zielinska et al., 2016). However, their cellular
characteristics also depend on their developmental stage and physiological
conditions (Fries et al., 1994; Lekic et al., 1997). On the other hand, as fibroblasts
are pleomorphic by nature, there is no defined threshold at which ‘a fibroblast
becomes a myofibroblast’ because increased contractile filament content does not
transform a fibroblast into a different cell type, and myofibroblasts do not have
unique lineages separate from fibroblasts. In fact, the actin or myosin content and
arrangement in cardiac fibroblasts can be affected by the environment, in
particular mechanical parameters. Given that, some authors consider that the
application of the term ‘myofibroblast’ may be more misleading than helpful
(Camellitti et al., 2005).
Focus on cardiac fibroblast cells, they represent the most predominant cell
type in cardiac tissue (about 70%) performing a variety of functions to maintain
normal physiology (Porter and Turner, 2009). Cardiomyocytes, whilst fewer in
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number, occupy the bulk volume of the myocardium and are contractile cells that
provide mechanical force that is transmitted throughout ECM network. The most
described function of cardiac fibroblasts is the maintenance of ECM homeostasis
in the normal heart. To perform this function, the major constituents are the fibrillar
collagens I (~80%) and III (~10%), with smaller amounts of collagens IV, V, VI,
elastin, laminin, proteeoglycans, glycosaminoglycans, and others (Bosman and
Stamenkovic, 2003). This process of regulation of ECM is achieved by the
alternation of synthesis and degradation cycles.
One reason that leads to deficiency in the studies about cardiac fibroblasts
is because of a lack of consistent cardiac fibroblast-cell markers. In fact, the
absence of comprehensive markers has inhibited our ability to study the complex
interactions between cardiac fibroblasts and the surrounding cells in vivo. An
example of this is the intermediate filament protein, vimentin, which is often used
as a fibroblasts marker, but it is expressed in many cell types including endothelial
cells (Lane et al., 1983). Other molecules, such as CD90 (Thy1), Fibroblasts
Specific Protein 1 (FSP1), platelet-derived growth factor-α (PDGF-α) and Periostin
have been used as cardiac fibroblasts markers. However, several studies
demonstrated that these molecules are frequently more associated to other cell
types, such as immune cells, than fibroblasts (Kong et al., 2013; Moore-Morris et
al., 2014). Transcription factor 21 (TCF21), a marker of pro-epicardium among
other mesothelial populations, has also been used to identify fibroblasts in
embryonic heart (Acharya et al., 2012). No one marker encompasses the
combination of sensitivity and specificity to be definitive. In fact, there is not even a
lineage marker currently in line that is specific to cardiac fibroblasts. Among
arguably more robust markers is Discoidin Domain Receptors 2 (DDR2), also
known as CD167b, which labels fibroblasts, but not endothelium, smooth muscle
or myocytes (Goldsmith et al., 2004). The DDR2, as well as DDR1, represent a
family of receptor tyrosine-specific kinase (RTK) that binds to collagen through its
extracellular discoidin domain. These receptors have the ability to control a wide
range of cellular responses including cell growth, differentiation, migration,
metabolism and survival (Vogel et al., 1997). In what concerns the identification of
activated fibroblasts (myofibroblasts), α-SMA is still the primary marker despite it is
also expressed in vascular smooth muscle cells and pericytes, which are both
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present in close proximity to fibroblasts, blighting its ability to distinguish fibroblasts
in some cases (Zeisberg and Kalluri, 2010).
In relation to the origin of cardiac fibroblasts, there are reportedly two major
sources. Firstly, cardiac fibroblasts are thought to be predominantly derived from
the pro-epicardial organ (Manner et al., 2001). Cells from the pro-epicardium
detach and migrate over the surface of the heart to form the epicardium (Lie-
Venema et al., 2007). Subsequently epithelial cells of the epicardium undergo
epithelial-mesenchymal-transition (EMT) to form mesenchymal cells that invade
the developing myocardium (Manner, 1999). In addition, a subset of these
mesenchymal cells acquires migratory properties and invades the developing
myofascial planes to occupy an interstitial position between cardiomyocytes and to
become resident cardiac fibroblasts (Gittenberger-de Groot et al., 1998; Perez-
Pomares et al., 2002). It is also known that some fibroblasts may originate from
progenitor stem cells present in the circulation or in the heart itself. Recent
evidence has shown postnatal recruitment of circulation fibroblast progenitor cells
into the ventricular myocardium (Visconti and Markwald, 2006). Another
consideration is that following birth, the neonatal heart adapts to a sudden
increase in systolic pressure by increasing ventricular wall thickness and tensile
strength (Borg et al., 1984). This occurs as a result of a significant increase in the
number of cardiac fibroblasts together with synthesis and deposition of collagen
that provides contact between cardiomyocytes and fibroblasts, the fibroblasts
themselves or the ECM. Thus, despite the major recognized source of cardiac
fibroblasts is an epithelial layer that forms over the mid-gestation heart and is
maintained in adult (Smith et al., 2011; Acharya et al., 2012), other lineages,
including, pericytes, smooth muscle cells and, perhaps, myocytes and
endothelium (Mikaway and Gourdie, 1996; Gittenberger-de Groot et al., 1998) also
derive from epicardium. On the other hand, in contrast to cardiac fibroblasts,
valvular fibroblasts are thought to be derived from the endothelium overlying the
region of the atrio-ventricular valve formation (Markwald et al., 1977; Eisenberg et
al., 1995). The endothelium overlying the valve leaflets undergoes endothelial-
mesenchymal-transition (EndMT) to generate cardiac fibroblasts that invade the
valvular mesenchyme and contribute to the collagenous structure of the valve.
Finally, a small subset of fibroblasts within myocardium, mostly found in the right
atrium, appear to be derived from the neural crest. These cells represents a very
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heterogeneous population derived from the dorsal aspect of the neural tube and
giving rise to various lineages including neurons, melanocytes and mesenchymal
cells (Le Douarin et al., 2012).
The origin of fibroblasts constituting fibrotic lesions in failing hearts has
been controversial. However, it is important to understand cardiac fibroblasts
origin given that these cells are involved in several heart disease complications,
such as myocardial fibrosis. Thus, the potential to limit or modulate their
proliferation or their derivation from other cells is an attractive therapeutic option.
As an example, inhibition of fibroblast formation from other cellular sources such
as endothelial cells via EndMT appears even more attractive because EndMT and
bone marrow-derived fibroblasts within the myocardium are exclusively associated
with pathological conditions, but not present in the normal heart.
As we can see, from birth to death, heart changes in a dynamic fashion
regarding its basic constituents, cell types and extracellular matrix. In fact, in the
rat heart, cardiac fibroblasts constitute approximately 30% of the total number of
heart cells on the first day of life. Conversely, by the 15th day of postnatal life,
these cells comprise approximately 2/3 of the total numbers of cells in the rat heart
(Zak, 1974; Banerjee et al., 2007). Similarly, in humans, non-myocyte cells also
comprise approximately 70% of the total number of cardiac cell types (Camelliti et
al., 2005). These findings support the idea that caution must be taken in
interpreting data obtained in developmentally immature cells when one wants to
extrapolate the results to adulthood (Porter and Turner, 2009).
In the heart, cardiac fibroblasts are arranged in sheets and strands that run
in parallel with muscle fibers and maintain continuity between cells in the different
layers of the myocardium (Kohl et al., 2005). Thus, cardiac fibroblasts provide a
structural scaffold for cardiomyocytes, distributing mechanical forces through the
cardiac tissue, and mediating electric conduction (Camelliti et al., 2005; Souders et
al., 2009). Due to their abundance, their strategic location and potential for
activation, cardiac fibroblasts may serve as sentinel cells that sense myocardial
injury and trigger inflammatory and reparative responses (Shinde et al., 2014).
Although cardiac fibroblasts are the predominant interstitial cells in normal
mammalian myocardium, their function in cardiac homeostasis remains poorly
understood. Cardiac fibroblasts are known to have a leading role in the synthesis
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and degradation of extracellular matrix of the heart (Camelliti et al., 2005). These
cells synthesize fibrillar collagen types I and III, as a precursor polypeptide that is
processed subsequently to a mature form of collagen, and interstitial collagen
types IV, V and VI, which are less abundant (Fan et al., 2012). However, these
cells are not only responsible for extracellular matrix production, they also
contribute to structural, mechanical, electrical and biochemical properties of the
heart (Krenning et al., 2010). In fact, cardiac fibroblasts respond differently to
environmental stimuli with differentiation into myofibroblasts, proliferation,
migration, cytokines and growth factors secretion, and extracellular matrix
modifications (Porter and Turner, 2009). The possibility that cardiac fibroblasts
may also contribute actively to cardiac electrophysiology has emerged only
recently. Cardiac fibroblasts have a high cell membrane resistance, which makes
them good conductors for electrical signals (Kohl, 2003). In addition, these cells
are coupled to cardiomyocytes through gap junctions containing connexin-43 and
connexin-45 (Kohl, 2003) and recent in vitro evidence showed that this coupling
allows for electrical signal transmission (Miragoli et al., 2006). Interconnectivity
between cardiomyocytes and fibroblasts may provide synchronization of
spontaneous activity in distant cardiac myocytes (Rohr, 2004). Another active
contribution of cardiac fibroblasts to cardiac electrophysiology may be found as
they exhibit mechano-sensory properties. Cardiac fibroblasts express multiple
stretch-activated ion channels that are permeable to Na+, K+ and Ca2+ (Hu and
Sachs, 1997). In response to mechanical stimuli, imposed by contractile activity of
the surrounding myocardium, these ion channels open and lower fibroblast
membrane potential making the fibroblast an efficient mechano-electrical
transducer (Kamkin et al., 2003). In fact, despite cardiac fibroblasts are electrically
non-excitable, it is important to recognize that they contain an array of ion
channels, exchangers, and pumps. Examples include voltage-gated K+ channels,
chloride channels, voltage-gated proton channels, sodium/calcium exchangers,
sodium/potassium ATPases, and stretch-activated channels. As an example, we
may appoint to the recently described transient potential receptors (TRP) TRPM7
(Guo et al., 2014), TRPV4 (Adapala et al., 2013), and TRPC6 (Davis et al., 2012),
that will be described with more details later in this manuscript.
Another consideration is that structural flexibility of fibroblasts and their
ability to release soluble mediators (e.g. ATP, UTP) in response to mechanical
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perturbation, associated with a favorably location in the heart, make these cells
preferential in propagation/amplification of signals. As already mentioned,
interactions between cardiac fibroblasts and cardiomyocytes are mostly mediated
via paracrine factors such as cytokines or growth factors, direct cell-cell contacts
via gap junctions or through indirect interactions via extracellular matrix proteins.
Both cell types can produce and secrete a number of different chemokines,
cytokines, and growth factors. In addition, ATP can also act in a paracrine manner
on early fibroblast activation in ischemic hearts (Dolmatova et al., 2012). During
cardiac stress, ATP is released from cardiomyocytes via pannexin 1 (Panx 1)
channels which led to fibroblasts conversion into activated myofibroblasts via the
activation of mitogen-activated protein kinase (MAPK) and p53 signaling pathways
(Dolmatova et al., 2012). Other paracrine factors include nucleic acids such as
regulatory RNA or DNA, which can act as paracrine signaling mediators between
cells (Hergenreider et al., 2012; Halkein et al., 2013). In addition, recent studies
demonstrated the importance of secreted exosomes for cardiovascular biology
(Sluijter et al., 2014). Thus, to develop promising strategies for the treatment of
heart failure it is important to consider both cell types, not separate from each
other, but as a collaborative network.
Finally some considerations must be taken in what concerns cardiac
fibroblasts in culture. Because fibroblasts in normal myocardium are evolved within
densely packed cardiomyocytes, a direct investigation of their function in situ is
extremely difficult. However, when interpreting results from studies with fibroblasts
kept under standard two-dimensional culture conditions, it is important to know
that they normally undergo a rapid phenotype switch to myofibroblasts. In fact,
there is vast consensus that the rigidity of the substrate for standard two-
dimensional culture systems is of core importance for phenotype switch induction.
In addition to the mechanical cues offered to the adhering cells by the culture
substrate, the phenotype switch is also controlled by cytokines and growth factors
among which TGF-β1 has the most prominent role. Because cultured fibroblasts
secrete TGF-β1 and simultaneously express the respective receptors, these
molecules may have an autocrine effect, contributing to their own phenotype
switch.
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1.2.2. Cardiac fibroblasts: calcium dynamics
The calcium ion (Ca2+) is an intracellular messenger that controls a wide
range of cellular processes, such as gene transcription, metabolic processes,
signal transduction, contraction, proliferation and differentiation (Resende et al.,
2013). In most cells, Ca2+ has its major signaling function when it is elevated in the
cytosolic compartment, where it can diffuse into organelles such as mitochondria
and the nucleus. The intracellular calcium concentration increase is dependent on
two mechanisms: calcium influx from the plasma membrane or release from
intracellular stores, such as the endoplasmic reticulum (Patergnani et al., 2011).
In what concerns cardiac fibroblasts, the electrophysiological properties of
these cells will influence their ability to exhibit excitation-secretion coupling,
fibroblasts-cardiomyocytes coupling as well as fibroblast-fibroblast interactions
(Yue et al., 2013). Despite it is not fully understood which channels determine
resting membrane potential in cardiac fibroblasts, it was reported that the resting
membrane potential of cardiac fibroblasts in situ is between -31 and -16 mV
(Kamkin et al., 1999; 2003). Thus, it is less negative than that of cardiomyocytes
(roughly -70 to -80 mV, for atrial cardiomyocytes).
Now, we will briefly describe some findings on calcium dynamics of cardiac
fibroblasts. In 1996, Kiseleva and colleagues demonstrated, for the first time, the
importance of Ca2+ in fibroblasts biology. Their work demonstrated that Ca2+ entry
through stretch-activated channels located in the plasma membrane and Ca2+
release from the endoplasmic reticulum play key roles in the generation of a
mechanical-induced-potential in rat cardiac fibroblasts (Kiseleva et al., 1996).
Other studies demonstrated that Ca2+ signals are essential for diverse cellular
functions including differentiation, gene expression, cell proliferation, growth, and
death (Berridge et al., 2003). For instance, in rat cardiac fibroblasts, chelating
external Ca2+ by EGTA has shown to prevent substance P-induced proliferation
(Shivakumar et al., 2001). In addition, it has been also described that intracellular
Ca2+ changes contribute to AngII-induced proliferation of cardiac fibroblasts (Olson
et al., 2008).
Some authors argued that cardiac fibroblasts lack voltage-gated Ca2+
channels (Kohl and Noble, 1996). However, in what concerns L-type Ca2+
channels, this issue is at least controversial. Some authors claim that cardiac
fibroblasts do not exhibit L-type Ca2+ currents (Kohl and Noble, 1996; Kamkin et al.,
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1999), while others demonstrate the existence of L-type calcium channels and
their involvement on TGF-β1- and Smad2-dependent protein synthesis in these
cells (Lei et al., 2011). Moreover, an in vivo study showed that mibefradil, a non-
selective L- and T-type Ca2+-channel blocker, reduced collagen production and
fibroblast differentiation in rats treated with AngII or aldosterone (Ramires et al.,
1998).
Another important consideration is the existence of the previously
mentioned TRP channels in cardiac fibroblasts. TRP channels are responsible for
Ca2+ entry in various cell types (Montell, 2005; Nilius, 2007) and they are not
voltage-gated channels, but are activated by a variety of stimuli including
membrane-receptor stimulation, oxidative stress, mechanical stretch, cell-
metabolite accumulation, and thermal or sensory stimuli (Montell, 2005; Nilius,
2007). In fact, TRP channels are highly expressed in the heart. In what concerns
cardiac fibroblasts, TRPC1-3 and TRPC5-7 mRNA were detected in rat species by
RT-PCR, and the presence of TRPM7-like (Runnels et al., 2002) and TRPV4
currents were demonstrated by whole-cell current recordings. Nishida and
colleagues reported the presence of TRPC1, TRPC3, TRPC6, and TRPC7 in rat
cardiac fibroblasts (Nishida et al., 2007). In cultured human cardiac fibroblasts,
TRPC1, TRPC4, and TRPC6 were found to be abundantly expressed at mRNA
levels (Chen et al., 2010). TRPC1, TRPC4, TRPC6, TRPV2, TRPV4, TRPM4, and
TRPM7 mRNA are expressed in human atrial fibroblasts (Du et al., 2010). These
channels have been involved in numerous cellular functions and in the
pathophysiology of many diseases in the cardiovascular systems and, thus, may
become potential therapeutic targets.
1.2.3. Cardiac fibroblasts as therapeutic targets
Despite the numerous signaling pathways implicated in the activation of
cardiac fibroblasts and in the pathological remodeling of the heart, currently exist
limited clinical intervention that effectively target this cell type and its pathological
contributions to disease progression. On the other hand, the actions of certain
pharmacological approaches may be mediated, at least in part, through effects on
fibroblasts. For example, the treatment with angiotensin-converting enzyme
inhibitors and AT1 receptor blockers reduces mortality and has protective effects
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on the development of heart failure. Despite, the classical described action
mechanism not include, usually, the effects on cardiac fibroblasts population, we
learned that these effects are associated with attenuated cardiac fibrosis. In
addition, aldosterone antagonism in patients with acute anterior myocardial
infarction attenuates remodeling, reducing plasma levels of pro-fibrotic markers.
However, because these approaches have multiple other effects on different cell
types, the extent to which their anti-fibrotic actions are responsible for the
observed clinical benefits is unknown.
As mentioned early, cardiac fibroblasts have an important role on structure
and function of the myocardium contributing to structural, biochemical, mechanical
and electrical characteristics of cardiac function (Camelli et al., 2005). Because the
absence of contractile capacity on cardiac fibroblasts, these cells are
underestimated. However, their placement outside the contractile machinery can
be an advantage. Thus, cardiac fibroblasts would offer a different modality of
mechano-receptive signals and, by direct gap-junctional coupling with other
fibroblasts and/or adjacent cardiomyocytes, have the potential to affect
electrophysiology. Therefore, it is important to remember that the modulation of
these cells may present potentially novel therapeutic targets or strategies for the
treatment of progressive heart diseases.
Despite countless findings suggesting novel pathways of physiological and
pathophysiological modulation of myocardial performance by cardiac fibroblasts,
several important details in these mechanisms are still missing. The knowledge
about the signaling mechanisms that regulate cardiac fibroblast functions, the
distinctive properties of these cells, the ability to integrate many stimuli through
receptor-specific signaling pathways as well as the diversity of endpoint responses,
may provide very important insights to the development of new drugs for the
treatment of heart diseases.
In addition, another area of increasing research is the study of mechanisms
underlying intercellular communication in normal and failing hearts. As mentioned
above, the homeostatic maintenance of heart physiology and/or remodeling
processes involve intercellular communication between cardiomyocytes,
fibroblasts, endothelial or immune cells. Thus, modulation of these processes by
intervention at different stages of these mechanisms may also contribute to novel
therapeutic approaches.
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1.3. Purinergic signaling
1.3.1. Purinergic signaling: an overview
The term ‘purinergic signaling’ was coined for the first time by Geoffrey
Burnstock who described the finding that the principal active substrate released
from nerves was the purine nucleotide adenosine triphosphate (ATP) (reviewed by
Abbracchio et al., 2009). In fact, until then, ATP was commonly conceptualized as
the currency of intracellular energy metabolism as well as a component of nucleic
acids. Since then, nucleotide signaling was found to be involved in many different
cell types and tissues and it was established a role for ATP outside the cell as an
intercellular messenger as well (Hattori and Gouaux, 2012). After these findings, it
was demonstrated that ATP may act either as a co-transmitter or a sole transmitter
in most nerves in the peripheral and central nervous systems (Abbracchio et al.,
2009; Burnstock et al., 2011).
Intracellular ATP is synthesized via complex mechanisms to maintain or
rapidly restore the intracellular level (Gordon, 1986). Thus, intracellular ATP
concentrations in eukaryotic cells are high (3–10 mM) and it can be concentrated
at even higher concentrations (up to 100 mM) inside synaptic vesicles (Burnstock,
2007) compared to very low physiological extracellular concentrations (400–700
nM) (Dubyak, 1991; Dubyak and El-Moatassin, 1993; Bours et al., 2006).
Consequently, in normal resting conditions, there is a constant efflux of ATP,
which is balanced by its extracellular enzymatic breakdown (Schwiebert, 1999;
Lazarowski et al., 2003). The low concentration is achieved by several
mechanisms like minimal permeation of cytosolic ATP across lipid bilayers, and
due to ubiquitous ectoenzymes that hydrolyze extracellular nucleotides. This
ensures that putative signaling agents, like ATP, are only transiently present and
only in response to specific physiological and/or pathological situations (Dubyak
and El-Moatassin, 1993; Dubyak, 1991). Under these situations, ATP may be
release by several mechanisms that will be discussed later. Thus, once released
into extracellular medium, these low micromolar ATP concentrations can affect a
variety of biological processes in various cells and tissues (Gordon, 1986; Dubyak
and El-Moatassin, 1993), like platelet aggregation, neurotransmission, cardiac
function and muscle contraction (Gordon, 1986).
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Extracellular ATP exerts its effects by binding to purinergic receptors, which
were first defined in 1976 (Burnstock, 1976). Several studies demonstrated that
cells are able to release purines and pyrimidines to the extracellular medium. In
fact, extracellular nucleotides have been implicated in a wide range of biological
processes as smooth muscle contraction, inflammation, platelet aggregation and
pain, but also, which is most relevant to this study, in the fibrosis process
(Burstock, 2006). Despite the fact that the potent biological action of ATP on most
cell types is well established, the source of extracellular ATP, the mechanism by
which cells release the nucleotide, the biochemical mechanisms regulating the
amount of these molecules within the heart or even the cell types involved are still
a matter of debate and also inclined for pharmacological manipulation.
An important consideration to take into account is that purinergic signaling
is not only a set of ligands and receptors, but a complex and dynamic system
consisting of nucleotide channels and transporters, enzymes and purinoceptors,
which are designated by the term ‘purinome’ (Volonté and D’Ambrosi, 2009). Each
component of the system will be explained in detail later on. The complex
cooperation between the different constituents of the purinome enables the
transfer of information and its extracellular processing contributes as a whole (not
alone) for triggering, maintaining and closing of purinergic signaling. This
coordination between the various compartments leads to the activation of specific
receptors, ending their signaling pathways by enzymatic metabolism or uptake
systems (Volonté and D'Ambrosi, 2009). Thus, with the purinome concept it
becomes evident that cooperation and molecular dynamics are responsible for
several physiological mechanisms. Changes on the global and dynamic balance
can be responsible for the emergence or spread of disease states (Volonté and
D'Ambrosi, 2009).
1.3.2. Purines and pyrimidines: releasing pathways
The release of endogenous nucleotides represents a critical component for
initiating a signaling cascade and it may occur by several mechanisms. Massive
escape of nucleotides might occur upon cell lysis, however this nonspecific
mechanism is restricted to organ injury, traumatic shock or certain inflammatory
conditions (Bours et al., 2006). Non-lytic mechanisms of nucleotide efflux
represent a distinct and important route of nucleotide appearance in the
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extracellular milieu (Figure 1A). On other hand, it is also known that various
excitatory/secretory tissues store purines, like ATP and ADP, together with other
neurotransmitters and extracellular mediators, in specialized granules, and
regulate the release of nucleotide-containing vesicles in a Ca2+-dependent manner
via regulated exocytosis (reviewed by Yegutkin, 2008) (Figure 1D). Moreover,
various cells release low nanomolar concentrations of ATP at certain basal rates
(Lazarowski et al., 2000; Abbracchio et al., 2006) and distinctive mechanisms
could underlie constitutive versus stress-stimulated nucleotide release. The
diversity of conditions in which the cells release nucleotides suggests the
implication of multiple nucleotide releasing pathways. The proposed cellular
mechanisms might include electrodiffusional movement through membrane ion
channels, including connexin hemichannels, stretch- and voltage activated
channels (Figure 1B); facilitated diffusion by nucleotide-specific ATP-binding
cassette (ABC) transporters (Figure 1C), and cargo-vesicle trafficking and
exocytotic granule secretion (Figure 1D).
Figure 1 - Schematic representation of different mechanisms of ATP release: (A) Cell damage; (B)
ATP release channels; (C) Nucleotide transporters; (D) Vesicular exocytosis; (E) Pericellular ATP
halo.
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1.3.3. Purines and pyrimidines: metabolic pathways
Like all signaling pathways, purinergic signaling requires mechanisms that
can inactivate the signaling cascade (Kegel et al., 1997; Zimmermann, 2000) and
define the endpoint of response. Thus, to remove or inactivate extracellular
signaling molecules, they can be taken up by the cell or be hydrolyzed by
ectonucleotidases. In addition, purinergic receptors can also be desensitized or
down regulated contributing to the termination of response.
After released, ATP and the other nucleotides may be hydrolyzed
extracellularly by a cascade of plasma membrane-bound enzymes -
ectonucleotidases - resulting in the formation of the respective nucleoside and free
phosphates. The cleaved off phosphate can be recycled and used for nucleotide
resynthesis and the nucleosides can be taken up by the cell via specific
transporters and rephosphorylated intracellularly (Zimmerman et al., 2000). In
addition to the role of ectonucleotidases in the control of ATP (and UTP)
responses, this pathway can lead to the production of biologically-active
derivatives as well (Zimmermann, 2000).
In this context, in addition to ADP and ATP, another important molecule,
adenosine, appears in the extracellular milieu either via direct release via
nucleoside transporters or as result of the breakdown of ATP/ADP via the
ectonucleotidase cascade. In fact, the extent of the paracrine activity mediated by
ATP/UTP (and related purines and pyrimidines) may be limited by the presence of
ectonucleotidases, which sequentially degrade nucleoside 5’-triphosphates to their
respective nucleoside 5’-di- and monophosphates, nucleosides and free
phosphates or pyrophosphate (Robson et al., 2006). These enzymes have distinct
biochemical properties.
According to substrate specificity and products formation,
ectonucleotidases are divided into four major families (Abbracchio et al., 2009):
ectonucleoside triphosphate diphosphohydrolases (E-NTPDases), ectonucleotide
pyrophosphatase and/or phosphodiesterases (E-NPPs), alkaline phosphatases,
and ecto-5’nucleotidase (CD73). E-NTPDases and E-NPPs hydrolyze ATP and
ADP. In particular, E-NTPDase1 hydrolyzes ATP and ADP equally well, E-
NTPDase2 preferentially hydrolyzes triphophonucleosides, and E-NTPDase3 has
an intermediate hydrolysis profile (Kukulski et al., 2005). The hydrolysis of tri- and
diphosphonucleosides by NTPDases yields AMP as final products that can be fully
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dephosphorylated to adenosine by ecto-5’-nucleotidase (Colgan et al., 2006).
Alkaline phosphatases equally hydrolyze nucleoside tri-, di- and monophosphates.
In what concerns dinucleoside polyphosphates, nicotinamide adenine nucleotide
(NAD+) and uridine diphosphate/UDP sugars, are substrates exclusively for E-
NPPs (Abbracchio et al., 2009).
Figure 2 - Schematic representation of ATP metabolism, inside and outside of the cell.
Furthermore, uracil nucleotides (UTP and UDP) can also be released as
extracellular signaling molecules. It has been described that various cells types
release low nanomolar UTP concentrations (reviewed by Yegutkin, 2008).
Moreover, studies with murine airway epithelial cells transfected with the P2Y4
receptor also demonstrated significant UTP release from mechanically stimulated
cells, which, in turn, contributes to the generation of Ca2+ waves and coordination
of the integrated epithelial stress response (Homolya et al., 2000). Thus, all these
molecules, extracellular purines (adenosine, ADP, and ATP) and pyrimidines
(UDP and UTP), are important signaling molecules that mediate diverse biological
effects through the activation of purinergic receptors that will de described in the
next section.
1.3.4. Purinergic receptors
As already mentioned, purinergic receptors were first described by G.
Burstock in 1976 and they can now be categorized into two major groups: those
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responding preferentially to adenosine (P1 receptors) and those responding to
ATP/UTP/ADP/UDP (P2 receptors) (Burnstock, 2006) (Figure 3).
There are four types of membrane-bound adenosine P1 receptors: A1, A2A,
A2B and A3 receptors, each encoded by separate gene and with different functions,
despite some common characteristics.
Figure 3 - Schematic representation of the three different families of purinergic receptors:
metabotropic P1 receptors, ionotropic P2X receptors and metabotropic P2Y receptors.
P1 receptors are G-protein coupled receptors (GPCR) composed of seven
transmembrane domains, an extracellular N-terminus and an intracellular C-
terminus (Figure 3). The A1 and A3 receptors couple to Gi protein and inhibit
adenylate cyclase, leading to a decrease in cellular cAMP levels, while A2A and
A2B receptors couple to Gs proteins, stimulate adenylate cyclase and consequently
leading to an increase in cellular cAMP levels (Moro et al., 2006). Additionally, to
the adenylate cyclase coupling, all four subtypes may positively couple to
phospholipase C via different G protein subunits (Moro et al., 2006). The primary
and secondary transduction mechanisms as well as the main agonists and
antagonists of the receptors are summarized in the Table 1.
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Table 1 - Characteristics of P1 receptors.
Receptor Endogenous
ligand
Transduction
mechanisms
Agonists Antagonists
A1
Adenosine
Primary:
Gi/Go→ AC inhibition
Secondary:
Gs→ AC stimulation
Gq/G11→ PLC stimulation
Adenosine, CCPA, R-
PIA, NECA
DPCPX, CGS15943,
CPT, FR194921,
WRC-0571, XAC, N-
040, MRS1754
A2A
Primary:
Gs→ AC stimulation
Secondary:
Gq/G11→ AC stimulation
and PLC activation
Adenosine, ATL146e,
CGS21680, CV-1808,
IAB-MECA, NECA
CGS15943,
MRS1093,
SCH58261,
ZM241385, KF17837
A2B
Primary:
Gs→ AC stimulation
Secondary:
Gq/G11 → PLC activation
Adenosine, NECA
AS99, AS101,
MRE2029-F20,
MRS17541,
OSIP339391, XAC
Enprofylline
A3
Primary:
Gi/Go→ AC inhibition
Secondary:
Gi/Go→ PLC stimulation
Adenosine, I-ABA, IAB
MECA, IB-MECA,
NECA, 2-CI-IB-MECA
MRS1177, MRS1220
MRE3010F20,
VUF8504, L-268605,
MRS1191, MRS1523
Adapted from IUPHAR and Burnstock (2007)
The P2 receptors were subdivided into two major families, a P2Y family of
G protein-coupled receptors and a P2X family of ligand-gated ion channel
receptors, based on their mechanism of action, pharmacology and molecular
cloning (Ralevic and Burnstock, 1998; Abbracchio et al., 2009). Currently, seven
subtypes of the P2X family and eight subtypes of the P2Y family have been cloned
and functionally characterized (reviewed by Burnstock, 2006).
Members of the existing family of ionotropic P2X1–7 receptors are
designated according to the historical order of cloning and show the following:
intracellular N- and C-termini, two transmembrane domains, a large extracellular
loop, with 10 conserved cysteine residues forming a series of dissulphide bridges
and an ATP-binding site, which may involve regions of the extracellular loop
adjacent to transmembrane domains.
The transduction mechanisms as well as the main agonists and antagonists
of the receptors are summarized in the Table 2.
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Table 2 - Characteristics of P2X receptors.
Receptor Endogenousligand
Transduction
mechanisms Agonists Antagonist
P2X1
ATP
Ion channel
(Ca2+ and Na+)
ATP,α,β-MeATP, 2-
MeSATP IP5I, NF023, NF449,TNP- ATP
P2X2 Ion channel(mainly Ca2+) ATP, ATP
γS
isoPPADS, NF279,
NF770, RB-2, suramin
P2X3 Intrinsic ion channel ATP, 2-MeSATP A317491, IP5I, NF110,PPADS, TNP-ATP,
RO-85
P2X4 Ion channel(mainly Ca2+) ATP, α,β-MeATP,Ivermectin potentiation
Coomassie blue, TNP-
ATP
5-BDBD, BBG
P2X5 Intrinsic ion channel (Cl-) ATP, α,β-MeATP, 2-
MeSATP, ATPyS
Coomassie blue,
PPADS, suramin,
BBG
P2X6 Intrinsic ion channel - -
P2X7 Intrinsic ion channel and apore ATP, BzATP
KN62, KN04,
MRS2427, O-ATP, A-
438079, A-740003
Adapted from IUPHAR and Burnstock (2007)
The P2Y receptors also belong to the GPCR family and share a common
topology: seven transmembrane domains and an extracellular N-terminus and an
intracellular C-terminus (Figure 3). These receptors show a high level of sequence
homology between some transmembrane domains but, on the other hand, a
structural diversity of intracellular loops and C-terminus among P2Y subtypes, thus
influencing the degree of coupling with Gq/11, Gs and Gi proteins. Each P2Y
receptor binds to a single heterotrimeric G protein (typically Gq/11), although P2Y11
can couple to both Gq/11 and Gs, whereas P2Y12, P2Y13 and P2Y14 couple to Gi
proteins P2Y receptors may form homo- and heteromultimeric assemblies under
some conditions, and many cells express multiple P2Y receptor subtypes.
Some P2Y receptors are activated mainly by nucleoside diphosphates
(P2Y1,6,12,13), while others are activated mainly by nucleoside triphosphates
(P2Y2,4). Some P2Y receptors are activated by both purine and pyrimidine
nucleotides (P2Y2,4,6,11), and others by purine nucleotides alone (P2Y1,12,13). In
response to nucleotide activation, recombinant P2Y receptors either activate
phospholipase C and release intracellular calcium or affect adenylyl cyclase and
alter cAMP levels. Besides the described characteristics of purinergic receptors, it
is important to note that the pharmacological properties of nucleotides may be
different depending on the species activating different signaling pathways.
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The primary and secondary transduction mechanisms as well as the main
agonists and antagonists of the receptors are summarized in the Table 3.
Table 3 - Characteristics of P2Y receptors.
Receptor Endogenousligand
Transduction
mechanisms Main agonists Main antagonist
P2Y1 ADP>ATP
Primary:
Gq/G11 → PLC activation
Secondary:
Gi/Go family → Ion
channel (K+ and Ca2+)
ADP, 2-MeSADP,
ATP, ATPγS
MRS2365, ADPβS
2-ClATP, 2-MeSATP,
MRS2179, MRS2279,
MRS2500
P2Y2 UTP=ATP
Primary:
Gq/G11→ PLC activation
Secondary:
Gi/Go family;
G12/G13 family
ATP, Ap4A, UTP,
UTPγS, 2-thio-UTP
ARC126312, suramin,
RB-2
P2Y4 UTP>ATP
Primary:
Gq/G11 → PLC activation
Secondary:
PLA2 stimulacion
ATP, Up4U, Up4dC,
UTP PPADS, RB-2, suramin
P2Y6 UDP>>UTP>ATP
Primary:
Gq/G11→ PLC activation
Secondary:
G12/G13 → AC
stimulation
MRS2693, UDP,
UDPβS, Up3U, 3-
Phenacyl-UDP
MRS2567, MRS2575,
MRS2578, RB-2
P2Y11 ATP>UTP
Primary:
Gq/G11 → PLC activation
Secondary:
Gs→AC stimulation
ARC67085, ATP,
ATPγS, BzATP,dATP
5'AMPS, NF157, NF340,
RB-2, suramin
P2Y12 ADP>>ATP
Primary:
Gi/Go→ AC inhibition
Secondary:
Gi/Go→ AC inhibition
ADP, ADPβS, 2-
MeSADP, 2-MeSATP
AZD6140, BX667,
Cangrelor, Clopidogrel,
INS50589, AR-
C66096, CT50547,
PSB0413, ARL66096
P2Y13 ADP>>ATP Primary:
Gi/Go→ AC inhibition
ADP, ADPβS, 2-
MeSADP, 2-MeSATP
Ap4A, Cangrelor,
2-MeSAMP,
MRS2211,
MRS2603, RB-2
P2Y14 UDP-glucose
Primary:
Gi/Go→ AC inhibition
Secondary:
Gi/Go→ PLC stimulation
UDP, UDP-galactose,
UDP-glucuronate,
UDP- glucose
UDP
Adapted from IUPHAR and Burnstock (2007)
1.4.Purinergic signaling in the heart
1.4.1. Purinergic signaling in the heart: an overview
Since the pioneering work of Drury and Szent-Gyorgyi (1929) on the effects
of the adenine compounds in the heart (Drury and Szent-Gyorgyi, 1929), an ever
increasing number of studies have been published in this area. Over the years,
various aspects of purinergic signaling have been issued, including: physiological
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roles of cardiac P2X and P2Y receptors, roles of adenosine in health and disease,
effects of ATP and adenosine on coronary myocytes and purine degradation
pathways in the myocardium (reviewed by Burnstock and Pelleg, 2015). Despite
the existence of all these works, there is still a lack of information on the purinergic
signalling mechanisms at cellular and molecular levels.
In the cardiac territory, cardiomyocytes, endothelial cell, smooth muscle
cells and fibroblasts may all release nucleotides (purines and pyrimidins) that,
under pathological situations, may assume particular relevance (Shryock and
Belardinelli, 1997). In fact, these released nucleotides may work as autocrine
and/or paracrine mediators leading to activation of surrounding cells via many
subtypes of purinergic receptors (Burnstock et al., 2006). Questions still remain
about the signaling mechanisms involved in the release, maintenance and
termination of the signal.
Concerning the discoveries about purinergic signaling in the heart, one may
emphasize the effect of ATP in heart’s physiology. It is well established that there
are several sources of ATP in the heart, both in physiological and pathological
conditions. Despite ATP and other adenine compounds are often stored with
sympathetic amines in nerve endings (Meldrum and Burnstock, 1983), several
studies demonstrated that these nucleotides may also come from ischemic
cardiomyocytes, erythrocytes, platelets, apoptotic cells, inflammatory cells, smooth
muscle cells or endothelial cells (Forrester and Williams, 1977; Pearson and
Gordon, 1979; Clemens and Forrester, 1981; Fredholm et al., 1982; Gordon, 1986;
Vial et al., 1987; Christie et al., 1992; Vassort, 2001). Some authors suggested
that ATP released from nerve terminals appears to be functionally important in the
pacemaker region because some the effects of sympathetic nerve stimulation,
including tachycardia, can be reproduced by ATP application. In addition, the early
stage of tachycardia can be deleted after P2 receptors desensitization (Bramich et
al., 1990). Thus, ATP released from sympathetic nerves can increase cardiac
contractility acting in an additive or synergistic fashion with β1 receptors. Several
effects of ATP in the cardiovascular system were described: negative or positive
inotropic effects depending on species, negative chronotropic and dromotropic
effect and anti-hypertrophic myocardial effect (Vassort, 2001).
Given its more widespread clinical application another relevant aspect of
purinergic signaling in the heart concerns adenosine. It is known that intravenous
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administration of this nucleoside rapidly slowdown the sinus rhythm (negative
chronotropism), decreases atrioventricular conduction (negative dromotropism),
reduces the contractile force of the myocardium (negative inotropism), and dilates
the coronary vessels (Drury and Szent-Gyorgyyi, 1929). Adenosine is a
“chronoselective” atrial depressant, because its bradicardic action is observed in
concentrations below those required to decrease inotropism. This may be of
significant clinical advantage to prevent cardiac stunning during cardioversion of
paroxysmal supraventricular tachyarrhythmias by adenosine or its stable
analogues (e.g. tecadenoson). Elucidation of the mechanisms responsible for
adenosine A1 receptor-mediated “chronoselectivity” was recently undertaken by
our group using the spontaneously beating rat atria (Bragança et al., 2016).
Adenosine decreases SA node automatism mainly by promoting K+ efflux through
βγ subunits of G protein-coupled inwardly rectifying GIRK/KIR3 channels. This
effect, may be counteracted by inhibition of KCa2/SK currents (probably via G
protein α subunit) leading to a subsequent prolongation of atrial repolarization. The
increase in the time available for Ca2+ influx through voltage-sensitive Cav1 (L-type)
channels seems to be crucial to sustain inotropy in the presence of adenosine in
concentrations causing significant negative chronotropic actions (Bragança et al.,
2016).
Finally, it is also worth to mention the role of uracil nucleotides in the heart.
Like ATP, uracil nucleotides also have a positive inotropic effect (Froldi et al., 1994;
Froldi et al., 1997; Podrasky et al., 1997; Froldi et al., 2001). On the other hand,
UTP causes hypertrophy of neonatal cardiomyocytes (Pham et al., 2003), and this
unlike the ATP effect which inhibits hypertrophy inducing cellular apoptosis and
necrosis (Zheng et al., 1996).
1.4.2. Purinergic signaling in the heart: cardiac fibroblasts
Numerous studies confirmed that cardiac fibroblasts express P2 receptors
and extracellular nucleotides could modulate several functions of these cells.
Table 4 summarizes the work around P2 receptors in these cells. Data so far
obtained strengthen the presence of P2 receptors in cardiac fibroblasts. However,
there is little information in the literature in what concerns the activity of purinergic
receptors in these cells.
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The most described effect of purines in cardiac fibroblasts is the anti-fibrotic
and anti-proliferative effect of adenosine (Epperson et al., 2009; Lu et al, 2013). It
was found that adenosine, acting through A2B receptors, inhibits collagen and
protein synthesis in cardiac fibroblasts (Dubey et al., 1998). Evidences coming
from different studies show that A2B receptors agonists might protect against
cardiac fibrosis. Other evidences demonstrated that elevated glucose levels
increases A1 and A2A receptors expression, decreased expression of A3 receptors,
but had no effect on A2B receptors expression in cardiac fibroblasts (Grden et al.,
2006). Another study using RT-PCR revealed that mRNA for all four P1 receptors
subtypes, A1, A2A, A2B and A3, are expressed in rat cardiac fibroblasts, with a
prevalence of A2 receptors, acting via cAMP second messenger (Epperson et al.,
2009). In primary cultures of adult rat cardiac fibroblasts, adenosine activated A2
receptors coupled to Gs-protein and adenylyl cyclase pathway; the resultant cAMP
reduced collagen synthesis via a PKA-independent, EPAC-dependent pathway
that feeds through PI3K (Villarreal et al., 2009).
Despite the existence of several studies describing the effects of adenosine
in the heart, in what concerns P2 receptors there is little information. Zheng and
collaborators claimed that P2Y receptors promote activation of c-fos gene
expression and inhibit DNA synthesis in cultured rat cardiac fibroblasts (Zheng et
al., 1998). Notwithstanding this, there is a consensus in the literature indicating
that ATP, as well as UTP, transiently increases cardiac fibroblasts proliferation via
the activation of P2Y2 receptors, both in rats (Braun et al., 2010) and in humans
(Chen et al., 2012): these findings suggest that antagonists of the P2Y2 receptor
may provide a mean to reduce cardiac fibrosis under pathological conditions. This
receptor subtype has also been involved on Ca2+ signaling in human valvular
myofibroblasts (Liang et al., 2008). Previous studies also demonstrated that ATP
activates ionotropic P2X(4/7) receptors and up-regulates the proliferation of
human cardiac fibroblasts by promoting cell cycling progression, in addition to the
previous implicated P2Y2 receptors (Chen et al., 2012). The existence of other
purinoceptors subtypes has been evidenced, but, so far, their roles in cardiac
fibroblast cells remain uncertain. For instance, Tansilla and collaborators
described that P2Y1, P2Y2, P2Y4, P2Y6 and P2Y11-like receptors are co-expressed
in neonatal rat cardiac myofibroblasts (Talasilla et al., 2009), but no evidences
have been produced regarding their role in these cells. Using reverse
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transcription-polymerase chain reaction (RT-PCR) and Northern blotting other
authors demonstrated the expression of P2Y1, P2Y2, P2Y4 and P2Y6 receptor
transcripts in neonatal rat cardiac fibroblasts (Zheng et al., 1998). The presence of
the P2Y13 receptor was also reported in neonatal rat cardiac myofibroblasts
(Talasila et al., 2009). Despite these findings, little information has been produced
regarding the role of all these receptors in cardiac fibroblasts and whether their
activity remains in adulthood.
It, thus, appears that purines may play a dual role in cardiac fibrosis through
direct activation ATP/ADP-sensitive P2 receptors exerting a pro-fibrotic activity,
which may be balanced by the indirect anti-fibrotic effect of adenosine via A2B
receptors (Lu and Insel, 2013). Another important issue regarding purinergic
signaling in cardiac fibroblasts is the preferential coupling of these receptors to
Gq/11 and Gs proteins leading to activation of phospholipase C and adenyly cyclase
pathways, respectively, but few reports demonstrate their coupling to the Gi
subtype (Meszaros et al., 2000). These authors claim that the expression of
receptors preferentially coupled to Gq/11-, but not to Gi-linked responses, may be a
way to differentiate signals affecting cardiac fibroblasts from those acting in
cardiomyocytes. Moreover, it has been demonstrated that agonists that stimulate
Gq/11-protein-dependent pathways in cardiac fibroblasts synergize with Gs-linked
mechanisms, but this does not occur in adult cardiomyocytes (Meszaros et al.,
2000). Thus, G protein-mediated signaling in cardiac fibroblasts has unique
characteristics and may contribute to increase specificity of drug actions on
individual cell types within the heart.
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Table 4 - Purinergic receptors expression by cardiac fibroblasts
Receptor Species Function References
P1
A1 rt - Gorden et al., 2006; Eppersonet al., 2009
A2a rt - Gorden et al., 2006; Eppersonet al., 2009
A2b rt ↑ Proliferation Gorden et al., 2006; Eppersonet al., 2009
A3 rt - Gorden et al., 2006; Eppersonet al., 2009
P2X
P2X4 hu ↑ Proliferation Chen et al., 2012
P2X6 hu, pig - Banfi et al., 2005;
P2X7 hu ↑ Proliferation Chen et al., 2012
P2Y
P2Y1 rt - Tansilla et al., 2009; Zheng etal., 1998; Braun et al., 2010
P2Y2 rt, hu
↑ Proliferation; Ca2+
signallig; regulation of
angiotensin-II induced
inflammatory response
Braun et al., 2010; Chen et al.,
2012; Liang et al., 2008; Tansilla
et al., 2009; Zheng et al., 1998;
Nishidaa et al., 2011;
P2Y4 rt - Tansilla et al., 2009; Zheng etal., 1998
P2Y6 rt - Tansilla et al., 2009; Zheng etal., 1998; Braun et al., 2010
P2Y11 rt - Tansilla et al., 2009
P2Y13 rt - Talasila et al., 2009
The findings assembled in Table 4 illustrate that although almost all P1 and
P2 purinoceptor subtypes seem to be present on cardiac fibroblasts, there is a
lack of information in what concerns their function in these cells. We will try to fill
this gap in our knowledge in the present work by focusing our efforts on the role of
metabotropic P2Y purinoceptors on Ca2+ signaling and proliferation / type I
collagen production by fibroblasts from the ventricles of adult rats.
1.5. Clinical relevance of study
As previously mentioned, heart failure is ultimately linked to myocardial
fibrosis that is characterized, among other events, by dedifferentiation of
cardiomyocytes and their substitution by fibroblasts leading to excess deposition of
ECM proteins (Cohn et al., 2000). These cardiac remodeling events lead to
distorted organ architecture and altered hemodynamic events.
Another relevant issue to the functional repercussions of myocardial fibrosis
is the contribution of cardiac fibroblasts to heart electrophysiology, as emerged
very recently. These cells have a high cell membrane resistance, which makes
them good conductors for electrical signals (Kohl, 2003) and, on the other hand,
they are coupled to cardiomyocytes through gap junctions containing connexins-
43 and connexin-45 (Kohl, 2003). In fact, many studies point towards an
interaction between cardiomyocytes and fibroblasts that may provide
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synchronization of spontaneous electrical activity in distant cardiomyocytes (Rohr,
2004). These findings support the concept that cardiac fibroblasts are important on
both heart’s physiology and pathophysiology, offering the possibility of these cells
being suitable drug targets for the treatment of various cardiac disorders.
Another interesting consideration is that purinergic signaling may potentially
play a role on cardiac fibroblasts activity, transdifferentiation into myofibroblasts,
intercellular cells communication and, subsequent, cardiac remodeling. Thus, a
better understanding of the factors that regulate cardiomyocytes signaling to
surrounding fibroblast and vice versa may provide new insights into the
development of cardiac fibrosis and will permit identification of novel therapeutic
targets for its management. As already mentioned, ATP and UTP are released in
huge amounts during myocardial infarction in humans and these, together with
some of their extracellular metabolites (e.g. ADP, UDP and adenosine), might play
putative important roles in myocardial remodeling through the activation of
purinoceptors in cardiac cells, both cardiomyocytes and cardiac fibroblasts.
Despite our knowledge on the multiple roles of endogenous nucleotides and
nucleosides on cardiac remodeling, further studies are required before
manipulation of these signaling molecules becomes accepted as a useful
therapeutic strategy for the treatment of heart diseases.
In this context, this study was designed to investigate the purinergic
signaling mechanisms involved in cell activation, proliferation and differentiation of
cardiac fibroblasts from adult rat ventricles and to clarify the underlying
intracellular molecular pathways responsible for P2Y receptor responses in these
cells.
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CHAPTER 2. GOALS
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Given the data from the literature reviewed in the previous chapter, we
aimed at investigating the purinergic signaling mechanisms involved in the
proliferation and differentiation of cardiac fibroblasts from ventricles of adult rats in
order to discover novel therapeutic targets to attenuate / prevent cardiac
remodeling.
The specific aims of the project were:
1. To investigate, the effect of uracil nucleotides on [Ca2+]i signaling and long-
term growth of cultured cardiac fibroblasts from adult rat ventricles in order
to find novel targets for therapeutic intervention in cardiac remodeling. In
addition, we attempted to investigate the intracellular signaling pathways
implicated in [Ca2+]i oscillations and proliferation of cardiac fibroblasts due
to activation of uracil nucleotides-sensitive P2Y receptors (P2Y2, P2Y4,
P2Y6 and P2Y11).
2. Likewise, we also attempted to fill a gap in our knowledge regarding the role
of the ATP intermediate metabolite, ADP, on [Ca2+]i signaling and
proliferation of cardiac fibroblasts mediated by ADP-sensitive P2Y1, P2Y12
and P2Y13 receptors.
3. G-protein coupled receptors, like all P2Y receptor subtypes, may (1)
assemble to membrane delimited pathways (e.g. ion channels, transporters,
enzymes) within lipd rafts/caveolae microdomains, and/or (2) promote the
release of intracellular soluble second messengers resulting in more
widespread modifications of cells activity. The functional repercussions of
the balance between these two signaling strategies regarding ADP-induced
[Ca2+]i oscillations, cell proliferation and type I collagen production by
cardiac fibroblasts, were also investigated in this study.
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PMID: 26324417.
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Abstract
During myocardial ischemia and reperfusion both purines and pyrimidines
are released into the extracellular milieu, thus creating a signaling wave that
propagates to neighboring cells via membrane-bound P2 purinoceptors activation.
Cardiac fibroblasts (CF) are important players in heart remodeling,
electrophysiological changes and hemodynamic alterations following myocardial
infarction. Here, we investigated the role UTP on calcium signaling and
proliferation of CF cultured from ventricles of adult rats.
Co-expression of discoidin domain receptor 2 and -smooth muscle actin indicate
that cultured CF are activated myofibroblasts. Intracellular calcium ([Ca2+]i) signals
were monitored in cells loaded with Fluo-4 NW. CF proliferation was evaluated by
the MTT assay.
UTP and the selective P2Y4 agonist, MRS4062, caused a fast desensitizing
[Ca2+]i rise originated from thapsigargin-sensitive internal stores, which partially
declined to a plateau providing the existence of Ca2+ in the extracellular fluid. The
biphasic [Ca2+]i response to UTP was attenuated respectively by P2Y4 blockers,
like reactive blue-2 and suramin, and by the P2Y11 antagonist, NF340. UTP and
the P2Y2 receptor agonist MRS2768 increased, whereas the selective P2Y11
agonist NF546 decreased, CF growth; MRS4062 was ineffective. Blockage of the
P2Y11 receptor or its coupling to adenylate cyclase boosted UTP-induced CF
proliferation. Confocal microscopy and Western blot analysis confirmed the
presence of P2Y2, P2Y4 and P2Y11 receptors.
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Data indicate that besides P2Y4 and P2Y2 receptors which are responsible
for UTP-induced [Ca2+]i transients and growth of CF, respectively, synchronous
activation of the previously unrecognized P2Y11 receptor may represent an
important target for anti-fibrotic intervention in cardiac remodeling.
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Introduction
Fibroblasts are highly abundant cells in the heart, where they contribute to
myocardial architecture and function. Cardiac fibroblasts (CF) secrete growth
factors, cytokines (such as IL-1β and TNF-α) and other signaling molecules in
response to a variety of stimuli (e.g. mechanic, noxious, inflammatory); this is done
in parallel to the well-known production of components of the extracellular matrix
(ECM), such as collagen and fibronectin, and matrix metalloproteinases (Brown et
al., 2005; Camelliti et al., 2005). Contraction of the collagen network by CF serves
to direct mechanical force around cardiomyocytes, which can theoretically have a
significant contribution to diastolic compliance. CF migration and proliferation,
enhanced deposition of ECM and cardiomyocyte hypertrophy lead to cardiac
remodeling and fibrosis (Brown et al., 2005) resulting in stiffness of the
myocardium, which accompanies heart aging and numerous cardiac diseases,
including ischemic and hypertensive heart failure and diabetic cardiomyopathy.
Due to their abundance, strategic localization and remarkable potential for
activation, CF may serve as sentinel cells that sense myocardial injury and trigger
inflammatory and reparative responses (Shinde et al., 2014). Disruption of cell-cell
communication can lead to dysregulation of chemical, mechanical and electrical
signals between cellular components of the heart. Involvement in myocardial
dysfunction and arrhythmogenesis makes CF natural therapeutic targets in cardiac
remodeling. Intense proliferative activity has been documented in CF infiltrating
the infarcted heart; however, the molecular signals and intracellular pathways
involved in CF proliferation remain poorly understood. Several growth factors (e.g.
fibroblast growth factor-2, platelet-derived growth factor) released by a variety of
cells (including macrophages, mast cells and cardiomyocytes) have been
implicated in stimulation of the proliferative potential of fibroblasts.
During myocardial infarction there is a huge increase in the extracellular
levels of adenine and uracil nucleotides (Wihlborg et al., 2006; Gerasimovskaya et
al., 2002). This feature led to the hypothesis that various subtypes of metabotropic
P2Y and ionotropic P2X purinoceptors play relevant roles in cardiac remodeling
following an ischemic insult by targeting fibroblast cells activation and growth
(Burnstock, 2006). However, in contrast to the compelling evidence for the
extracellular signaling role of adenine nucleotides on cardiac fibroblasts (Lu et al.,
PhD THESIS – MARIANA DE SOUSA CERTAL GOMES 51
2012; Wakeno et al., 2006; McIntosh and Lasley, 2012; Chen et al., 2012), only
recently attention has been given to the contribution of uracil nucleotides as
autocrine/paracrine mediators in the heart (Braun et al., 2012; Yitzhaki et al.,
2006).
The presence of UTP-sensitive P2Y2, P2Y4 and P2Y11 receptors, as well as
the UDP-sensitive P2Y6 receptor, was demonstrated in neonatal rat cardiac
myofibroblasts (Talasila et al., 2009), but no evidences have been produced
regarding their role in these cells. Consensus exists in the literature suggesting
that UTP transiently increases CF proliferation via the activation of P2Y2 receptors,
both in rats (Braun et al., 2010) and humans (Chen et al., 2012). This receptor
subtype has also been involved on Ca2+ signaling in human valvular
myofibroblasts (Liang et al., 2008). Despite these findings, some authors ascertain
that UTP may be cardioprotective by decreasing infarct size and restoring cardiac
function following myocardial infarction in rats (Yitzhaki et al., 2006). Recent
studies suggest that P2Y11-like receptors afford cardioprotection against ischemia
and reperfusion (Djerada et al., 2013). As a matter of fact, loss-of-function
polymorphisms of this receptor increase the risk of acute myocardial infarction in
humans (Aminsten et al., 2007). The prominent action of the P2Y11 receptor in
controlling cardiomyocyte contractility and possible alterations in its function during
cardiomyopathy suggests that this receptor may be a potential therapeutic target
(Balogh et al., 2005), yet the role of this receptor on CF activation and growth has
not been explored so far.
The P2Y11 receptor has unique properties among all P2 receptor subtypes
because it may dually couple to phospholipase C (PLC) and adenylate cyclase
(AC) pathways, respectively via Gq and Gs proteins (Balogh et al., 2005; White et
al., 2003). This makes the P2Y11 receptor the only P2 receptor subtype capable of
increasing intracellular cyclic AMP levels. Recruitment of distinct signaling
cascades by the P2Y11 receptor seems to be agonist specific, since while both
ATP and UTP equally increase intracellular Ca2+ concentration the intracellular
signaling pathway leading to Ca2+ recruitment diverge when the receptor is
activated by each nucleotide (White et al., 2003).
In this context, this study was designed to investigate the effect of uracil
nucleotides on [Ca2+]i signaling and long-term growth of cultured CF from adult rat
ventricles using recently available subtype-selective agonists and antagonists of
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P2Y2, P2Y4, P2Y6 and P2Y11 receptors in order to find novel targets for therapeutic
intervention in cardiac remodeling. We also attempted to investigate the
intracellular signaling pathways implicated in [Ca2+]i oscillations and proliferation of
CF induced by UTP using specific enzymatic inhibitors of the two main pathways,
PLC and AC.
Methods
Drugs and solutions
Adenosine 5′-triphosphate sodium salt (ATP), adenosine 5′-[γ-
thio]triphosphate tetralithium salt (ATPγS), 2-aminoethoxydiphenylborane (2-APB),
brefeldin A (BFA), caffeine, carbenoxolone (CBX), α-[2-(3-
Chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-b-oxo-3-isoxazole
propanenitrile (ESI-09), cis-N-(2-phenylcyclopentyl)-azacyclotridec-1-en-2-amine
hydrochloride (MDL 12,330a), 2-[(3,4-dihydro-2-phenyl-2H-1-benzopyran-6-
yl)oxy]-5-nitro-pyridine (ORM-10103), 1-(4,5-dimethylthiazol-2-yl)-3,5-
diphenylformazan (thiazolyl blue formazan – MTT), direct red 80,
ethylenediaminetetraacetic acid (EDTA), ethylene glycol-bis(2-aminoethylether)-
N,N,N′,N′-tetraacetic acid (EGTA), fetal bovine serum (FBS), N-[2-(p-
bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride (H-89), 1-
methyl-3-isobutylxanthine (IBMX), mefloquine (MFQ), phosphate buffered saline
system (PBS), picric acid, reactive blue-2 (RB-2), suramin sodium salt, uridine 5′-
diphosphate (UDP), uridine 5′-triphosphate (UTP), type I collagenase, and cell
culture reagents were from Sigma-Aldrich. (S)-(+)-2-Methyl-1-[(4-methyl-5-
isoquinolinyl)sulfonyl]-hexahydro-1H-1,4-diazepine dihydrochloride (H1152), 4,4'-
(carbonylbis(imino-3,1-(4-methyl-phenylene)carbonylimino)) bis(naphthalene-2,6-
disulfonic acid) tetrasodium salt (NF340), 4,4'-(carbonylbis(imino-3,1-phenylene-
carbonylimino-3,1-(4-methyl-phenylene)carbonylimino))-bis-1,3-xylene-
alpha,alpha′-diphosphonic acid tetrasodium salt (NF546), N,N''-1,4-
butanediylbis[N'-(3-isothiocyanatophenyl)thiourea (MRS2578), N4-
phenylpropoxycytidine-5'-O-triphosphate tetra(triethylammonium) salt (MRS4062),
2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl]isothiourea mesylate (KB-R7943),
thapsigargin, uridine-5'-tetraphosphate δ-phenyl ester tetrasodium salt (MRS2768),
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10Panx, 1-[6-[[(17β)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-
2,5-dione (U73122), 9-(tetrahydro-2-furanyl)-9H-purin-6-amine (SQ 22536) were
obtained from Tocris Cookson Inc.. Brefeldin A, ESI-09, IBMX, H1152, mefloquine,
U73122, SQ 22536, thapsigargin and KB-R7943 were dissolved in
dimethylsulphoxide (DMSO). The other drugs were dissolved in distilled water.
DMSO (<0.05% v/v) did not affect the parameters under study. All stock solutions
were stored as frozen aliquots at -20ºC.
Fluo-4 NW dye was supplied by Molecular Probes (Invitrogen). ATP
bioluminescence assay kit HS II was from Roche Applied Science. Bicinchoninic
acid (BCA) Protein Assay Kit was from Pierce. Tissue culture plates: 96-well plates
were purchased from Corning; FluoroDish plates for confocal microscopy were
from World Precision Instruments; chamber slides were from Nunc. Polyvinyl
difluoride (PVDF) membranes were obtained from Millipore.
Animals
Wistar rats (150-200 g) of either sex (Charles River, Barcelona, Spain) were
kept at a constant temperature (21 ºC) and a regular light (06.30 –19.30 h) – dark
(19.30–06.30 h) cycle, with food and water ad libitum. Animal handling and
experiments were in accordance with the guidelines prepared by Committee on
Care and Use of Laboratory Animal Resources (National Research Council, USA)
and followed the European Communities Council Directive (86/609/EEC).
Cell cultures
Rat cardiac fibroblasts were isolated from heart ventricles of adult Wistar
rats by the explant technique in which fibroblasts migrate from minced tissue and
grow in fibroblast growth medium (Song et al., 2012). Cells were cultured in
DMEM medium supplemented with 15% fetal bovine serum (FBS), 1% of
amphotericin B and 1% of penicillin/streptomycin, at 37ºC in a humidified
atmosphere of 95% air and 5% CO2. Medium was replaced twice a week. Primary
cultures were maintained until near confluence (~3-4 weeks), then adherent cells
were enzymatically released with 0.04% trypsin-EDTA solution plus 0.025% type I
collagenase in phosphate-buffered saline (PBS). The resultant cell suspension
was cultured and maintained in the same conditions mentioned above (Pinheiro et
al., 2013a; Pinheiro et al., 2013b).
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Measurement of [Ca2+]i
Changes in [Ca2+]i were measured with the calcium sensitive dye Fluo-4
NW (Molecular Probes, Invitrogen) in a multi detection microplate reader (Synergy
HT Multi-Mode Microplate Reader, BioTek Instruments). In some of the
experiments, single-cell [Ca2+]i imaging was obtained using a laser scanning
confocal microscope (FV1000, Olympus) in the time lapse mode (Pinheiro et al.,
2013 a; Pinheiro et al., 2013b). Briefly, rat cardiac fibroblasts were seeded in flat
bottom 96 well plates (Costar, Corning Inc.) at a density of 3x104 cells/mL. Cells
were cultured for 7 days in supplemented DMEM as described before. On the day
of the experiment, cells were washed twice with Tyrode’s solution (137 mM NaCl,
2.7 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 0.4 mM NaH2PO4, 11.9 mM NaHCO3,
and 11.2 mM glucose, pH 7.4) and incubated at 37ºC for 45 minutes with the cell-
permeant fluorescent Ca2+ indicator, Fluo-4 NW (2.5 µM), in 1X HBSS, 20 mM
HEPES and 2.5 mM probenecid. After removal of the fluorophore loading solution,
cells were washed again twice and 150 µL of Tyrode’s solution was added per
culture well. For the recordings, temperature was maintained at 32ºC and readings
were made with 5 seconds of interval, during approximately 30 minutes, using a
tungsten halogen lamp. Fluorescence was excited at 485/20 nm and emission was
measured at 528/20 nm. For single-cell [Ca2+]i imaging, culture dishes were
mounted on a thermostatic (32ºC) perfusion chamber on the stage of an inverted
laser-scanning confocal microscope equipped with a 20x magnification objective
lens (LUCPLFLN 20x PH; NA: 0.45). The chamber was continuously superfused
(1 mL/min) with gassed (95% O2, 5% CO2, pH 7.4) Tyrode’s solution and drugs
were delivered using a multichannel valve controlled perfusion system. Changes in
fluorescence of the Fluo-4 NW dye were detected in a time-lapse mode. Fluo-4
NW was excited with a 488 nm Multi-line Ar laser and the emitted fluorescence
was detected at 510-560 nm, using the scanner of the confocal microscope. Time-
lapse sequences were recorded at scanning rates with 20 seconds of interval for
approximately 30 min, digitized, and processed off-line. Regions of interest were
defined manually. For both methods, calcium measurements were calibrated to
the maximal calcium load produced by the calcium ionophore, ionomycin (5 μM,
100% response) (Pinheiro et al., 2013a; Pinheiro et al., 2013b; Henriksen et al.,
2006; Panupinthu et al., 2007).
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Measurement of intracellular cyclic AMP
Rat cardiac fibroblasts were assayed for cyclic AMP production in the
presence of a cyclic nucleotide phosphodiesterase inhibitor,
isobutylmethylxanthine (IBMX, 100 µM final concentration in Tyrode’s solution).
Five min after IBMX application, incubation proceeded in the absence or in the
presence of UTP (3 and 100 µM) for an additional 5-min period. The adenylate
cyclase activator, forskolin (10 µM) was used as a positive control. Incubations
were stopped by addition of 0.1% HCl. Cell lysates were harvested, neutralized
and centrifuged. Supernatants were collected and acetylated according to the
manufacturer’s instructions. The samples were then analyzed for cyclic AMP
content using a cyclic AMP-specific enzyme immunoassay (Cyclic AMP EIA kit,
Cayman Chemicals Co.). Absorbance readings were done at 410 nm against
blank. Cyclic AMP concentration in each sample was expressed as pmol per mg of
protein.
Extracellular ATP quantification by bioluminescence
Extracellular ATP was quantified by the luciferin-luciferase ATP
bioluminescence assay kit HS II (Roche Applied Science) using a multi detection
microplate reader (Synergy HT, BioTek Instruments), as previously described by
our group (Pinheiro et al., 2013a; Pinheiro et al., 2013b). Briefly, cells were seeded
in flat bottom 96 well plates at a density of 3x104 cells/mL for 7 days. At the
beginning of the experiment, cells were washed twice with Tyrode’s solution at
37ºC and let rest during 30 minutes (basal), after which samples were collected
(100 µL). MRS 4062 (10 µM) contacted with the cells for 5 min either in the
absence or in the presence of release modifiers, which were added to the
incubation fluid at least 5 min before the P2Y4 agonist. Collected samples were
immediately snap-frozen and stored at -80ºC. Luciferin-luciferase experiments
were performed at room temperature and light emission acquisition was performed
20 seconds after addition of luciferin-luciferase to the collected sample.
Cell viability/proliferation
Viability/proliferation studies included the MTT assay as previously
described (Costa et al., 2011; Pinheiro et al., 2013a; Pinheiro et al., 2013b). Rat
cardiac fibroblasts were seeded in flat bottom 96 well plates at a density of 3x104
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cells/mL and cultured in supplemented DMEM as described before. Cell cultures
were routinely monitored by phase contrast microscopy and characterized at days
1, 7, 14, 21 and 28. The MTT assay consists on the reduction of 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) to a purple formazan
reaction product by viable cells. In the last 4 h of each test period, cells were
incubated with 0.5 mg/mL of MTT for 4 h in the conditions referred above. The
medium was carefully removed, decanted and the stained product dissolved with
DMSO before absorbance (A) determination at 600 nm using a microplate reader
spectrometer (Synergy HT Multi-Mode Microplate Reader, BioTek Instruments).
Results were expressed as A/well.
Type I collagen determination
Type I collagen determination was performed using the Sirius Red staining
assay. Rat cardiac fibroblasts were cultured as described for the
viability/proliferation studies. The staining protocol was adapted from Tullberg-
Reinert & Jundt (1999) (Tullberg-Reinert et al., 1999). Cell layers were washed
twice in PBS before fixation with Bouin’s fluid for 1 h. The fixation fluid was
removed by suction and the culture plates were washed by immersion in running
tap water for 15 minutes. Culture dishes were allowed to air dry before adding the
Sirius Red dye (Direct Red 80). Cells were stained for 1 h under mild shaking on a
microplate shaker. To remove non-bound dye, stained cells were washed with
0.01 N hydrochloric acid and then dissolved in 0.1 N sodium hydroxide for 30
minutes at room temperature using a microplate shaker. Optical density was
measured at 550 nm using 0.1 N sodium hydroxide as blank (Tullberg-Reinert et
al., 1999; Pinheiro et al., 2013a; Pinheiro et al., 2013b). Results were expressed
as A/well.
Immunocytochemistry
Rat cardiac fibroblasts were seeded in chamber slides at a density of
2.5x104 cells/mL and allowed to grow for 7-28 days. Cultured cells were fixed in
4% paraformaldehyde (PFA) in PBS for 10 minutes, washed 3 times in PBS (10
minutes each) and, subsequently, incubated with blocking buffer I (10% FBS, 1%
bovine serum albumin (BSA), 0.1% Triton X, 0.05% NaN3 in PBS) for 1 h. Primary
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antibodies, diluted in blocking buffer II (5% FBS, 1% BSA, 0.1% Triton X, 0.05%
NaN3), were applied [mouse anti-porcine vimentin 1:250 (DAKO); goat anti-human
DDR2 1:25 (Santa Cruz); mouse anti human α-smooth muscle actin-FITC 1:250
(Sigma); rabbit anti-rat P2Y2 1:100 (Alomone), rabbit anti-rat P2Y4 1:75 (Alomone),
rabbit anti-human P2Y11 1:50 (Alomone), rabbit anti-human connexin 43 1:600
(Abcam)] and the slides incubated overnight at 4ºC. After incubation, cells were
washed 3 times in PBS (10 min each). The donkey anti-rabbit IgG Alexa Fluor 488,
donkey anti-mouse IgG Alexa Fluor 488 and donkey anti-goat IgG Alexa Fluor 633
secondary antibodies (Invitrogen) were diluted in blocking buffer II and applied for
1h at dark. A last wash was performed with PBS and glass slides were mounted
with VectaShield medium and stored at 4ºC. Observations were performed and
analysed with a laser scanning confocal microscope (FV1000, Olympus) (Alqallaf
et al., 2009; Noronha-Matos et al., 2012; Pinheiro et al., 2013a; Pinheiro et al.,
2013b)
SDS–PAGE and Western blotting
Cardiac fibroblasts were homogenized in a lysis buffer with the following
composition: 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.5% sodium deoxycholate,
1% Triton-X-100, 0.1% SDS and a protease inhibitor cocktail. Protein content of
the samples was evaluated using the BCA protein assay kit according to the
manufacturer’s instructions (Pierce, Rockford, IL, USA). Samples were solubilized
in SDS reducing buffer (0.125 mM Tris-HCl, 4% SDS, 0.004% bromphenol blue,
20% glycerol, and 10% 2-mercaptoethanol, pH 6.8 at 70ºC for 10 minutes),
subjected to electrophoresis in 10% SDS-polyacrylamide gels and
electrotransferred onto PVDF membranes (MilliPore, MA). Protein loads were 15
µg for connexin 43 (Cx43) and 100 µg for P2Y2, P2Y4 and P2Y11 receptors. The
membranes were blocked for 1 h in Tris-buffered saline (TBS: 10 mM Tris-HCl, pH
7.5, 150 mM NaCl) containing 0.05% Tween 20 + 5% BSA. Membranes were
subsequently incubated with rabbit anti-rat P2Y2 1:200 (Alomone), rabbit anti-rat
P2Y4 1:300 (Alomone), rabbit anti-human P2Y11 1:200 (Alomone) and rabbit anti-
human Cx43 1:6000 (Abcam) in the above blocking buffer overnight at 4ºC.
Membranes were washed three times for 10 minutes in 0.1% Tween 20 in TBS
and then incubated with donkey anti-rabbit IgG (HRP) 1:30000 (Abcam) secondary
antibody, for 60 minutes at room temperature. For comparison purpose, the
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membranes were also incubated with rabbit anti-human β-tubulin 1:2500 (Abcam)
or rabbit anti-human β-actin 1:2500 (Abcam) antibodies following the procedures
described above. Membranes were washed three times for 10 minutes and
antigen-antibody complexes were visualized by chemiluminescence with an ECL
reagent using the ChemiDoc MP imaging system (Bio-Rad Laboratories).
Presentation of data and statistical analysis
Data are expressed as mean ± S.E.M. from an n number of individuals.
Data from different individuals performed in triplicate were evaluated by one-way
analysis of variance (ANOVA). Statistical differences found between control and
drug-treated cultures were determined by the Bonferroni’s method. P values <
0.05 were considered to represent significant differences.
Results
Characterization of adult rat cardiac fibroblasts in culture
The fibroblast nature of cells in culture was confirmed by
immunocytochemistry. Adult rat CF exhibited positive immunoreactivity against
discoidin domain receptor 2 (DDR2) (Figure 4B and 4E), a collagen specific
receptor tyrosine kinase that is the most specific marker for CF and myofibroblasts
(Morales et al., 2005; Goldsmith et al., 2010). Cells also stained positive for
vimentin (Figure 4A and 4C), the intermediate protein filament considered a
reliable fibroblast-cell marker (Agocha and Eghbali-Webb, 1997), and α-smooth
muscle actin (α–SMA) (Figure 4D and 4F), a myofilament protein that typically is
expressed by activated fibroblasts (myofibroblasts) (Brown et al., 2005). This
staining pattern indicates that adult rat CF used in this study present a
myofibroblast phenotype, which is the CF lineage most committed to myocardial
remodeling (Stephan, 2011). Rapid and spontaneous transition to myofibroblast
phenotype is characteristic for CF cultured in standard two-dimensional conditions
(Rohr, 2011).
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Figure 4 - Immunocytochemical staining of CF isolated from heart ventricles of adult rats. Cells
exhibited positive immunoreactivity against vimentin, which has been described as a reliable
fibroblast marker (green, A), α-smooth muscle actin (α-SMA), a myofilament protein that typically is
expressed by activated fibroblasts (myofibroblasts) (green, D) and discoidin domain receptor 2
(DDR2), a collagen specific receptor tyrosine kinase that is the most specific marker for cardiac
fibroblasts and myofibroblasts (red, B and E). Panels C and F show merge of vimentin and DDR2,
and α-SMA and DDR2, respectively. Yellow denotes co-localization. Scale bar: 100 µm.
UTP stimulates fast Ca2+ recruitment from intracellular stores, which is kept
at high levels via Ca2+ influx from the extracellular space
UTP (0.03-300 µM) concentration-dependently increased [Ca2+]i above the
control level (Tyrode’s solution) when applied to 7-day cultures of adult rat CF
(Figure 5A). UTP typically produced a biphasic response (Figure 5B). UTP (3 µM,
n=26) caused a fast (within seconds) rise in [Ca2+]i (phase I), which attained
33±1% of the maximal calcium load produced by ionomycin (5 µM, 100%
response); beyond this point, [Ca2+]i levels declined to a plateau of elevated [Ca2+]i
(phase II) that remained fairly constant. The initial [Ca2+]i rise (phase I) produced
by UTP decreased (p<0.05) in the presence of the selective inhibitor of
endoplasmic reticulum Ca2+-ATPase, thapsigargin (5 µM) (Thastrup et al., 1990),
which is known to accelerate the depletion of intracellular Ca2+ stores when
applied together with internal Ca2+ mobilizing agents, such as caffeine (10 mM,
n=5) (Figure 5C). Removal of external Ca2+ (plus EGTA, 100 µM, n=6) significantly
(p<0.05) depressed the late component of UTP (3 µM, n=6) response (phase II),
keeping unaltered the initial fast rise (Figure 5D). Ca2+ influx through the Na+/Ca2+
exchanger (NCX) operating in the reverse mode does not account for UTP-
induced [Ca2+]i rise in rat CF because selective inhibition of NCX with anti-
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arrhythmogenic compounds, like KB-R7943 (10 µM, n=5) (Ladilov et al., 1999) or
ORM-10103 (3 µM, n=4) (Jost et al., 2013), were devoid of effect (data not shown).
Figure 5 - UTP stimulates fast Ca2+ recruitment from intracellular stores in cultured CF, which is
kept at high levels via Ca2+ influx from the extracellular space. Panel A depicts the concentration-
response curve of [Ca2+]i rises produced by UTP (0.03-300 µM). Panels B, C and D illustrate UTP
(3 µM)-induced intracellular Ca2+ ([Ca2+]i) transients in cultured CF from adult rats loaded with the
fluorescent calcium indicator, Fluo-4 NW (2.5 µM, see Methods) in control conditions (B) and after
depletion of intracellular Ca2+ stores with thapsigargin (5 µM) plus caffeine (10 mM) (C) or after
removal of extracellular Ca2+ (Ca2+-free medium plus EGTA, 100 µM, D). [Ca2+]i transients were
calibrated to the maximal calcium load produced by ionomycin (5 μM, 100% response). Black
arrows indicate the time of UTP (3 µM) application. Each point represents pooled data from an n
number of individuals; experiments were performed in triplicate. The vertical bars represent S.E.M..
*p<0.05 represent significant differences from UTP (3 µM) alone.
Pharmacological characterization of P2 receptors mediating UTP-induced
[Ca2+]i oscillations in adult rat cardiac fibroblasts
Regarding the initial [Ca2+]i rise, UTP (100 µM, n=11) was about equipotent
to ATP (100 µM, n=16) and ATγS (100 µM, n=4, a stable ATP analogue) (Figure
6A), but it was much potent (p<0.05) than UDP (100 µM, n=4), which may be
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originated from the extracellular hydrolysis of UTP by ectonucleotidases (Figure
6B). Involvement of the UDP-sensitive P2Y6 receptor was further ruled out since
blockade of this receptor with a selective antagonist, MRS2578 (300 nM)
(Mamedova et al., 2004), did not affect UTP- and UDP-induced [Ca2+]i oscillations
(Figure 6B). The effect of UTP (3 µM) on [Ca2+]i oscillations was attenuated
(p<0.05) by suramin (100 µM, n=7) and reactive blue-2 (RB-2, 100 µM, n=7)
(Figure 7Ai and 7Aii); two broad spectrum P2 receptor antagonists which on their
own were devoid of effect on [Ca2+]i oscillations (data not shown).
Figure 6 - UTP-induced [Ca2+]i transients in cultured CF of adult rats are mediated by a P2Y
purinoceptor that is equally sensitive to ATP and ATPγS, but not to UDP. Panel A represents the
magnitude of the initial [Ca2+]i response of ATP (100 µM), UTP (100 µM) and ATPγS (100 µM).
Panel B compares the magnitude of [Ca2+]i peak produced by UTP (100 µM) and UDP (100 µM)
applied in the absence and in the presence of the selective P2Y6 receptor antagonist, MRS 2578
(300 nM). [Ca2+]i transients were calibrated to the maximal calcium load produced by ionomycin (5
μM, 100% response). Each bar represents pooled data from an n number of individuals;
experiments were performed in triplicate. The vertical bars represent S.E.M.. *p<0.05 represent
significant differences from control values obtained in the absence of test drugs, #p<0.05 represent
significant differences from UTP (100 µM) alone. Not significant: ns.
Pharmacological data suggest the participation of UTP-sensitive P2
purinoceptors operating [Ca2+]i oscillations, which can be of P2Y2, P2Y4 or P2Y11
subtypes as all these receptors were identified in adult rat CF by
immunofluorescence confocal microscopy and Western blot analysis (Figure 7B).
Our data also show that the selective P2Y4 receptor agonist, MRS 4062 (10 µM,
n=7) (Maruoka et al., 2011), mimicked the effect of UTP on [Ca2+]i oscillations,
whereas selective activation of P2Y2 and P2Y11 receptors with MRS 2768 (10 µM,
n=5) (Ko et al., 2008) and NF546 (10 µM, n=5) (Meis et al., 2010), respectively,
caused only minor effects typically lacking the initial fast [Ca2+]i rise (Figure 7C and
7D). The P2Y4 receptor-induced fast [Ca2+]i rise desensitizes rapidly with repeated
and/or prolonged applications of UTP (30 µM) or MRS 4062 (10 µM) (Figure 7E).
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To investigate this, we performed single-cell [Ca2+]i imaging experiments using a
laser scanning confocal microscope in the time-lapse mode; agonists were applied
to the superfusion fluid during 1-min followed by 8-min washout intervals between
consecutive applications.
Figure 7 - UTP-induced [Ca2+]i rises depend on a dominant P2Y4 receptor activation in rat CF that
also co-express P2Y2 and P2Y11 receptor subtypes. Panel A shows the amplitude of UTP (3 µM)-
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induced [Ca2+]i rise in the absence and in the presence of two non-selective P2 receptors
antagonists, suramin (100 µM, Ai) and reactive blue-2 (RB-2, 100 µM, Aii), and of the selective
P2Y11 receptor antagonist, NF 340 (10 µM, Aiii). Each point represents pooled data from an n
number of individuals; experiments were performed in triplicate. The vertical bars represent S.E.M..
*p<0.05 represent significant differences from UTP (3 µM) alone. Panel B shows
immunofluorescence confocal micrographs and representative immunoblots of P2Y2 (Bi), P2Y4 (Bii)
and P2Y11 (Biii) receptors. (-actin and (-tubulin were used as references. Images are representative
of three independent experiments; scale bar is 100 µm. Panels C and D compare the magnitude of
[Ca2+]i transients produced by selective agonists of P2Y2, P2Y4 and P2Y11 receptors, respectively
MRS 2768 (10 µM), MRS 4062 (10 µM) and NF 546 10 µM), on rat CF maintained for 7 days in
culture. Black arrows indicate the time of drugs application. [Ca2+]i transients were calibrated to the
maximal calcium load produced by ionomycin (5 μM, 100% response). Each bar/point represents
pooled data from an n number of individuals; experiments were performed in triplicate. The vertical
bars represent S.E.M.. *p<0.05 represent significant differences from control values obtained in the
absence of test drugs. Panel E represents [Ca2+]i oscillations induced by UTP (3 µM, Ei) and MRS
4062 (10 µM, Eii) applied to the superfusion fluid during 1-min followed by 8-min washout intervals
between consecutive applications. Changes in fluorescence were detected in the time-lapse mode
using a laser scanning confocal microscope. Horizontal lines indicate the time of drugs application.
Fluorescence confocal micrographs were obtained at the indicated time points (a, b and c) (Eiii).
Scale bar is 100 µm.
Interestingly, the plateau phase, but not the initial [Ca2+]i rise, induced by
UTP (3 µM) was partially decreased (p<0.05) by blocking the P2Y11 receptor with
NF340 (10 µM, n=14) (Meis et al., 2010) (Figure 7Aiii). As previously mentioned,
the P2Y11 receptor may positively couple to both PLC and AC, whereas other
UTP-sensitive receptors, namely P2Y2 and P2Y4, lead to accumulation of inositol
1,4,5-trisphosphate (IP3) and subsequent mobilization of Ca2+ from internal stores
through the activation of PLC (Kugelgen, 2006). Inhibition of either PLC with
U73122 (30 µM, n=5) or the IP3-receptor with 2-APB (50 µM, n=6) decreased
(p<0.05) both the initial rise (phase I) and the plateau (phase II) of UTP (3 µM)-
induced [Ca2+]i response (Figure 8Ai, 8Aii and 8D). Participation of a P2Y11
receptor-coupled AC pathway in the plateau phase of [Ca2+]i response is
supported by our findings showing that inhibition of AC either with MDL12,330a
(10 µM, n=9) or with SQ 22536 (30 µM, n=4) mimicked the blocking effect of the
P2Y11 receptor antagonist, NF340 (10 µM, n=14) (Figure 8Aiii and 8Aiv, for
comparison see Figure 7Aiii). Figure 8Dii shows that the inhibitory effects of
U73122 (30 µM) and MDL12,330a (10 µM) were additive on UTP (3 µM)-induced
[Ca2+]i plateau (phase II), but the same was not verified regarding the initial [Ca2+]i
rise (phase I) (Figure 8Di). These findings suggest that PLC and AC act
independently in a cooperative manner to keep [Ca2+]i at high levels during the
plateau (phase II) of the UTP response, while the PLC/IP3 is the dominant pathway
responsible for the initial [Ca2+]i rise.
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UTP increases intracellular cyclic AMP accumulation leading to activation of
an EPAC-mediated signaling pathway in cardiac fibroblasts of adult rats
Figure 8B shows that UTP (3 and 100 µM) concentration-dependently
increased intracellular cyclic AMP levels, strengthening our assumption that the
P2Y11 receptor is involved in UTP signaling in adult rat CF considering that this is
the only P2 subtype operating increases in intracellular cyclic AMP. Most cyclic
AMP effects are attributed to the activation of protein kinase A (PKA), yet several
cyclic AMP-mediated cellular events may be insensitive to PKA inhibition. Figure
8Ci shows that UTP (3 µM)-induced [Ca2+]i rise was not modified in the presence
of the potent PKA inhibitor, H-89 (10 µM, n=5), regardless of the inhibitory effects
obtained by blocking the activity of AC with MDL12,330a (10 µM) or SQ 22536 (30
µM) (Figure 8A). This prompted us to investigate novel cyclic AMP targets, namely
the exchange protein directly activated by cyclic AMP (EPAC). Selective inhibition
of EPAC with ESI-09 (10 µM, n=5) significantly (p<0.05) decreased UTP (3 µM)-
induced [Ca2+]i rise in adult rat CF (Figure 8Cii), suggesting that this pathway
mediates UTP actions downstream activation of membrane-bound P2Y11
receptors.
UTP-induced [Ca2+]i accumulation partially depends on ATP release from rat
cardiac fibroblasts via hemichannels containing connexin-43
Stimulated fibroblasts can release substantial amounts of ATP leading to
supplementary activation of membrane-bound P2 purinoceptors (see e.g. Pinheiro
et al., 2013 a and b). Such a mechanism may contribute to sustain elevated [Ca2+]i
levels during the late plateau (phase II) response to UTP. Using the luciferin-
luciferase bioluminescence assay, we show here that selective activation of the
P2Y4 receptor with MRS 4062 (10 µM, n=6) significantly (p<0.05) increased ATP
release from CF isolated from adult rat ventricles compared to the control situation
where the cells were exposed to Tyrode’s solution (Figure 9A). Unfortunately,
contrary to MRS 4062 (10 µM), UTP interferes with ATP determinations using the
luciferin-luciferase bioluminescence assay given rise to false positive results,
which precluded further tests with this compound.
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Figure 8 - Role of phospholipase C (PLC) and adenylate cyclase (AC) pathways on UTP-induced
[Ca2+]i transients in CF of adult rats. Panel A represents [Ca2+]i oscillations induced by UTP (3 µM)
in the absence and in the presence of PLC, IP3-receptor and AC inhibitors, respectively U73122
(30 µM, Ai), 2-APB (50 µM, Aii), MDL12,330a (10 µM, Aiii) and SQ 22536 (30 µM, Aiv). Black
arrows indicate the time of UTP (3 µM) application; inhibitors were applied at least 6 min before
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UTP. [Ca2+]i transients were calibrated to the maximal calcium load produced by ionomycin (5 μM,
100% response). The vertical bars represent S.E.M.. *p<0.05 represent significant differences from
UTP (3 µM) alone. Panel B shows UTP-induced cAMP accumulation in rat cardiac fibroblasts.
Each bar represents pooled data from an n number of experiments. The vertical bars represent
S.E.M.. *p<0.05 represent significant differences from baseline values; #p<0.05 represent
significant differences from control values obtained in the absence of the nucleotide. Panel C
represents [Ca2+]i oscillations induced by UTP (3 µM) in the absence and in the presence of PKA
and EPAC inhibitors, respectively H-89 (10 µM, Ci) and ESI-09 (10 µM, Cii). The vertical bars
represent S.E.M.. *p<0.05 represent significant differences from UTP (3 µM) alone. Panel D
compares the influence of these inhibitors on the initial [Ca2+]i rise (phase I, 0-15 s, Di) and delayed
plateau (phase II, 150-300 s, Dii) response produced by UTP (3 µM). Each bar represents pooled
data from an n number of individuals; experiments were performed in triplicate. The vertical bars
represent S.E.M.. *p<0.05 represent significant differences from UTP (3 µM) alone.
Hemichannels containing connexins and pannexins are putative mediators
of ATP translocation into the extracellular milieu in fibroblasts (Pinheiro et al.,
2013a; Pinheiro et al., 2013b). It has been shown that connexin-43 (Cx43) plays
an important role in the differentiation of CF to activated myofibroblasts (Asazuma-
Nakamura et al., 2009). Using immunofluorescence confocal microscopy and
Western blot analysis, we confirmed that CFs from adult rats express Cx43 (Figure
9B). Carbenoxolone (CBX, 300 µM), the most potent inhibitor of Cx43-containing
hemichannels significantly (p<0.05) attenuated ATP release triggered by MRS
4062 (10 µM, n=7) (Figure 9A), as well as the sustained [Ca2+]i accumulation
following UTP (3 µM, n=5) application (Figure 9C and 9D). Compounds that affect
hemichannels pore permeability, like the Rho kinase inhibitor, H1152 (3 µM, n=4)
(Sasaki et al., 2002), also decreased (p<0.05) the release of ATP induced by the
P2Y4 receptor agonist, MRS 4062 (10 µM) (Figure 9A). A similar interference was
observed with the IP3-receptor inhibitor, 2-APB (50 µM, n=4) (Figure 9A). The
inhibitory effect of CBX (300 µM) on the late component (phase II) of UTP (3 µM)-
induced [Ca2+]i response was not reproduced by the selective pannexin-1 (Panx1)
mimetic inhibitory peptide, 10Panx (100 µM, n=5) (Wang et al., 2007) (Figure 9D),
neither by mefloquine (MFQ, 3 µM, n=4), which is known to completely block
Cx36- and Cx50-containing hemichannels (Cruikshank et al., 2004).
Involvement of ATP release by vesicle trafficking and exocytotic granule
secretion was assessed using the vesicular transport inhibitor, brefeldin A (BFA)
(Nebenfuhr et al., 2002). No statistical significant (p<0.05) differences were found
in UTP (3 µM)-induced [Ca2+]i responses obtained in the absence and in the
presence of BFA (20 µM, n=8, Figure 9D).
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Figure 9 - UTP-induced [Ca2+]i accumulation partially depends on ATP release from rat cardiac
fibroblasts via hemichannels containing connexin-43 (Cx43). Panel A represents the ATP content
of samples collected from rat cardiac fibroblast culture media 5 min after incubation with MRS 4062
(10 µM) in the absence and in the presence of carbenoxolone (300 µM), 2-APB (50 µM) and
H1152 (3 µM). Each bar represents pooled data from an n number of experiments. The vertical
bars represent S.E.M.. *p<0.05 represent significant differences from control values obtained when
only Tyrode’s solution was added to the cultures; #p<0.05 represent significant differences from the
effect of MRS 4062 (10 µM) alone. Panel B shows the presence of Cx43 immunoreactivity in
cultured CF; shown is a confocal micrograph and representative immunoblots from two different
individuals (a and b). Images are representative of three independent experiments; scale bar is 100
µm. Panel C represents [Ca2+]i oscillations induced by UTP (3 µM) in the absence and in the
presence of the Cx43-containing hemichannel blocker, carbenoxolone (CBX, 300 µM). Panel D
shows the influence of CBX (300 µM), Mefloquine (MFQ, 3 µM), 10Panx (100 µM), and the vesicular
transport inhibitor, brefeldin A (20 µM), on UTP (3 µM)-induced [Ca2+]i plateau (phase II, 150-300 s).
[Ca2+]i transients were calibrated to the maximal calcium load produced by ionomycin (5 μM, 100%
response). Each point/bar represents pooled data from an n number of individuals; experiments
were performed in triplicate. The vertical bars represent S.E.M.. *p<0.05 represent significant
differences from UTP (3 µM) alone.
P2Y2 receptor-induced cardiac fibroblasts growth is partially counteracted
by co-activation of P2Y11 receptors
Previous reports from the literature suggest that UTP promotes growth of
CF through the activation of the P2Y2 receptor (Braun et al., 2010), but there are
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reasons to believe that profibrotic responses mediated by this receptor are
transient (<24 h) and the interplay with other receptors sensitive to UTP may also
play a role. Figure 10Ai shows that CF cultures from adult rats grown for 28 days
in control conditions proliferate slowly throughout the test period (Lindner et al.,
2012). Results concerning type I collagen production followed a similar pattern to
that obtained in the MTT (viability/proliferation) assay (Figure 10Aii), indicating that
under the present experimental conditions the amount of extracellular matrix being
produced depend directly on the number of viable cells in the culture.
Figure 10 - Role of uracil nucleotides, UTP and UDP, on proliferation/viability and type I collagen
production by adult rat CF grown for 28 days in culture. Panel A represents viability/proliferation of
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cells measured by the MTT assay (Ai) and total type I collagen production assessed by Sirius Red
staining (Aii); the ordinates represent absorbance determinations at 600 nm and 550 nm per well at
certain time points, respectively for the MTT assay and the Sirius Red staining. In panel B the
ordinates represent UTP (100 µM)- or UDP (100 µM)-induced changes in cell growth (MTT values,
Bi) and type I collagen production (Sirius Red values, Bii) as compared to controls in the absence
of uracil nucleotides at the same points (see panels Ai and Aii). Zero represents similarity between
the two values (uracil nucleotide vs control); positive and negative values represent facilitation or
inhibition of either cell growth or type I collagen production relative to control data obtained at the
same time points. Each bar represents pooled data from an n number of individuals; four replicas
were performed for each individual experiment. The vertical bars represent S.E.M.. *p<0.05
represent significant differences from control values obtained in the absence of test drugs, #p<0.05
represent significant differences from UTP (100 µM) alone.
Incubation of CF cultures with UTP (100 µM, n=20), but not with UDP (100
µM, n=4), increased (p<0.05) CF proliferation from the first week onwards. At days
21 and 28, the MTT values increased (p<0.05) by 17±3% and 22±3%, respectively,
in the presence of UTP (100 µM, n=20) as compared to control values (Figure
10Bi). UTP and UDP (100 µM) failed to increase (p>0.05) type I collagen
production above the control level indicating that uracil nucleotides act
predominantly to promote proliferation/viability of adult rat CF (Figure 10Bii and
Table 5).
Table 5 - Normalization of type I collagen production values to cell growth (MTT assay values) in
CF from adult rats grown in culture during 28 days. UTP (100 μM) was incorporated in culture
media, and, therefore, contacted with the cells throughout the whole assay. Because the amount of
type I collagen produced depends on the number of viable cells in culture, we normalized Sirius
Red absorbance values by the corresponding MTT values. Values are means ± SEM from an n
number of individuals; four replicas were performed for each individual experiment. *p<0.05
represent significant differences from control values obtained in the absence of UTP (100 μM).
Type I collagen (λ=550 nm) / MTT (λ= 600 nm)
Days Control (n=44) UTP 100 µM (n=17)
7 0.476 ± 0.025 0.453 ± 0.027
14 0.484 ± 0.018 0.426 ± 0.018
21 0.523 ± 0.025 0.407 ± 0.018 *
28 0.540 ± 0.026 0.377 ± 0.019 *
In order to characterize the P2Y receptor subtype involved on UTP-induced
proliferation, CF cultures were treated during 28 days with enzymatically-stable
and selective P2Y2, P2Y4 and P2Y11 receptor agonists. The P2Y2 receptor agonist,
MRS 2768 (30 µM, n=4), but not the P2Y4 agonist, MRS 4062 (10 µM, n=4),
increased (p<0.05) CF proliferation (Figure 11A and 11B). Conversely, selective
activation of the P2Y11 receptor with NF 546 (10 µM, n=9) significantly (p<0.05)
decreased CF growth (Fig. 11C). None of these agonists affected significantly
70 PhD THESIS – MARIANA DE SOUSA CERTAL GOMES
(p>0.05) type I collagen production with the exception of a small inhibitory effect
verified at day 28 in cultures treated with MRS 4062 (10 µM) (Figure 11B).
Figure 11 - Effects of selective P2Y2, P2Y4 and P2Y11 receptor agonists on proliferation/viability
and type I collagen production by adult rat CF grown for 28 days in culture. MRS 2768 (30 µM,
P2Y2 agonist), MRS 4062 (10 µM, P2Y4 agonist) or NF 546 (10 µM, P2Y11 agonist) were
incorporated in culture media, and, therefore, contacted with the cells during the whole assay. The
ordinates represent changes in cell growth (MTT values) and type I collagen production (Sirius Red
values) as compared to controls in the absence of test drugs at the same points (see Fig. 6). Zero
represents similarity between the two values (drugs vs control); positive and negative values
represent facilitation or inhibition of either cell growth or type I collagen production relative to
control data obtained at the same time points. Each bar represents pooled data from four
individuals; four replicas were performed for each individual experiment. The vertical bars
represent S.E.M.. *p<0.05 represent significant differences from control values obtained in the
absence of test drugs.
Involvement of the P2Y2 receptor on CF proliferation was further confirmed
by our results showing that suramin (Figure 12Ai), but not reactive blue-2 (Figure
12Aii), attenuated (p<0.05) UTP (100 µM)-induced CF growth, when the two
antagonists were applied in a concentration (30 µM) that, on its own, was devoid
of effect on cell proliferation. UTP (100 µM)-induced CF growth increased further
(p<0.05) upon blocking the P2Y11 receptor activation with NF 340 (10 µM, n=6)
(Figure 12Aiii); this finding reiterates the anti-proliferative action of the P2Y11
receptor on CF growth. Interestingly, blockade of Cx43-containing hemichannels
with CBX (10 µM) and, thereby, ATP release from the cells also boosted CF
proliferation induced by UTP (100 µM) in a similar manner to that obtained in the
presence of the P2Y11 receptor antagonist, NF 340 (10 µM) (Figure 12B).
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Figure 12 - The proliferative action of UTP via suramin-sensitive P2Y2 receptor on CF from adult
rats is partially counteracted by synchronous activation of P2Y11 receptors. UTP (100 µM) with or
without suramin (30 µM, Ai), reactive blue-2 (RB-2, 30 µM, Aii), NF 340 (10 µM, Aiii) or
Carbenoxolone (CBX 10 µM, B) were incorporated in culture media, and, therefore, contacted with
the cells during the whole assay. In panel A and B, the ordinates represent changes in cell growth
(MTT values) as compared to controls in the absence of test drugs at the same points (see Fig. 6).
Zero represents similarity between the two values (drugs vs control); positive and negative values
represent facilitation or inhibition of cell growth relative to control data obtained at the same time
points. Each bar represents pooled data from an n number of individuals; four replicas were
performed for each individual experiment. The vertical bars represent S.E.M.. *p<0.05 represent
significant differences from control values obtained in the absence of test drugs. #p<0.05 represent
significant differences from UTP (100 µM) alone. Panel C shows P2Y2 and P2Y11 receptors
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immunoreactivity of adult rat CF cultured with UTP (100 µM) during 28 days. Confocal micrographs
shown are representative of three independent experiments; scale bar is 100 µm.
After growing cells in culture during 28 days in the presence of UTP (100
µM), adult rat CF differentiate into stellate shaped myofibroblasts (see also Figure
4) which still express significant amounts of P2Y2 and P2Y11 receptors (Figure
12C). Cell processes of activated CF exhibit outstanding P2Y11 receptor
immunoreactivity, whereas the P2Y2 receptor staining is sparser.
Cyclic AMP mediates the anti-proliferative effect of the P2Y11 receptor in rat
cardiac fibroblasts
Considering the involvement of the AC / cyclic AMP cascade on UTP-
induced [Ca2+]i responses operated by the P2Y11 receptor in CF, we investigated
the contribution of this pathway to the anti-proliferative effect of NF 546 using a
similar experimental strategy. Figure 13 shows that the inhibitory effect of the
selective P2Y11 receptor agonist, NF 546 (10 µM), decreased consistently (p<0.05)
upon blocking the activity of AC and EPAC respectively with SQ 22536 (30 µM,
n=3) (Figure 13A) and ESI-09 (10 µM, n=3) (Figure 13B). Modification of the anti-
proliferative action of NF 546 (10 µM) in the presence of the potent PKA inhibitor,
H-89 (10 µM, n=3), was restricted to culture day 21 (Figure 13AC).
Figure 13 - Cyclic AMP mediates the anti-proliferative effect of the P2Y11 receptor in rat cardiac
fibroblasts. Shown is the variation of cell growth caused by continuous application of UTP (100 µM)
to the culture medium in the absence and in the presence of inhibitors of AC, PKA and EPAC,
respectively SQ 22536 (30 µM, A), H-89 (10 µM, B) and ESI-09 (10 µM, C). The ordinates
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represent changes in MTT values compared to control cultures grown in the absence of test drugs
at the same time points. Each column represents pooled data from n individuals; 4 replicates were
performed for each individual experiment. The vertical bars represent S.E.M.. *p < 0.05 represent
significant differences compared with the effect of UTP (100 µM) alone.
Discussion
Using selective agonists and antagonists of pyrimidine-sensitive P2Y
purinoceptors, our results indicate that metabotropic P2Y2 and P2Y4 exert
dominant roles on UTP-induced proliferation and [Ca2+]i signaling, respectively, in
cardiac myofibroblasts isolated from adult rat ventricles. While these findings
agree with the previously described pro-fibrotic action of the nucleotide (Chen et
al., 2012; Yitzhaki et al., 2006), we suggest here that this characteristic may be
partially counteracted by synchronous activation of a previously unrecognized
P2Y11 receptor that is positively coupled to the AC / cyclic AMP / EPAC pathway in
CF (see e.g. Kugelgen et al., 2006). The anti-proliferative action of the P2Y11
receptor may contribute to the reported cardioprotective effect of this receptor
against ischemia and reperfusion (Djerada et al., 2013), since in this condition high
extracellular adenine and uracil nucleotide levels are detected (Wihlborg et al.,
2006).
Notwithstanding the fact pyrimidine-sensitive P2Y2, P2Y4, P2Y6 and P2Y11-
like receptors have been reported in cardiac myofibroblasts from neonatal rats
(Talasila et al., 2009), there is a lack of information regarding the role of these
receptors on cell proliferation and differentiation during a time (e.g. 28 days)
required to operate remodeling changes in the heart in vivo. Moreover, data
obtained in developmentally immature cells must be interpreted with caution when
one wants to extrapolate the results to adulthood (Zhou and Dobrev, 2012). As a
matter of fact, it has been shown that activation of P2Y2 receptors up-regulates the
proliferation of human CF (Chen et al., 2012) and that these receptors are involved
in Ca2+ signaling in human valvular myofibroblasts (Liang et al., 2008). The pro-
fibrotic effect of UTP, via the activation of P2Y2 receptors, was also observed in
adult rat CF and this effect was blunted in P2Y2-/- mice (Braun et al., 2010). There
are, however, reasons in the literature to believe that P2Y2 receptor-mediated pro-
fibrotic responses are transient (<24 h) and UTP effects may implicate ATP
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release from stimulated cells and the interplay with other P2Y receptors, which
pharmacological profile was explored in our study.
Intracellular calcium is essential for CF proliferation, migration and
transdifferentiation into (activated) myofibroblasts. Moreover, abnormalities in Ca2+
handling by cardiac cells may determine arrhythmogenesis and heart fibrosis. We
report here that adult rat CF respond to UTP by increasing [Ca2+]i through the
activation of fast desensitizing P2Y4 receptors, which are co-expressed with P2Y2
and P2Y11 receptors that maintain their presence and activity in cells for weeks as
demonstrated by immunofluorescence confocal microscopy, Western blot analysis
and long-term (28 days) proliferation studies. The dominant role of the P2Y4
receptor over P2Y2 and P2Y11 receptors on fast [Ca2+]i signals operated by UTP
was inferred by the rank order of potency of subtype-selective agonists: MRS
4062 > MRS 2768 ~ NF 546, respectively. Furthermore, attenuation of UTP-
induced [Ca2+]i transients by both suramin and reactive blue-2 also supports the
involvement of the P2Y4 receptor (Kugelgen et al., 2006). Participation of the P2Y6
receptor, which could be activated by UDP resulting from the extracellular
catabolism of UTP by ectonucleotidases, was discarded since UDP (100 µM) was
the least potent agonist and no changes were verified on [Ca2+]i transients
produced by both UTP and UDP in the presence of MRS 2578 (Mamedova et al.,
2004); it is worth to note that in this study MRS 2578 was applied in a higher
concentration (300 nM) than that required to prevented activation of P2Y6
receptors at the rat urinary bladder (Carneiro et al., 2014) and in human bone
marrow stromal cells (Noronha-Matos et al., 2012).
Functional data shows that UTP and the P2Y4 receptor agonist MRS 4062
trigger fast [Ca2+]i responses, which desensitize very rapidly upon repeated
agonist applications. Rapid mobilization of [Ca2+]i seems to occur via the activation
of a Gq protein-coupled receptor linked to the PLC/IP3 pathway in CF. This
conclusion is based on several lines of evidence, including the fact that (1)
inhibition of PLC with U73122, (2) blockade of the IP3 receptor with 2-APB, and (3)
depletion of intracellular Ca2+-stores with thapsigargin plus caffeine, all attenuated
the fast [Ca2+]i mobilization by UTP. Extracellular Ca2+ may also play some role to
sustain the late component (phase II) of UTP-induced [Ca2+]i rise, since its removal
from the incubation medium significantly attenuated the nucleotide response.
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Fibroblasts lack voltage-gated Ca2+ channels and Ca2+ influx in response to
activation of G-protein-coupled receptors sensitive to UTP is more likely to occur
predominantly via ligand-gated ion channels. Cooperation between metabotropic
P2Y receptors and ionotropic P2X4 and P2X7 receptors could be one possibility to
explain late [Ca2+]i oscillations induced by UTP, since these receptor subtypes
coexist in CF and possess unified pro-fibrotic actions (reviewed in Lu et al., 2014).
The fact that ionotropic P2X receptors are almost exclusively activated by ATP
and, thus, insensitive to uracil nucleotides, is apparently not a problem since we
showed here that selective activation of the P2Y4 receptor with MRS 4062
facilitates ATP translocation to the extracellular milieu in CF. Regrettably, we failed
to block [Ca2+]i responses produced by ATP (3-300 µM) in the presence of two
highly selective and potent P2X4 and P2X7 receptor antagonists, respectively 5-
BDBD (3-10 µM) and A 438079 (3-10 µM) (unpublished observations).
Crosstalk between UTP-sensitive P2Y receptors and other ligand-gated ion
channels, such as TRPM7 and TRPC3, may have pathophysiological impact given
that these receptors contribute to fibroblast-to-myofibroblast transition and cardiac
arrhythmogenesis (reviewed in Zhou et al., 2012). Coincidently or not, the TRPM7
channel is activated by a cyclic AMP-dependent pathway and is blocked by 2-APB,
when the latter compound is applied in the micromolar concentration range
(reviewed in Chatelier et al., 2012). 2-APB also blocks all members of the TRPC
family, which can be stimulated by diacylglycerol and act as store operated
channels to compensate for depletion of intracellular Ca2+ stores (Parekh and
Putney, 2005). These features fit in the results obtained in this study. However,
most of the pharmacological tools available to study the activity of TRP channels
lack specificity, thus preventing investigation of more definitive involvement of
these channels on Ca2+ influx into CF besides our data showing that 2-APB (50
µM) depresses UTP-induced [Ca2+]i plateau.
Another possibility to increase Ca2+ influx into cardiac myofibroblasts linked
to activation of UTP-sensitive P2Y receptors is their interplay with the Na+/Ca2+-
exchanger (NCX) operating in the reverse mode. Involvement of the NCX is
possible because these cells express Nav1.5 channels, which are responsible for
larger and persistent Na+ currents compared to those observed in cardiomyocytes
(Chatelier et al., 2012). NCX has been shown to contribute to intracellular Ca2+
overload in cardiomyocytes during myocardial infarction (Chao and Xia, 2010), a
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situation that favors adenine and uracil nucleotides overflow into the extracellular
milieu (Wihlborg et al., 2006). Notwithstanding this possibility, selective inhibition
of NCX with KB-R7943 (Lailov et al., 1999) or ORM-10103 (Jost et al., 2013) did
not affect UTP-induced [Ca2+]i signals in rat CF.
Involvement of an AC / cyclic AMP pathway on late [Ca2+]i oscillations was
hypothesized because stimulation of CF with UTP concentration-dependently
increased intracellular cyclic AMP levels. Moreover, we showed that both
reversible and irreversible inhibition of the AC activity respectively with SQ 22536
and MDL12,330a impacted on the magnitude of UTP-induced [Ca2+]i plateau.
Considering that the P2Y11 receptor is the only P2 receptor subtype positively
coupled to AC (Balogh et al., 2005; Amisten et al., 2007), accumulation of cyclic
AMP points towards the concurrent activation of this receptor as a consequence of
CF stimulation by UTP. In agreement with this hypothesis data demonstrated that
the inhibitory effects of SQ 22536 and MDL12,330a were very similar to that
obtained with the selective P2Y11 receptor antagonist, NF340.
Cellular effects operated by cyclic AMP have been mostly attributed to the
activation of PKA. However, novel cyclic AMP targets have emerged to explain cell
responses that are insensitive to PKA inhibition (reviewed in Dekkers et al., 2013).
The exchange protein directly activated by cAMP (EPAC) is a cyclic AMP-
regulated guanine nucleotide exchange factor (GEF) that favors GDP/GTP
exchange and, thereby, activation of small Ras-like GTPases, such as Rho, Rac
and Ras. Interestingly, EPAC is known to control distinct cellular responses,
including calcium handling, cell proliferation, differentiation, migration, fibrogenic
and inflammatory responses. In the present study, we show that inhibition of
EPAC with ESI-09, but not PKA with H-89, decreased UTP-induced [Ca2+]i
oscillations and attenuated the anti-proliferative effect of the P2Y11 agonist, NF
546. This is not surprising since data in the literature indicate that EPAC and PKA
differentially inhibit specific fibroblast functions (Dekkers et al., 2013). For instance,
activation of PKA inhibits collagen synthesis by inhibiting the pro-fibrotic protein
kinase C-  , whereas activation of EPAC inhibits fibroblast growth by activating
Rap1 and subsequent inhibition of extracellular signal-regulated kinases (ERK) in
the airways. Notwithstanding, both PKA and EPAC contribute to inhibit fibroblast
transdifferentiation to myofibroblasts induced by several G-protein-coupled
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receptors. Investigation of all putative downstream effectors of the EPAC pathway
in CF, which include phospholipase C-ε, phospholipase D, extracellular signal-
regulated kinases (ERK1/2), phosphoinositide 3-kinase-dependent protein-kinase
B (PKB)/Akt, and nuclear factor (NF)-κB (reviewed in Dekkers et al., 2013), is still
lacking yet it is certainly beyond the scope of this study. Alternatively, the P2Y11
receptor can contribute to sustain [Ca2+]i by favoring cyclic adenosine diphosphate
ribose (cADPR) production and subsequent ADP-ribosylcyclase (ADPRC)
activation, which catalyzes the synthesis of various molecules endowed with Ca2+
mobilizing activity (Moreschi et al., 2008), but this also needs further investigations.
To our knowledge this is the first time that the UTP-sensitive P2Y11 receptor
has been involved in Ca2+ influx from the extracellular milieu required to sustain
the plateau phase of [Ca2+]i response in CF. Other authors reported that ATP and
UTP equally increased [Ca2+]i in 1321N1 neuroblastoma cells transfected with the
human P2Y11 receptor (Communi et al., 1999), but the two nucleotides diverge on
the signaling pathways recruited to increase [Ca2+]i even though they might be
acting on the same receptor population (Balogh et al., 2005; Amisten et al., 2007).
Synergism between P2Y4 and P2Y11 receptors to increase [Ca2+]i in CF may be
explained either by synchronous activation of both receptors coupled to distinct
signaling pathways or by the involvement of UTP-induced ATP release
(Kringelbach et al., 2014) leading to subsequent P2Y11 receptor activation. Our
findings suggest that AC and PLC act independently in a cooperative manner to
sustain elevated [Ca2+]i levels during the plateau (phase II) of the UTP response.
Release of ATP and autocrine positive feedback through P2Y11 receptors has
been demonstrated in macrophages activation by lipopolysaccharide (Sakaki et al.,
2013). CF can release ATP via connexin hemichannels) (Lu et al., 2012) and the
release of the nucleotide has been involved in [Ca2+]i signaling cooperation
between P2Y and other metabotropic receptors (e.g. histamine H1, bradykinin B2)
in human fibroblasts of the subcutaneous tissue (Pinheiro et al., 2013a; Pinheiro et
al., 2013b). Data from this study show that activation of the P2Y4 receptor with
MRS 4062 facilitates the translocation of ATP to the extracellular milieu.
Involvement of hemichannels containing Cx43 in ATP release was inferred (1) in
confocal microscopy and Western blot studies, demonstrating that CF exhibit Cx43
immunoreactivity, and (2) in functional studies, showing that blockage of Cx43-
containing hemichannels with CBX and H-1152 decreased both the release of
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ATP and the magnitude of late [Ca2+]i signals produced by UTP. Interestingly, the
use of connexin-blocking antibodies can disrupt both myocyte-fibroblast and
fibroblast-fibroblast communication aside from electrical regulation (Baudino et al.,
2008). A better understanding of these interactions may elucidate if ATP release
via Cx43-containing hemichannels also play a role in cell-to-cell signaling and
cardiac remodeling.
Proliferation and migration of CF are key events in the fibrotic response of
cardiac remodeling, and extracellular nucleotides are known to have mitogenic
properties in several types of cells. Our data also demonstrate that adult rat CF
respond to UTP, but no to UDP, by increasing cell growth through the activation of
P2Y2 receptors. This was suggested because the selective P2Y2 receptor agonist,
MRS 2768 (Ko et al., 2008), mimicked the proliferative effect of UTP, whereas
activation of the P2Y4 receptor with MRS 4062 (Meis et al., 2010) was without
effect on long-term CF growth evaluation. Differences between the blocking
potency of suramin and reactive blue-2, with the latter being a weaker P2Y2
receptor antagonist than suramin (Kugelgen et al., 2006), strengthen our
assumption that UTP favors proliferation of rat CF preferentially via P2Y2 receptor
activation. The lack of a P2Y4 receptor-mediated effect on CF growth is not
surprising given that we show here that this receptor desensitizes rapidly upon
repeated applications or prolonged contact with its agonists, either UTP or MRS
4062. Normalization of type I collagen production by the number of viable cells
(MTT assay) indicates that UTP exerts a preferential effect on cell growth rather
than in extracellular matrix deposition. Interestingly, the overall effect of UTP on
CF growth was balanced by synchronous activation of P2Y11 receptors and this
was concluded because selective blockade of this receptor with NF 340 (Meis et
al., 2010) potentiated growth of CF caused by long-term exposure to the
nucleotide. The anti-proliferative effect of the P2Y11 receptor was confirmed using
the selective agonist of this receptor, NF 546, which significantly decreased CF
growth under similar experimental conditions.
Conclusion
In conclusion, our findings show that UTP-sensitive P2Y2, P2Y4 and P2Y11
receptors differentially affect [Ca2+]i signals and proliferation of rat CF. Activation of
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the P2Y4 receptor is the main responsible for UTP-induced [Ca2+]i accumulation,
an effect that was prolonged by synchronous activation of the P2Y11 receptor by
ATP released through Cx43-containing hemichannels leading to Ca2+ influx from
the extracellular milieu. More importantly, data from this study show that long-term
activation of the P2Y11 receptor counteracts the proliferating effect of UTP
operated by the P2Y2 receptor on cultured CF. The anti-proliferative property of
the novel P2Y11 receptor seems to be mediated by downstream activation of the
AC / cyclic AMP / EPAC pathway. This property, together with the prominent
action of the P2Y11 receptor in controlling cardiomyocyte contractility may point
towards this receptor being an important target for therapeutic intervention to
prevent deleterious cardiac remodeling under various pathological conditions.
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Abstract
Nucleotides released during heart injury affect myocardium
electrophysiology and remodelling through P2 purinoceptors activation in cardiac
fibroblasts (CF). ATP and UTP endorse [Ca2+]i accumulation and growth of DDR-
2/(-SMA-expressing myofibroblasts from adult rat ventricles via P2Y4 and P2Y2
receptors activation, respectively. Ventricular myofibroblasts also express ADP-
sensitive P2Y1, P2Y12 and P2Y13 receptors as demonstrated by
immunocytochemistry and western blot analysis, but little information exists on
ADP effects in these cells. ADP (0.003-3mM) caused fast [Ca2+]i transients
originated from thapsigargin-sensitive internal stores, which partially declined to a
plateau sustained by capacitative Ca2+ entry through transient receptor potential
(TRP) channels that can be inhibited by 2-APB (50µM) and flufenamic acid
(100µM). Hydrophobic interactions between Gq/11-coupled P2Y purinoceptors and
TRP channels were suggested by prevention of the ADP-induced [Ca2+]i plateau
after PIP2 depletion with LiCl (10mM) and removal of cholesterol from lipid rafts
with methyl-ß-cyclodextrin (2mM). ADP [Ca2+]i transients were insensitive to P2Y1,
P2Y12 and P2Y13 receptor antagonists, MRS2179 (10µM), AR-C66096 (0.1µM)
and MRS2211 (10µM), respectively, but were attenuated by suramin and reactive
blue-2 (100 µM) which also blocked P2Y4 receptors activation by UTP. CF growth
and type I collagen production were favoured upon activation of MRS2179-
sensitive P2Y1 receptors with ADP or ADPßS (30 µM). In conclusion, ADP exerts
a dual role on ventricular myofibroblasts: [Ca2+]i transients are mediated by fast-
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desensitizing P2Y4 receptors, whereas the pro-fibrotic effect of ADP involves the
P2Y1 receptor. Data also show that ADP-induced capacitative Ca2+ influx depends
on phospholipase C-linked TRP channels opening in lipid raft microdomains.
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Introduction
Cardiac fibroblasts (CF) outnumber cardiomyocytes in adult hearts (Porter
and Turner, 2009). Due to their abundance, strategic localization and remarkable
potential for activation, CF may serve as sentinel cells that sense myocardial injury
and trigger reparative responses (Shinde and Frangogiannis, 2014). These cells
contribute to maintain extracellular matrix (ECM) homeostasis and to distribute
mechanical forces throughout the myocardium; CF also serve as an electrical
barrier between atria and ventricles in order to facilitate proper cardiac contraction
(Camelliti et al., 2005; Zeisberg and Kalluri, 2010). Mounting evidences
demonstrate that upon activation by mechanic, noxious and inflammatory stimuli
resident quiescent CF transdifferentiate into myofibroblasts, a fibroblast-smooth
cell hybrid that more effectively secretes growth factors, cytokines and other
signalling molecules through mechanisms mostly driven by intracellular Ca2+
transients. Besides the paracrine effects of cardiac myofibroblasts, disruption of
direct cell-cell communication can lead to dysregulation of biochemical,
mechanical and electrical signals to neighbouring cardiomyocytes (Baudino et al.,
2008). Thus, involvement of CF in myocardial dysfunction and arrhythmogenesis
makes these cells natural targets in cardiac remodelling, yet the molecular signals
and intracellular pathways underlying their activation, proliferation and
differentiation remain incompletely understood.
During stressful conditions, such as cardiac ischemia/reperfusion and
myocardium overload, ATP and UTP are released in huge amounts into the
extracellular milieu (Wihlborg et al., 2006) favouring the activation of multiple P2
purinoceptor subtypes (Burnstock, 2006). The extent of P2 purinoceptors-
mediated actions by adenine and uracil nucleotides may be limited by the
presence of membrane-bound ecto-nucleotidases, which sequentially degrade
nucleoside 5’-triphosphates to their respective nucleoside 5’-di- and
monophosphates (Yegutkin, 2008; Cardoso et al., 2015). Besides the well-
recognized roles of ATP and its end-product, adenosine, few reports have
questioned the action of biologically-active intermediate metabolites, such as ADP,
in cardiac function and remodelling. ADP is a preferential activator of G-protein-
coupled P2Y1, P2Y12 and P2Y13 receptors (Burnstock, 2006), but the nucleotide
may also activate the UTP-preferring P2Y4 receptor (Bogdanov et al., 1998)
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implicated on fast [Ca2+]i transients in cardiac myofibroblasts (Certal et al., 2015).
While P2Y1 and P2Y4 receptors couple to the phospholipase C / IP3 /
diacylglycerol (DAG) pathway via a Gq/11 protein anchor, the P2Y12 and P2Y13
receptors most frequently inhibit adenylate cyclise activity through Gi/o protein
coupling (Alexander et al., 2015).
The presence of P2Y1, P2Y4 and P2Y13 receptor transcripts has been
demonstrated in neonatal rat cardiac fibroblasts by reverse transcription-
polymerase chain reaction (RT-PCR) and/or Northern blot analysis (Zheng et al.,
1998; Talasila et al., 2009). In a recent study, we demonstrated by
immunofluorescence confocal microscopy and Western blot analysis that CF from
adult rat ventricles express UTP-sensitive P2Y2, P2Y4 and P2Y11 receptors, which
activation differently regulates [Ca2+]i signalling and cells growth (Certal et al.,
2015). However, little information exists on the role of ADP-preferring P2Y
receptors in CF physiology.
Assembly of metabotropic purinergic receptors and signalling molecules is
highly dependent on specialized membrane microdomains (lipid rafts, raft-like
structures, caveolae) (D’Ambrosi and Volonté, 2013). These specialized
membrane structures enclose complex control systems involving molecular
association, cooperation, conformational or electronic state changes of enzymes,
receptors and channels. Caveolae are 50- to 100-nm omega-shaped invaginations
at the plasma membrane formed by polymerization of caveolins, hairpin-like
palmitoylated integral membrane proteins from lipid rafts that tightly bind
cholesterol (Williams and Lisanti, 2004). Caveolin-1 is the principal structural
component of caveolae in CF and can be used as a marker of these structures
(Gratton et al., 2004). Caveolin-binding motifs are present in many caveolae-
associated proteins, like G proteins, protein kinase C (PKC), ion channels and
transporters. Binding to caveolin is able to segregate cellular processes during
signal transduction by promoting isolated assembly of membrane protein
superstructures and to focus signalling input by accumulation of specific receptors
within lipid raft/caveolae microdomains. It is well known that P2 purinoceptors (in
particular metabotropic P2Y1, P2Y2, P2Y4, P2Y6 and P2Y12, but also P2Y13), as
well as ectonucleotidases and nucleotide transporters, localize in lipid
rafts/caveolae in many cell types (Garcia-Marcos et al., 2009; reviewed in
D’Ambrosi and Volonté, 2013), but no data is available concerning CF.
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This study was designed to investigate the role of ADP on [Ca2+]i signalling
and long-term growth of cultured CF from adult rat ventricles using subtype-
selective agonists and antagonists of P2Y1, P2Y4, P2Y12 and P2Y13 receptors. We
also attempted to investigate the signalling pathways implicated in ADP-induced
[Ca2+]i oscillations, cell proliferation and type I collagen production by CF using
enzymatic inhibitors and subtype-specific ion channel blockers. The impact of lipid
raft/caveolae organization of the plasma membrane in the lateral assembly
between ADP-sensitive P2Y receptors and corresponding signalling pathways was
evaluated using methyl-ß-cyclodextrin, which depletes cholesterol from plasma
membrane lipid rafts.
Methods
Drugs and solutions
Adenosine 5′-diphosphate sodium salt (ADP), adenosine 5’-(α,β-methylene)
diphosphate (ADPßS), 2-aminoethoxydiphenylborane (2-APB), bovine serum
albumin (BSA), bromophenol blue, caffeine, 2-mercaptoethanol, methyl-β-
cyclodextrin, 1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan (thiazolyl blue
formazan – MTT), direct red 80, ethylenediaminetetraacetic acid (EDTA), ethylene
glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA), fetal bovine
serum (FBS), flufenamic acid, glycerol, phosphate buffered saline system (PBS),
picric acid, protease inhibitor cocktail, reactive blue-2 (RB-2), suramin sodium salt,
sodium deoxycholate, sodium dodecyl sulphate (SDS), trypsin, Tween 20, type I
collagenase, uridine 5′-triphosphate (UTP), and cell culture reagents were from
Sigma-Aldrich (St. Louis, USA). 2-(propylthio)adenosine-5’-O-(ß,γ-difluoro
methylene) triphosphate tetrasodium salt (AR-C66096), 1,2-dimethoxy-12-
methyl[1,3]benzodioxolo[5,6-c]phenanthridinium chloride (Chelerytrine), 2-[2-[4-(4-
nitrobenzyloxy) phenyl]ethyl]isothiourea mesylate (KB-R7943), cis-N-(2-
phenylcyclopentyl)-azacyclotridec-1-en-2-amine hydrochloride (MDL 12,330a), 2-
[(2-chloro-5-nitrophenyl)azo]-5-hydroxy-6-methyl-3-[(phosphornooxy)methyl]-4-
pyridine carboxaldehyde disodium salt (MRS2211), 2’-deoxyN6-methyladenosine
3’,5’-biphosphate tetrasodium salt (MRS2179), [[(1R,2R,3S,4R,5S)-4-[6-Amino-2-
(methylthio)-9H-purin-9-yl]-2,3-dihydroxybicyclo [3.1.0]hex-1-yl]methyl]
diphosphoric acid mono ester trisodium salt (MRS2365), thapsigargin, 1-[6-[[(17β)-
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3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122)
and 9-(tetrahydro-2-furanyl)-9H-purin-6-amine (SQ 22536) were obtained from
Tocris Cookson Inc. (Bristol, UK). LiCl was obtained from Merck (Darmstadt,
Germany). Fluo-4 NW dye was supplied by Molecular Probes (Eugene, OR, USA).
U73122, thapsigargin and SQ 22536 were dissolved in dimethylsulphoxide
(DMSO). The other drugs were dissolved in distilled water. All stock solutions were
stored as frozen aliquots at -20ºC. Dilutions of these stock solutions were made
daily and appropriate controls were done. DMSO (<0.05% v/v) did not affect the
parameters under study.
Animals
Wistar rats (150-200 g) of either sex (Charles River, Barcelona, Spain) were
kept at a constant temperature (21 ºC) and a regular light (06.30 –19.30 h) - dark
(19.30–06.30 h) cycle, with food and water ad libitum. Animal handling and
experiments were in accordance with the guidelines prepared by Committee on
Care and Use of Laboratory Animal Resources (National Research Council, USA)
and followed the European Communities Council Directive (86/609/EEC). All
studies involving animals are reported in accordance with the ARRIVE guidelines
for reporting experiments involving animals (McGrath et al., 2010).
Cell cultures
Rat cardiac fibroblasts were isolated from the ventricles of adult Wistar rats
by the explant technique in which fibroblasts migrate from minced tissue and grow
in fibroblast growth medium (Certal et al., 2015). Cells were cultured in DMEM
medium supplemented with 15% fetal bovine serum (FBS), 1% of amphotericin B
and 1% of penicillin/streptomycin, at 37 ºC in a humidified atmosphere of 95% air
and 5% CO2. Medium was replaced twice a week. Primary cultures were
maintained until near confluence (~3-4 weeks), then adherent cells were
enzymatically released with 0.04% trypsin-EDTA solution plus 0.025% type I
collagenase in phosphate-buffered saline (PBS). The resultant cell suspension
was cultured and maintained in the same conditions mentioned above.
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Measurement of [Ca2+]i
Changes in [Ca2+]i were measured with the calcium sensitive dye Fluo-4
NW (Molecular Probes, Eugene, OR, USA) in a multi detection microplate reader
(Synergy HT, BioTek Instruments Inc., Winooski, VT, USA) (Certal et al., 2015).
Briefly, rat cardiac fibroblasts were seeded in flat bottom 96 well plates (Costar,
Corning Inc., NY, USA) at a density of 3x104 cells/mL. Cells were cultured for 7
days in supplemented DMEM as described before. On the day of the experiment,
cells were washed twice with Tyrode’s solution (137 mM NaCl, 2.7 mM KCl, 1.8
mM CaCl2, 1 mM MgCl2, 0.4 mM NaH2PO4, 11.9 mM NaHCO3, and 11.2 mM
glucose, pH 7.4) and incubated at 37ºC for 45 minutes with the cell-permeant
fluorescent Ca2+ indicator, Fluo-4 NW (2.5 µM), in 1x HBSS, 20 mM HEPES and
2.5 mM probenecid. After removal of the fluorophore loading solution, cells were
washed again twice and 150 µL of Tyrode’s solution was added per culture well.
For the recordings, temperature was maintained at 32 ºC and readings were made
with 5 s of interval, during approximately 30 min, using a tungsten halogen lamp.
Fluorescence was excited at 485/20 nm and emission was measured at 528/20
nm. Calcium measurements were calibrated to the maximal calcium load produced
by the calcium ionophore, ionomycin (5 µM, 100% response) (Certal et al., 2015;
Pinheiro et al., 2013a; Pinheiro et al., 2013b).
Cell viability/proliferation
Viability/proliferation studies included the MTT assay as previously
described (Certal et al., 2015; Pinheiro et al., 2013a; 2013b). Rat cardiac
fibroblasts were seeded in flat bottom 96 well plates at a density of 3x104 cells/mL
and cultured in supplemented DMEM as described before. Cell cultures were
routinely monitored by phase contrast microscopy and characterized at days 1, 7,
14, 21 and 28. The MTT assay consists on the reduction of 3-[4,5-dimethylthiazol-
2-yl]-2,5-diphenyltetrazolium bromide (MTT) to a purple formazan reaction product
by viable cells. In the last 4h of each test period, cells were incubated with 0.5
mg/mL of MTT in the conditions referred above. The medium was carefully
removed, decanted and the stained product dissolved with DMSO before
absorbance (A) determination at 600 nm using a microplate reader spectrometer
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(Synergy HT, BioTek Instruments Inc., Winooski, VT, USA). Results were
expressed as A/well.
Type I collagen determination
Type I collagen determination was performed using the Sirius Red staining
assay (see Certal et al., 2015). Rat cardiac fibroblasts were cultured as described
for the viability/proliferation studies. The staining protocol was adapted from
Tullberg-Reinert and Jundt (2009). Cell layers were washed twice in PBS before
fixation with Bouin’s fluid for 1 h. The fixation fluid was removed by suction and the
culture plates were washed by immersion in running tap water for 15 min. Culture
dishes were allowed to air dry before adding the Sirius Red dye (Direct Red 80).
Cells were stained for 1 h under mild shaking on a microplate shaker. To remove
non-bound dye, stained cells were washed with 0.01 N hydrochloric acid and then
dissolved in 0.1 N sodium hydroxide for 30 minutes at room temperature using a
microplate shaker. Optical density was measured at 550 nm using 0.1 N sodium
hydroxide as blank (Tullberg-Reinert and Jundt, 1999; Certal et al., 2015). Results
were expressed as A/well.
Immunocytochemistry
Rat cardiac fibroblasts were seeded in chamber slides at a density of
2.5x104 cells/mL and allowed to grow for 7-28 days. Cultured cells were fixed in
4% paraformaldehyde (PFA) in PBS for 10 minutes, washed 3 times in PBS (10
minutes each) and, subsequently, incubated with blocking buffer I (10% FBS, 1%
bovine serum albumin (BSA), 0.1% Triton X, 0.05% NaN3) for 1 h. Primary
antibodies, diluted in blocking buffer II (5% FBS, 1% BSA, 0.1% Triton X, 0.05%
NaN3 in PBS), were applied [mouse anti-porcine vimentin 1:250 (DAKO); goat anti-
human DDR2 1:25 (Santa Cruz); mouse anti human α-smooth muscle actin-FITC
1:250 (Sigma); rabbit anti-mouse P2Y1 1:50 (Alomone), rabbit anti-mouse P2Y12
1:100 (Alomone), rabbit anti-human P2Y13 1:25 (Alomone); mouse anti-human
caveolin-1 1:400 (Abcam)] and the slides incubated overnight at 4ºC. After
incubation, cells were washed 3 times in PBS 1X (10 minutes each). The donkey
anti-rabbit IgG Alexa Fluor 488, donkey anti-mouse IgG Alexa Fluor 488, donkey
anti-goat IgG Alexa Fluor 633 and anti-guinea pig IgG Alexa Fluor 568 secondary
antibodies (Invitrogen) were diluted in blocking buffer II and applied for 1h at dark.
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Cross-reactivity of the secondary antibodies was tested in control experiments in
which primary antibodies were omitted. Finally, a last wash was performed with
PBS 1X and glass slides were mounted with VectaShield medium and stored at
4ºC. Observations were performed and analysed with a laser scanning confocal
microscope (Olympus FV1000, Olympus, Tokyo, Japan) (Noronha-Matos et al.,
2012; Pinheiro et al., 2013a; Pinheiro et al., 2013b; Certal et al., 2015).
SDS-PAGE and Western blotting
Cardiac fibroblasts were homogenized in a lysis buffer with the following
composition: 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.5% sodium deoxycholate,
1% Triton-X-100m 0.1% SDS and protease inhibitor cocktail. Protein content of the
samples was evaluated using the BCA protein assay kit according to the
manufacturer’s instructions (Pierce, Rockford, IL, USA). Samples were solubilized
in SDS reducing buffer (0.125 mM Tris-HCl, 4% SDS, 0.004% bromophenol blue,
20% glycerol, and 10% 2-mercaptoethanol, pH 6.8 at 70 ºC for 10 min), subjected
to electrophoresis in 10% SDS-polyacrylamide gels and electrotransferred onto
PVDF membranes (Millipore, MA, USA). Protein loads were 100 µg for P2Y1,
P2Y12 e P2Y13 receptors. The membranes were blocked for 1 h in Tris-buffered
saline (TBS: 10 mM Tris-HCl, pH 7.5, 150 mM NaCl) containing 0.05% Tween 20
+ 5% BSA. Membranes were subsequently incubated with rabbit anti-mouse P2Y1
1:200 (Alomone), rabbit anti-mouse P2Y12 1:200 (Alomone) and rabbit anti-human
P2Y13 1:200 (Alomone) in the above blocking buffer overnight at 4 ºC. Membranes
were washed three times for 10 min in 0.1% Tween 20 in TBS and then incubated
with donkey anti-rabbit IgG (HRP) (1:30000) (Abcam) and donkey anti-goat IgG
(HRP) (1:25000) (Abcam) secondary antibody, for 60 min at room temperature.
For comparison purpose, the membranes were also incubated with rabbit anti-
human ß-actin 1:2500 (Abcam) and rabbit anti-human ß-tubulin 1:2500 (Abcam)
antibodies following the procedures described above. Membranes were washed
three times for 10 min and antigen-antibody complexes were visualized with the
Immun-Star WesternC Chemiluminescent Kit (Bio-Rad Laboratories) using the
ChemiDoc MP imaging system (Bio-Rad Laboratories).
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Presentation of data and statistical analysis
Concentration-response curves were fitted by non-linear regression using
GraphPad Prism 5.04 software (La Jolla, CA, USA) function: log(drug) vs.
response. We assumed that data share best-fit values from top and bottom and a
hill slope equal to 1. Fitting used the least squares method. Data are expressed as
mean ± S.E.M. from an n number of individuals. Data from different individuals
performed in triplicate were evaluated by one-way analysis of variance (ANOVA).
Statistical differences found between control and drug-treated cultures were
determined by the Bonferroni’s method. P values < 0.05 (two-tailed) were
considered to represent significant differences.
Results
ADP causes a biphasic effect on intracellular Ca2+ ([Ca2+]i) in myofibroblasts
from adult rat ventricles
Figure 14A shows that cells cultured from adult rat ventricle explants exhibit
positive immunoreactivity against both vimentin (Figure 14Ai; Agocha et al., 1997)
and discoidin domain receptor 2 (DDR2) (Figure 14Ai and 14Aii; Morales et al.,
2005; Goldsmith et al., 2010), which are reliable cardiac fibroblast-cell markers.
These cells also stained positively for α-smooth muscle actin (α-SMA), a
myofilament protein that is typically expressed by activated cardiac fibroblasts
(myofibroblasts) (Figure 14Aii; Brown et al., 2005; Davis and Molkentin, 2014).
Incubation with ADP (100 µM) caused a fast (within seconds) [Ca2+]i rise
(phase I) in cardiac myofibroblasts, which attained 32±1% of the maximal calcium
load produced by ionomycin (5 µM, 100% response); beyond this point, [Ca2+]i
levels declined to a plateau of elevated [Ca2+]i (phase II) that remained fairly
constant (Figure 14B and 14C). The initial [Ca2+]i rise (phase I) produced by ADP
decreased (p<0.05) in the presence of the selective inhibitor of endoplasmic
reticulum Ca2+-ATPase, thapsigargin (5 µM, n=4) (Thastrup et al., 1990), which is
known to accelerate the depletion of intracellular Ca2+ stores when applied
together with internal Ca2+ mobilizing agents, such as caffeine (10 mM) (Figure
14B). Removal of external Ca2+ (plus EGTA, 100 µM) significantly (p<0.05)
depressed the late component of ADP (100 µM, n=4) response (phase II), keeping
unaltered the initial fast rise (Figure 14C).
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Figure 14 - ADP causes a biphasic effect on intracellular Ca2+ ([Ca2+]i) in myofibroblasts from adult
rat ventricles Panel A shows that cells exhibited positive immunoreactivity against vimentin, which
has been described as a reliable fibroblast marker (green, Ai), α-smooth muscle actin (α-SMA), a
myofilament protein that typically is expressed by activated fibroblasts (myofibroblasts) (green, Aii)
and discoidin domain receptor 2 (DDR2), a collagen specific receptor tyrosine kinase that is the
most specific marker for cardiac fibroblasts and myofibroblasts (red, Ai and Aii). Negative controls,
in which the cells were incubated only with the secondary antibodies labelled with Alexa Fluor 488
(green) and Alexa Fluor 568 (red) dyes, are shown in Aiii. Nuclei are stained with DAPI, which was
included in the mounting medium. Scale bar 100 µm. Panels B and C represent [Ca2+]i oscillations
produced by ADP (100 µM) in cultured myofibroblasts from adult rat ventricles loaded with the
fluorescent calcium indicator, Fluo-4 NW (2.5 µM, see Methods) in control conditions and after
depletion of intracellular Ca2+ stores with thapsigargin (5 µM) plus caffeine (10 mM) (B) or after
removal of extracellular Ca2+ (Ca2+-free medium plus EGTA, 100 µM, C). [Ca2+]i transients were
calibrated to the maximal calcium load produced by ionomycin (5 μM, 100% response). Black
arrows indicate the time of ADP (100 µM) application. Each point represents a pooled data from an
n number of individuals; experiments were performed in triplicate. The vertical bars represent
S.E.M.. *p < 0.05 represent significant differences from ADP (100 µM) alone.
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Characterization of the P2Y receptor mediating ADP-induced [Ca2+]i
transients in ventricular myofibroblasts
ADP is a preferential activator of G-protein-coupled P2Y1, P2Y12 and P2Y13
receptors (Burnstock, 2006). The presence of all these receptors was confirmed in
7-day cultures of adult rat ventricular myofibroblasts by immunofluorescence
confocal microscopy (Figure 15A). Figure 15B shows that ADP (0.001-3000 µM,
EC50 = 121 µM) concentration-dependently increased [Ca2+]i accumulation in these
cells, but its effect was 1.5 log concentration units less potent than that observed
with UTP (0.001-3000 µM, EC50 = 3 µM) in the same experimental conditions
(Figure 15B; see Certal et al., 2015).
The highly potent P2Y1 receptor agonist, MRS2365 (N-methanocarba-
2MeSADP), which has the ability to discriminate Gq/11-coupled from Gi/o-linked
ADP-sensitive P2Y12 and P2Y13 receptors (Chhatriwala et al., 2004), had a limited
effect on [Ca2+]i accumulation in ventricular myofibroblasts; MRS2365 caused an
effect of less than 10% of the maximal Ca2+ load produced by ionomycin (5 µM)
when it was applied at a concentration (10 µM) high above its EC50 value of 0.4
nM for P2Y1 receptor-mediated effects (Figure 15C).
Pre-treatment of ventricular myofibroblasts with selective P2Y1, P2Y12 and
P2Y13 receptor antagonists, respectively MRS2179 (10 µM, n=6), AR-C66096 (0.1
µM, n=5) and MRS2211 (10 µM, n=4), did not modify the magnitude and profile of
ADP-induced [Ca2+]i transients (Figure 15D). These results suggest that ADP-
preferring receptors, such as P2Y1, P2Y12 and P2Y13, are not involved in [Ca2+]i
signals produced by ADP (100 µM) in cultured ventricular myofibroblasts from
adult rats. Taking into consideration that the UTP-sensitive P2Y4 receptor
dominates purinergic [Ca2+]i transients in cardiac myofibroblasts (Certal et al.,
2015) and that ADP is able to stimulate this receptor (Bogdanov et al., 1998;
Burnstock, 2012), we tested whether the P2Y4 receptor was mediating ADP [Ca2+]i
responses. As a matter of fact, [Ca2+]i accumulation caused by ADP (100 µM) was
attenuated (p<0.05) by suramin (100 µM, n=5) and reactive blue-2 (100 µM, n=5),
with the latter being more potent than the former (Figure 15E-G). A similar
antagonist profile was observed when UTP (3 µM) was used instead of ADP (100
µM) (Certal et al., 2015), thus strengthening our assumption that ADP-induced
[Ca2+]i transients were indeed operated by the P2Y4 receptor.
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Figure 15 - Despite the presence of ADP-preferring P2Y1, P2Y12 and P2Y13 receptors in ventricular
myofibroblasts, [Ca2+]i transients induced by ADP (100 µM) were predominantly mediated by P2Y4
receptors activation. Panel A shows immunofluorescence confocal micrographs of fibroblasts from
adult rat ventricles grown in culture for 7 days stained against P2Y1, P2Y12 and P2Y13 receptors.
Images are representative of three independent experiments; scale bar is 100 µm.. Panel B shows
concentration-response curves of [Ca2+]i oscillations produced by UTP (0.03-1000 μM) and ADP
(1-1000 μM). Panel C compares the magnitude of initial [Ca2+]i rises produced by ADP (100 μM)
and the selective P2Y1 receptor agonist, MRS 2365 (10 μM). Panel D compares the magnitude of
[Ca2+]i peaks produced by ADP (100 μM) applied either in the absence or in the presence of
selective P2Y1, P2Y12 and P2Y13 receptors antagonists, respectively MRS 2179 (300 nM), AR-
C66096 (0.1 μM), and MRS 2211 (10 μM). Panels E-G show the blocking effects of two non-
selective P2 receptor antagonists, reactive blue-2 (RB-2, 100 µM) and suramin (100 µM), on ADP
(100 µM)-induced [Ca2+]i oscillations. In all the experiments [Ca2+]i transients were calibrated to the
maximal calcium load produced by ionomycin (5 μM, 100% response). Each point/bar represents
pooled data from an n number of individuals; experiments were performed in triplicate. The vertical
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bars represent S.E.M.. *p < 0.05 represent significant differences from control values obtained in
the absence of test drugs, #p<0.05 represent significant differences from ADP (100 µM) alone.
ADP-induced fast [Ca2+]i rise (phase I) depends on activation of
phospholipase C, but it is protein kinase C independent
The P2Y4 receptor couples via Gq/11-protein to phospholipase C releasing
inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) from the plasma
membrane, which favour Ca2+ recruitment from internal stores and protein kinase
C (PKC) activation, respectively. Among the ADP-preferring P2Y receptors, only
the P2Y1 subtype shares a common transduction pathway with the P2Y4 receptor,
whereas both P2Y12 and P2Y13 receptor subtypes are Gi/o-linked leading to the
inhibition of adenylate cyclase activity (Alexander et al., 2015). Pharmacological
inhibition of these transduction pathways may offer additional inputs to
discriminate the receptors involved in ADP-induced [Ca2+]i response in these cells.
Selective inhibition of phospholipase C (PLC) activity with U73122 (3 µM, n=5)
decreased (p<0.05) both the initial rise (phase I) and the plateau (phase II) of ADP
(100µM)-induced [Ca2+]i response in ventricular myofibroblasts (Figure 16A), but
the same was not observed after pre-treatment of these cells with selective
adenylate cyclase inhibitors, such as SQ22536 (30 µM, n=6, Figure 16B) and
MDL12,330a (10 µM, n=2, data not shown). Inhibition of PKC activity with
chelerythrine (3 µM) also failed to change the magnitude and shape of [Ca2+]i
transients produced by ADP (100 µM) (Figure 16C).
Capacitative Ca2+ entry through transient receptor potential (TRP) channels
is responsible for the [Ca2+]i plateau (phase II) produced by ADP
Phospholipase C activated downstream Gq/11-coupled receptors stimulation
is the main modulator of Ca2+-permeable transient receptor potential (TRP)
channels. TRP channels are a family of six-transmembrane domain proteins that
are regulated by phosphoinositides, such as PtIns(4,5)P2 (PIP2) and IP3 (reviewed
in Ramsey et al., 2006), with certain subtypes (TRPC2, TRPC3, TRPC6 and
TRPC7) being also activated by DAG independently of PKC stimulation
(Harteneck and Gollasch, 2011). Our results show that the plateau (phase II) of
ADP-induced [Ca2+]i accumulation requires Ca2+ influx from the extracellular milieu
and is dependent on PLC, but not PKC, activation, which led us to hypothesize the
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participation of TRP channels as mediators of ADP-induced capacitative Ca2+
entry.
Although the pharmacology of most TRP channels is poorly developed and
the effects reported are often complex, broad spectrum agents, such as 2-
aminoethoxydiphenylborane (2-APB), have been instrumental to explore the
participation of these channels in diverse experimental conditions (Ramsey et al.,
2006; Harteneck and Gollasch, 2011). The late component of ADP (100 µM)-
induced [Ca2+]i response (phase II) was significantly (p<0.05) depressed in the
presence of 2-APB (50 µM, n=5), which did not affect the initial fast [Ca2+]i rise
(Figure 16D). Likewise, flufenamic acid (100 µM), a non-selective blocker of TRP
channels (Guinamard et al., 2013), decreased (p<0.05) ADP-induced [Ca2+]i
plateau in ventricular myofibroblasts (Figure 16E).
Inhibition of inositol monophosphatase with LiCl (10 mM), thus preventing
the synthesis of phosphoinositides (Hanson, 1991) and the regeneration of
adequate PIP2 levels to be hydrolyzed to IP3 and DAG (Berridge and Irvine, 1989),
also significantly (p<0.05) reduced the second (plateau) phase of [Ca2+]i response
produced by ADP (100 µM) in ventricular myofibroblasts (Figure 16F).
Ca2+ influx through Na+/Ca2+ exchanger (NCX) operating in the reverse mode
does not account for ADP-induced [Ca2+]i accumulation
Another possibility to increase Ca2+ influx linked to activation of
metabotropic P2Y receptors is the putative interplay of these receptors with the
Na+/Ca2+ exchanger (NCX) operating in the reverse mode, which can be energized
by Na+ influx through Nav1.5 channels presented in cardiac fibroblasts (Chatelier
et al., 2012). Notwithstanding this possibility, preferential inhibition of NCX with
KB-R7943 (50 µM) (Ladilov et al., 1999), did not significantly (p>0.05) affect ADP
(100 µM)-induced [Ca2+]i transients in ventricular myofibroblasts (Figure 16E) and
the same occurred when UTP was used instead of ADP (Certal et al., 2015).
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Figure 16 - Mechanisms underlying ADP-induced biphasic [Ca2+]i response by cultured ventricular
fibroblasts. Panels A-C show that ADP-induced fast [Ca2+]i rises (phase I) depend on
phospholipase C (PLC) activity, but are independent on adenylate cyclase (AC) and protein kinase
C (PKC) activation. Shown are the effects of ADP (100 µM) obtained in the absence and in the
presence of U73122 (3 µM, A, a PLC inhibitor), SQ 22536 (30 µM, B, an AC inhibitor) and
chelerythrine (3 µM, C, a PKC inhibitor). Panels D and E show that the capacitative Ca2+ entry
through transient receptor potential (TRP) channels is responsible for the late [Ca2+]i plateau
(phase II) of the ADP (100 µM) response. Shown are the effects of ADP (100 µM) obtained in the
absence and in the presence of two TRP channel inhibitors, 2-APB (50 µM), and flufenamic acid
(100 µM), and KB-R7943 (50 µM) that inhibits the Na+/Ca2+ exchanger working in the reverse
mode. Phase I was considered during the first 150 seconds after ADP application, while phase II
was calculated thereafter. Panels F and G represent [Ca2+]i oscillations produced by ADP (100 µM)
in the absence and in the presence of signalling disruptors by acting on membrane lipids, namely
the inositol monophosphatase inhibitor, LiCl (10 mM, F), and methyl-β-cyclodextrin (MβC, 2 mM,
G), which extracts cholesterol from the plasma membrane leading to decreases in caveolin-1
content (see Panel H; immunofluorescence confocal micrographs shown are representative of two
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independent experiments; scale bar is 100 µm). Black arrows indicate the time of ADP (100 µM)
application. Each point/bar represents pooled data from an n number of individuals; experiments
were performed in triplicate. The vertical bars represent S.E.M.. *p<0.05 represent significant
differences from ADP (100 µM) alone.
ADP-induced [Ca2+]i plateau (phase II) requires hydrophobic interactions
between P2Y receptors and TRP channels in lipid raft microdomains
Lateral assembly between G-protein-coupled receptors, such as P2Y
receptor subtypes, PLC and TRP channels occur most probably at lipid
raft/caveolae membrane microdomains. Caveolin-1 specifically binds Gαq and
stabilizes its activation state resulting in an enhanced Ca2+ signal upon activation.
More relevant to the present study, it has been demonstrated that hydrophobic
interactions between TRP channels and lipid rafts modulate the opening properties
of these channels. Therefore, we decided to evaluate ADP-induced [Ca2+]i
responses after acute depletion of cholesterol from the plasma membrane of intact
cells with methyl-ß-cyclodextrin (2 mM), which results in perturbation of lipid rafts
architecture eventually leading to caveolae disappearance (Thomsen et al., 2002).
Micrographs shown in Figure 16G foresee that reduction of membrane cholesterol
with methyl-ß-cyclodextrin (200 µM) affects the structural integrity of caveolae in
the plasma membrane as suggested by the downregulation of caveolin-1
immunoreactivy in ventricular myofibroblasts (Figure 16H). Pretreatment with
methyl-ß-cyclodextrin (2 mM, n=8) depressed (p<0.05) the late component of ADP
(100 µM)-induced [Ca2+]i response (phase II), without modifying the initial fast
[Ca2+]i rise (Figure 16G). The effect of methyl-ß-cyclodextrin (2 mM) had a similar
pattern to that observed in the presence of LiCl (10 mM), 2-APB (50 µM) and
flufenamic acid (100 µM) (see above).
ADP favours cell growth and type I collagen production by ventricular
myofibroblasts via P2Y1 receptors activation
Previous reports from the literature demonstrate that ADP promotes fibrosis
in a number of different tissues by increasing the proliferation of fibroblasts
(Pinheiro et al., 2013b; Garbuzenko et al., 2002), yet the role played by ADP and
ADP-preferring P2Y purinoceptors on cardiac fibroblasts from adult rats has not
been investigated so far. Incubation of cultured ventricular fibroblasts with ADP or
its enzymatically-stable analogue, ADPβS, increased (p<0.05) cells proliferation
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(MTT assay) from the first week onwards; these compounds were about
equipotent when applied at a concentration of 30 µM (Figure 17Ai). Likewise, both
ADP and ADPβS (30 µM) enhanced (p<0.05) type I collagen production above the
control level, but the magnitude of the increments were smaller and shifted
towards later time periods when compared to their effects on cells growth (Figure
17Aii).
Figure 17 - Role of ADP and its stable analogue ADPβS on cell growth and type I collagen
production by fibroblasts from adult rat ventricles grown for 28 days in culture. In panel A the
ordinates represent ADP (30 µM)- or ADPβS (30 µM)-induced changes in cell growth (MTT values,
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Ai) and type I collagen production (Sirius Red values, Aii) as compared to controls in the absence
of the nucleotides at the same points. Zero represents similarity between the two values
(nucleotides vs control); positive and negative values represent facilitation or inhibition of either cell
growth or type I collagen production relative to control data obtained at the same time points. Each
bar represents pooled data from an n number of individuals; four replicas were performed for each
individual experiment. The vertical bars represent S.E.M. *p<0.05 represent significant differences
from control values obtained in the absence of test drugs, Panel B shows P2Y1, P2Y12 and P2Y13
receptors immunoreactivity of adult rat ventricular fibroblasts cultured with ADP (100 µM) during 28
days. Confocal micrographs shown are representative of three independent experiments; scale bar
is 100 µm. Panel C shows representative immunoblots of P2Y1 (Ci), P2Y12 (Cii) and P2Y13 (Ciii)
receptors obtained from homogenates of ventricular fibroblasts grown in culture for 28 days in
control conditions. α-actin and β-tubulin were used as reference proteins. Images are
representative of three independent experiments.
Figure 17B shows that after growing cells in culture for 28 days in the
presence of ADP (100 µM, n=3), ventricular fibroblasts differentiate into stellate
shaped myofibroblasts with protruding dendritic-like processes which still express
significant amounts of P2Y1, P2Y12 and P2Y13 receptors. Immunofluorescence
confocal microscopy and Western blot analysis indicate that the non-desensitizing
P2Y1 receptor is the most abundant receptor subtype among all ADP-preferring
P2Y purinoceptors in ventricular myofibroblasts of adult rats, followed by P2Y12
and P2Y13 receptor subtypes in that order (Figure 17B and 17C). Cell processes of
activated ventricular myofibroblasts exhibit outstanding P2Y1 receptor
immunoreactivity compared to P2Y12 and P2Y13, which receptor staining is sparser.
In order to characterize the P2Y receptor subtype involved on ADPβS (30 µM)-
induced proliferation and type I collagen production, ventricular fibroblast cell
cultures were treated during 28 days with the ADP stable analogue in the
presence of selective P2Y1, P2Y12 and P2Y13 receptor antagonists, MRS2179 (0.3
µM, n=6), AR-C66096 (0.1 µM, n=6) and MRS2211 (10 µM, n=6), respectively.
Under these experimental conditions, the P2Y1 receptor antagonist, MRS2179 (0.3
µM), was the only compound capable of attenuating ADPβS (30 µM)-induced
fibroblast cells growth and type I collagen production (Figure 18), while both AR-
C66096 (0.1 µM, n=6) and MRS2211 (10 µM, n=6) were ineffective. On its own,
MRS2179 (0.3 µM) marginally decreased (p<0.05) type I collagen production by
ventricular myofibroblasts at later cultures stages, i.e. days 21 and 28 (Figure 18i
and 18iv).
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Figure 18 - The pro-fibrotic effect of ADPβS depends on the activation of P2Y1 receptors. ADPβS
(30 µM) with or without MRS 2179 (300 nM, a selective P2Y1 antagonist, Ai and Aiv), AR-C 66096
(0.1 µM, a selective P2Y12 antagonist, Aii and Av) and MRS 2211 (10 µM, a selective P2Y13
antagonist, Aiii and Avi) were incorporated in culture media, and, therefore, contacted with the cells
during the whole assay. The ordinates represent changes in cell growth (MTT values, top panels)
and type I collagen production (Sirius Red values, bottom panels) compared to controls in the
absence of test drugs at the same points. Zero represents similarity between the two values (drugs
vs control); positive and negative values represent facilitation or inhibition of cell growth relative to
control data obtained at the same time points. Each bar represents pooled data from an n number
of individuals; four replicas were performed for each individual experiment. The vertical bars
represent S.E.M.. *p<0.05 represent significant differences from control values obtained in the
absence of test drugs. #p<0.05 represent significant differences from ADPβS (30 µM) alone.
These findings reiterate a long-term pro-fibrotic action of ADPβS on
ventricular fibroblasts via dominant activation of the P2Y1 receptor, which differs
from the predominance of the P2Y4 receptor on fast [Ca2+]i transients (see above;
Certal et al., 2015). This hypothesis is strengthen by the results presented in
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Figure 19, showing that ADPβS (30 µM)-induced fibroblast cells growth was
significantly (p<0.05) attenuated by U73122 (3 µM, n=6), chelerythrine (3 µM, n=4)
and 2-APB (50 µM, n=5), but not SQ22536 (30 µM, n=3), thus confirming the
participation of a PLC transduction pathway linked to long-term effects of ADPβS
operated by PKC and TRP channels, respectively. .
Figure 19 - The proliferative effect of ADPβS on ventricular fibroblasts involves activation of
phospholipase C (PLC), protein kinase C (PKC) and TRP channels, but not the adenylate cyclase
(AC) pathway. Shown is the variation of cell growth at 7 and 28 culture days caused by continuous
application of ADPβS (30 µM) to the culture medium in the absence and in the presence of
inhibitors of PLC, PKC, TRP channels, and AC, respectively U73122 (3 µM, Ai), chelerythrine (3
µM, Aii), 2-APB (50 µM, Aiii) and SQ 22536 (30 µM, Aiv). The ordinates represent changes in MTT
values compared to control cultures grown in the absence of test drugs at the same time points.
Each column represents pooled data from n individuals; four replicas were performed for each
individual experiment. The vertical bars represent S.E.M.. *p<0.05 represent significant differences
from control values obtained in the absence of test drugs. #p<0.05 represent significant differences
from ADPβS (30 µM) alone.
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Discussion
In this study, we show that ADP possibly resulting from the extracellular
catabolism of released ATP by ectonucleotidases exerts a dual role on [Ca2+]i
transients and proliferation of myofibroblasts from adult rat ventricles through
differential activation of fast-desensitizing P2Y4 and long-acting P2Y1 receptors,
respectively. Although it has been previously demonstrated that the P2Y4 receptor
is the dominant receptor subtype mediating fast [Ca2+]i transients caused by UTP
and ATP in these cells (Certal et al., 2015), we show here that this receptor is also
involved in ADP-induced effects. Moreover, our results suggest for the first time
that sustained P2Y4 receptor-mediated [Ca2+]i accumulation produced by ADP
might be due to capacitative Ca2+ entry through TRP channels opening
downstream to Gq/11-protein-coupled PLC activation in lipid raft microdomains.
ADP may also exert long-term pro-fibrotic effects by increasing proliferation and
type I collagen production by ventricular myofibroblasts via the activation of ADP-
preferring P2Y1 receptors. Unlike fast [Ca2+]i rises, the proliferative action of ADP
may involve phosphorylation of intracellular constituents by PKC subsequently to
PLC activation and DAG release from the plasma membrane. The detailed
intracellular mechanism(s) underlying the pro-fibrotic effect of ADP via P2Y1
receptors activation remains to be investigated in future studies.
Notwithstanding our results (from immunofluorescence confocal microscopy
and Western blot analysis) showing that cultured myofibroblasts from adult rat
ventricles express all ADP-preferring receptor subtypes, namely P2Y1, P2Y12 and
P2Y13, we failed to demonstrate their activity when measuring [Ca2+]i oscillations in
the presence of subtype selective antagonists, respectively MRS2179, AR-C66096
and MRS2211. Taking into consideration that ADP is competent to activate the rat
P2Y4 receptor with a similar potency as ATP and UTP (Bogdanov et al., 1998;
Burnstock, 2012), we tested whether this receptor was involved in our
experimental conditions. The dominant role of the P2Y4 receptor on ADP-induced
[Ca2+]i transients was inferred by differences in the blocking potency of suramin
and reactive blue-2, with the latter being a more effective P2Y4 antagonist than
suramin (von Kugelgen, 2006). This assumption is further strengthen by previous
findings from our group using the selective P2Y4 receptor agonist, MRS4062,
which along with UTP exhibited a similar pharmacology, together with confirmation
by confocal microscopy and Western blot analysis that ventricular myofibroblasts
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of adult rats express P2Y4 receptors (Certal et al., 2015).
Signals operated by intracellular calcium oscillations are essential for
cardiac fibroblasts proliferation, migration and transdifferentiation into (activated)
myofibroblasts. Moreover, abnormalities in [Ca2+]i handling by cardiac cells may
determine arrhythmogenesis and heart fibrosis. We report here that myofibroblasts
from adult rat ventricles respond to ADP through activation of the PLC
transduction pathway downstream Gq/11-protein-coupled P2Y4 receptors
stimulation. The initial [Ca2+]i rise (phase I) depends on rapid Ca2+ mobilization
from internal stores that is most likely due to the release of IP3 from membrane
phospholipids. This conclusion is based on the fact that both (1) inhibition of PLC
with U73122, and (2) depletion of intracellular Ca2+-stores with thapsigargin plus
caffeine, attenuated the fast [Ca2+]i mobilization by ADP. Adenine nucleoside
diphosphates trigger PLC activation followed by the production of IP3 in neonatal
cardiac fibroblasts (Talasila et al., 2009), but as we show here ADP-induced [Ca2+]i
rises are independent on PKC activation by DAG since inhibition of this enzyme
with chelerythrine failed to affect the ADP [Ca2+]i response. The participation of
ADP-sensitive P2Y12 and P2Y13 receptor subtypes negatively coupled to adenylate
cyclase (Alexander et al., 2015) was also rejected because selective inhibition of
this enzyme with SQ22536 or MDL12,330a did not impact on the magnitude
and/or shape of ADP-induced [Ca2+]i response.
We show here that extracellular Ca2+ also plays a role to sustain the late
component (phase II) of ADP [Ca2+]i response. This was assumed because
omission of Ca2+ (plus EGTA) from the incubation medium significantly attenuated
the nucleotide response. Fibroblasts lack voltage-gated Ca2+ channels and Ca2+
influx from the extracellular milieu is more likely to occur via ion channels activated
by PLC downstream of Gq/11-protein-coupled receptors, such as the P2Y4 subtype.
TRP channels are widely expressed proteins forming non-selective cation
channels. The vast majority of TRP channels is permeable to Ca2+ and directly
contributes to cellular Ca2+ influx. TRP channel subunits contain six putative
transmembrane domains assembled as homo- or heterotetramers. Following PLC
activation, breakdown of phosphatidylinositides (PIP2) leads to the formation of IP3
and DAG, which may directly activate certain types of canonical TRPC channels
(e.g. TRPC2, TRPC3, TRPC6, and TRPC7) in a PKC-independent manner
PhD THESIS – MARIANA DE SOUSA CERTAL GOMES 105
(Ramsey et al., 2006; Harteneck and Gollasch, 2011). This scenario fits in the
results obtained in our study. The presence of TRPC1, TRPC3, TRPC6, and
TRPC7 channels has been demonstrated in rat cardiac fibroblasts and they have
been implicated in cardiac hypertrophy (Nishida et al., 2007). Other authors also
argue that TRPM7, TRPC3, TRPC6 and TRPV4 are crucial for fibroblast-to-
myofibroblast transition and cardiac arrhythmogenesis (Adapala et al., 2013; Davis
et al., 2012; Du et al., 2010; Tadevosyan et al., 2012; reviewed in Thodeti et al.,
2013). Attenuation of spontaneous [Ca2+]i oscillations by PLC and TRP channel
inhibitors has been observed in cultured human cardiac fibroblasts, but information
is still lacking regarding the mechanisms how Ca2+ signals regulate the biological
activity of these cells and cardiac remodeling under pathological conditions.
Unfortunately, the pharmacology of most TRP channels is poorly developed thus
preventing the investigation of more definitive involvement of these channels on
Ca2+ signaling by ventricular myofibroblasts. Definitive characterization of TRP
channel subtypes is further aggravated because mixed activation properties often
occur as a consequence of heteromerization of several pore forming subunits
and/or of tight association with diverse membrane proteins to form signaling
complexes (e.g. NCX, CaM, PLC, IP3 receptor). Notwithstanding this, we used two
broad spectrum TRP inhibitors, 2-APB and flufenamic acid, which have been
instrumental to explore the participation of these channels in diverse experimental
settings (Ramsey et al., 2006; Harteneck and Gollasch, 2011; Guinamard et al.,
2013). Our findings indicate that non-selective blockade of TRP channels
significantly decreased ADP-induced capacitative Ca2+ entry resulting in
attenuation of the [Ca2+]i plateau (phase II) without changing the initial [Ca2+]i rise
(phase I). Response profile to ADP in the presence of TRP channels inhibition by
2-APB and flufenamic acid resembled that obtained in the absence of external
Ca2+ (plus EGTA) and in the presence of LiCl, which inhibits inositol
monophosphatase thus preventing the synthesis of phosphoinositides (Hanson,
1991) and the regeneration of adequate PIP2 levels to be hydrolysed to IP3 and
DAG (Berridge and Irvine, 1989).
Another possibility to increase [Ca2+]i entry into ventricular myofibroblasts
linked to ADP-sensitive P2Y4 receptor activation is a putative interplay between
this receptor and the Na+/Ca2+-exchanger (NCX) operating in the reverse mode. It
has been demonstrated that NCX may contribute to intracellular Ca2+ overload in
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cardiomyocytes during myocardial infarction (Chen and Li, 2012). Even though this
situation may putatively contribute to increase the extracellular levels of adenine
and uracil nucleotides (Wihlborg et al., 2006), there are no reports available linking
NCX and P2Y purinoceptors activity in cardiac fibroblasts. Under the present
experimental conditions, inhibition of NCX with KB-R7943 (50 µM) did not affect
[Ca2+]i signals induced by ADP in ventricular myofibroblasts.
Regulation of lateral association between G-protein-coupled receptors, PLC
activation and opening of TRP channels by lipid rafts has been documented in
several cell types. Here we show that lipid rafts disruption by cholesterol depletion
with methyl-ß-cyclodextrin (Thomsen et al., 2002) significantly attenuated the
plateau of ADP-induced [Ca2+]i response (phase II) without affecting the fast [Ca2+]i
rise (phase I). Taken together, these results suggest that hydrophobic interactions
between P2Y4 and PLC-linked TRP channels activation leading to capacitative
Ca2+ entry in ventricular myofibroblasts occur most likely in lipid raft microdomains,
whereas the initial [Ca2+]i rise depends on IP3 release from the plasma membrane
that is required for rapid Ca2+ mobilization from internal reservoirs. Using
immunofluorescence confocal microscopy we also showed that depletion of
cholesterol from lipid rafts by methyl-ß-cyclodextrin may disrupt the architecture of
caveolae (Schönfelder et al., 2006) and decrease the expression of caveolin-1
(Williams and Lisanti, 2004) in these cells. Unlike other types of G protein subunits,
Gαq binds to the scaffold domain of caveolin-1 and -3, and this binding is
strengthened when Gαq is activated (Sengupta et al., 2008). The association site
between caveolin and Gαq differs from Gαq and PLC, and so Gαq continues to
signal through PLC when bound to caveolae. The interaction between caveolin
proteins and Gαq has the effect of targeting Gαq and its associated receptors to
caveolae domains (Calizo and Scarlata, 2012). Since the interactions between
caveolin-1 and Gαq are strengthened upon activation, localization of Gαq to
caveolae can stabilize its activated state and enhance Ca2+ signals. Taking this
into account and considering that diverse phenotypes induced by altered caveolar
gene function encoding mostly caveolin-1 are involved in cardiomyopathy, cardiac
hypertrophy, cardiac arrhythmias and exercise intolerance (reviewed in Cheng and
Nichols, 2015), we may speculate about the pharmacological manipulation of rapid
coupling/uncoupling of P2Y purinoceptors and signal transduction pathways at
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lipid rafts/caveolae microdomains as an important clue to design drugs for
therapeutic intervention in cardiac remodeling.
Proliferation and type I collagen production are key events in the fibrotic
response to cardiac remodelling. It is known that extracellular nucleotides are able
to modulate these processes in various cell types (Chen et al., 2012; Weber,
2000). Combining the findings from previous studies showing that UTP (Braun et
al., 2010; Certal et al., 2015) and ATP (Chen et al., 2012) are pro-fibrotic in
cardiac fibroblasts, together with the fact that ATP may be rapidly converted
extracellularly into ADP by membrane-bound ectonucleotidases, this prompted for
the interrogation about the contribution of ADP to nucleotides-induced cell
proliferation and type I collagen production by myofibroblasts from adult rat
ventricles. Our data demonstrate that these cells respond equally to ADP and to its
stable analogue, ADPβS, by increasing cells growth and type I collagen production
through the activation the P2Y1 receptor, the most abundant ADP-preferring
receptor subtype in ventricular myofibroblasts. This was suggested because the
selective P2Y1 antagonist, MRS2179, but not AR-C66096 and MRS2211,
significantly attenuated myofibroblast cells proliferation (MTT assay) and type I
collagen production (Sirius Red staining assay). Thus, in spite of the presence of
ADP-sensitive P2Y1 and P2Y13 receptors in cardiac myofibroblasts from neonatal
rats (Talasila et al., 2009), the pathophysiological role of the P2Y13 receptor in
adult animals requires further elucidation. On its own, the P2Y1 receptor
antagonist, MRS2179, decreased type I collagen production at culture days 21
and 28, without much affecting the proliferation of the cells. These results suggest
that tonic activation of the P2Y1 receptor may exert a preferential effect on
extracellular matrix deposition than on cells growth. The pro-fibrotic effect of ADP
is consistent with other studies demonstrating that the nucleotide can modulate
cellular proliferation in various cell types, like subcutaneous connective tissue
fibroblasts, keratinocytes, and lung fibroblasts (Pinheiro et al., 2013b;
Gendaszewska-Darmach and Kucharska, 2011), although one study argued that
stimulation of the P2Y1 receptor may inhibit noradrenaline-induced DNA synthesis
in neonatal cardiac fibroblasts (Zheng et al., 1998).
The lack of an ADP-induced P2Y4 receptor-mediated effect on cells growth
and type I collagen production is not surprising because this receptor desensitizes
rapidly in cardiac fibroblasts by repeated applications or prolonged contact with its
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agonists (see Certal et al., 2015). It has been demonstrated that P2 purinoceptors
association to lipid rafts/caveolae may be regulated by agonists; indeed, rapid
internalization and slow cell surface recycling of the receptors have been
associated with prolonged fading of the responses in the presence of agonists
(D’Ambrosi and Volonté, 2013). In contrast to the P2Y4 receptor subtype, we
confirmed by immunofluorescence confocal microscopy that the density of the
P2Y1 receptor remained steady after growing the cells in culture during 28 days in
the presence of 100 µM ADP. If something has to be noted in these experiments is
the transition of fibroblasts to more mature/activated myofibroblasts exhibiting a
typical stellate-shaped morphology, which is usually observed in situ when these
cells are committed to myocardial remodelling (Rohr, 2011).
While PLC-coupling to Ca2+-permeable TRPC3 and TRPM7 channels has
been shown to be up-regulated in human atrial fibroblasts (Du et al., 2010; Harada
et al., 2012), the TRPC6 channel (that is also sensitive to blockade by 2-APB)
along with the mechanically-stimulated TRPV4 channel may be critical for
ventricular fibroblast differentiation (Thodeti et al., 2013). The signalling cascades
by which TRP channels regulate fibroblast differentiation to myofibroblasts during
cardiac remodelling may differ, but all culminate in increased (-SMA expression
that is the primary contractile protein in myofibroblasts. It is interesting to note that
transgenic expression of human TRPC3 channel in mouse heart is associated with
increased capacitative Ca2+ entry, activation of Erk1/2 and/or calcineurin-nuclear
factor of activated T cells (NFAT) in vivo, cardiomyopathy, and increased
hypertrophy after neuroendocrine agonist or pressure overload stimulation
(Nakayama et al., 2006). Genetic ablation of TRPC6 gene in fibroblasts made
them refractory to inducers of myofibroblast transformation (e.g. TFGβ,
angiotensin-II) and TRPC6 null mice had greater death rates after myocardial
infarction due to defective scar formation with wall rupture; conversely, TRPC6
induction led to enhanced Ca2+ entry in response to agonist stimulation suggesting
that Ca2+ is likely an effector of myofibroblast transformation (Davis et al., 2012).
Moreover, a synergistic interplay between P2Y1-mediated responses and TRPV4
channel activation involving the PKC pathway has recently been proposed in
satellite glial cells of sensory ganglia (Rajasekhar et al., 2015). Aligned with these
findings, we show here for the first time that the pro-fibrotic effect of ADP involves
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P2Y1 receptors coupled to U73122-sensitive PLC pathway, which results in
enduring activation of PKC and TRP channels blocked by chelerythrine and 2-APB,
respectively. It remains, however, to be elucidated the TRP channel subtype most
involved in long-term effects of ADP on myofibroblasts from adult rat ventricles.
The time-course and magnitude of the proliferative effect of ADP on
ventricular myofibroblasts (via P2Y1 receptors activation) was very similar to that
observed upon activating P2Y2 receptors with UTP in the same cell type, but ADP
and its stable analogue, ADPβS, were more potent than UTP regarding type I
collagen production and, hence, extracellular matrix deposition (see Certal et al.,
2015). The power ratio between these two pro-fibrotic receptors and the anti-
proliferative effect recently attributed to the P2Y11 receptor (Certal et al., 2015) is
still unknown and deserves to be fully explored in the future. Despite this
uncertainty, inhibition of adenylate cyclase activity with SQ22536 did not affect
cells growth induced by ADPβS. Results indicate that, in contrast to ATP and UTP,
the pro-fibrotic effect of adenine nucleoside diphosphates is apparently
unrestrained by synchronous activation of the anti-fibrotic P2Y11 receptor coupled
to the adenylate cyclase/cyclic AMP/EPAC (exchange protein directly activated by
cyclic AMP) pathway.
Conclusions
In summary, adenine and uracil nucleotides can be released from
endothelial cells, cardiomyocytes and fibroblasts in the heart during stressful
pathological conditions (e.g. myocardial infarction, vascular stress forces, hypoxia,
pressure overload). Besides the most studied mechanisms underlying
cardiomyocyte hypertrophic responses, nucleotides may promote fibroblast growth
and fibroblast-to-myofibroblast transition leading to cardiac fibrosis. Repercussions
of myocardial fibrosis are decrease in compliance, arrhythmias, diastolic
dysfunction and accompanying heart failure. Despite its pathophysiological
relevance, little information is available on the fate and activity of released
nucleotides including binding and autocrine/paracrine activation of P2
purinoceptors in cardiac fibroblasts. ATP and UTP are strongly pro-fibrotic through
the activation of P2Y2 receptors, which are highly expressed in ventricular
fibroblasts (reviewed in Lu and Insel, 2014). Besides the P2Y2 receptor, ATP may
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directly activate ionotropic P2X4 and P2X7 receptors on cardiac fibroblasts to
stimulate cell proliferation. ATP-mediated pro-fibrotic effects may be counteracted
by indirect stimulation of Gs-protein-coupled A2B receptors by adenosine generated
by ATP hydrolysis via ectonucleotidases (reviewed in Ferrari et al., 2015). More
recently, it has been proven that manoeuvres that increase intracellular cyclic AMP
diminish proliferation and type I collagen production by cardiac fibroblasts; for
instance, the previous unrecognized anti-fibrotic role of UTP-sensitive P2Y11
receptors implicates such a mechanism in ventricular fibroblasts (Certal et al.,
2015). Here, we added valuable information regarding the unrestrained pro-fibrotic
action of ADP, a by-product of the extracellular hydrolysis of ATP by
ectonucleotidases. Data show that ADP strengthens the effect of released ATP
and UTP on [Ca2+]i accumulation through activation of fast desensitizing P2Y4
receptors, while it promotes myofibroblast cells growth and type I collagen
production via long-acting P2Y1 receptors. The mechanisms underlying ADP
effects involve PLC activation linked (1) to the release of IP3 from the plasma
membrane and its diffusion to the endoplasmic reticulum leading to fast Ca2+
recruitment from internal stores, and subsequent (2) capacitative Ca2+ entry via
opening of TRP channels compartmentalized in lipid rafts microdomains.
Enrolment of a PKC-mediated pathway was verified only by looking to the long-
term proliferative effect of ADP. Thus, targeting the mechanisms controlling
purinergic signals revealed in this study may be of therapeutic interest to design
new drug strategies to prevent cardiac fibrosis and its deleterious effects on
myocardial function.
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CHAPTER 4. DISCUSSION AND CONCLUSIONS
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Cardiac fibroblasts play a crucial role in cardiac remodeling,
electrophysiology and hemodynamic alterations following myocardial infarction
(Porter and Turner, 2009). As mentioned early, ATP and UTP are released in huge
amounts during ischemia and reperfusion and may act as autocrine and/or
paracrine mediators via the activation of a variety of P2 purinoceptors (Wihlborg et
al., 2006). In order to understand the underlying purinergic signaling mechanisms
that could be involved in the regulation of fibroblast cells function and cell-to-cell
communication in the heart, we decided to isolate its major cell constituent,
cardiac fibroblasts. In this thesis, we evaluated the role of metabotropic P2Y
receptors through their effect on [Ca2+]i oscillations, given that Ca2+ is an
intracellular messenger that controls a huge range of cellular processes. In
addition, we also selected the assessment of proliferation and type I collagen
synthesis by cardiac fibroblast cell cultures because of the core importance of
these events to the mycardium remodeling process.
Our results provided evidences that cardiac fibroblasts really undergo a
phenotype switch to myofibroblasts in vitro given that, under our experimental
conditions, cardiac fibroblasts exhibited positive immunoreactivity for α-SMA, in
addition to specific markers of these cells, vimentin and DDR2. As a matter of fact,
the differentiation of cardiac fibroblasts into a myofibroblast phenotype was
described in two-dimension cultures in the absence of additional stimulation
(Porter et al., 2004; Jarvis et al., 2006). Thus, the cells used in this work resemble
those undergoing myofibroblastic differentiation in vivo secondary to pathological
conditions and/or to mechanical, inflammatory, chemical stimulation.
Since adenine and uracil nucleotides play important roles in the
propagation/amplification of cells communication (Burnstock, 2006;
Gendaszewska-Darmach and Kucharska, 2011), we tried to elucidate the
repercussions of these nucleotides on cardiac fibroblasts activation. Our findings
demonstrate that ATP, ADP, UTP and UDP increased [Ca2+]i accumulation. In this
regard, nucleoside triphosphates, like ATP and UTP, were more potent than their
diphosphate metabolites, ADP and UDP, respectively. In view of this, one may
conclude that the extracellular catabolism of released nucleoside triphosphates by
ectonucleotidases may establish a set point on their effects on [Ca2+]i signaling in
cardiac fibroblasts.
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This study contributes to functionally characterize the role of UTP- and
ADP-senstive P2Y receptors in cardiac fibroblasts, given that there was a gap in
our knowledge regarding this issue in the literature. UTP exerts its effects acting
directly through P2Y2, P2Y4 and P2Y11 receptors, which are the only P2 receptor
subtypes sensitive to both ATP and UTP (Talasila et al., 2009). The presence of
these receptors in fibroblasts from adult rat ventricles was demonstrated here by
immunofluorescence confocal microscopy and Western blot analysis. Data
indicate that UTP exerts a dual role via the activation of fast-desensitizing P2Y4
and long-acting P2Y2 receptors, which are responsible for [Ca2+]i transients and
growth of ventricular fibroblasts, respectively. UTP may also exert its effects via
the P2Y6 receptor after its extracellular conversion to UDP through NTPDases
action (Burnstock, 2007). Using a selective agonist and antagonist of the P2Y6
receptor we failed to detect any functional role for this receptor on cardiac
fibroblasts.
We reveal here for the first time that synchronous activation of the P2Y11
receptor by released ATP counteracts the pro-fibrotic effect of the P2Y2 receptor
stimulation by UTP. Moreover, the prominent role of the P2Y11 receptor in
controlling cardiomyocyte contractility may point towards this receptor being an
important target for therapeutic intervention to prevent deleterious cardiac
remodeling under various pathological conditions. We also show here that the
P2Y11 receptor is involved in sustaining high intracellular Ca2+ levels during the
second phase of UTP-induce response. The mechanism underlying the synergism
between P2Y4 (dominant receptor) and P2Y11 purinoceptors regarding UTP-
induced [Ca2+]i accumulation may depend on endogenous ATP outflow from
stimulated cardiac fibroblasts via Cx43-containing hemichannels, which can be
blocked by carbenoxolone and H1152 (an inhibitor of Rho kinase-operated Cx43-
pore permeability).
Released ATP can be rapidly hydrolyzed extracellularly to ADP by
membrane-bound ectonucleotidases, but until now no functional characterization
of the putative roles of this intermediate metabolite has been attempted on cardiac
fibroblast cells function and myocardial remodeling. Using immunofluorescence
confocal microscopy and Western blot analysis, we confirmed the presence of
ADP-sensitive P2Y1, P2Y12 and P2Y13 receptor subtypes in cardiac fibroblasts of
adult rat ventricles. Notwithstanding this, the most abundant P2Y1 receptor
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subtype was the only that appears to have a role in adult rat ventricular fibroblasts
by increasing cells proliferation and type I collagen production. The magnitude of
the P2Y1 receptor-mediated proliferative effect on ventricular myofibroblasts was
very similar to that observed upon activating P2Y2 receptors with UTP, but ADP
and its stable analogue ADPβS were more potent than UTP on type I collagen
production by these cells. Whether this discrepancy is due to the anti-fibrotic effect
of UTP operated by synchronous activation of Gs-protein-coupled P2Y11 receptor
remains to be investigated. As a matter of fact, inhibition of adenylate cyclase
activity (with SQ22536) did not modify cells proliferation and type I collagen
production induced by ADPβS, as it did when UTP was used instead. Data, thus,
suggest that ADP-mediated effects on fibroblast cells proliferation and matrix
deposition is apparently unrestrained by synchronous activation of the anti-fibrotic
P2Y11 receptor coupled to the adenylate cyclase/cyclic AMP/EPAC pathway, in
contrast to that observed with UTP.
Much to our surprise, none of the ADP-sensitive P2Y receptors (P2Y1,
P2Y12 and P2Y13) seem to be involved in acute [Ca2+]i transients in ventricular
fibroblasts of adult rats. ADP concentration-dependenly increased [Ca2+]i
accumulation through a non-canonical activation of fast desensitizing P2Y4
receptors (Bogdanov et al., 1998; Burnstock, 2012), although with a lesser
potency than that observed for UTP and ATP under the same experimental
conditions. The mechanisms underlying [Ca2+]i transients induced by P2Y4
receptors activation implicate PLC stimulation and the release of IP3 and DAG
from membrane phospholipids (PIP2). Whereas soluble IP3 may trigger the P2Y4-
induced fast [Ca2+]i rise by favoring the recruitment of Ca2+ from thapsigargin-
sensitive internal stores, DAG might promote the opening of 2-APB-sensitive TRP
channels leading to capacitative Ca2+ influx from the extracellular milieu to sustain
the plateau phase of the [Ca2+]i response. Lateral assembly of the P2Y4 receptor,
Gq/11 protein, PLC and TRP channels may occur at lipid rafts/cavelae
microdomains, because plasma membrane depletion of PIP2 and cholesterol with
LiCl and methyl-β-cyclodextrin, respectively, equally downsized the late [Ca2+]i
plateau. It is known that Gq/11 binding to caveolin-1 is strengthen by (P2Y4)
receptors activation, which contributes to stabilization of PLC within caveolae
resulting in increased Ca2+ signals (Calizo and Scarlata, 2012). Interestingly,
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activation of Gq/11 protein-linked mechanisms also favour activation of adenylate
cyclase by Gs-protein-coupled receptors, which may additionally explain the
synergism between Gq/11-coupled P2Y4 and Gs-linked P2Y11 receptors on [Ca2+]i
transients when mutual ligands were used (e.g. UTP or ATP), but not when only
the P2Y4 receptor was activated by ADP.
Ca2+ permeable TRP channels are widely expressed in many cell types,
including cardiac fibroblasts. Four different TRP channels, TRPM7, TRPC3,
TRPC6 and TRPV4, were found to be critical for fibroblasts differentiation to
myofibroblasts (Adapala et al., 2013; Davis et al., 2012; Du et al., 2010). Other
groups also claimed the presence of TRPC1, TRPC3, TRPC6, and TRPC7 in rat
cardiac fibroblasts (Nishida et al., 2007). More importantly, all these channels have
been involved in fibrotic heart disease opening the doors for the development of
drugs targeting TRP channels modulation. The poor pharmacology of most TRP
channels prevented a more definitive functional characterization of the subtypes
involved in nucleotide-induced [Ca2+]i transients and growth of ventricular
fibroblasts.
Association between transmembrane receptors and signaling molecules
within lipid rafts/caveolae provides an enriched environment for protein-protein
interactions necessary for signal transduction. Receptors may translocate into
submembrane compartments after ligand binding curtailing there activity, but
others can move in the opposite direction favoring their actions (D’Ambrosi et al.,
2013). Disruption of cholesterol from submembrane compartments can shift the
purinergic receptors from lipid raft/caveolar to non-raft/non-caveolar fraction, and
thereby abolish their ability to activate phospholipid-dependent signaling pathways
and to integrate additional lipid-controled signaling events. In this context, it is
tempting to speculate about the possibility to target rapid coupling/uncoupling
subtype-specific purinergic receptors from signal transduction pathways by
changing lipid rafts/caveolae microenvironment as an important clue for designing
drugs for therapeutic intervention in cardiac remodeling.
In summary, data presented here show that UTP-sensitive P2Y2, P2Y4 and
P2Y11 receptors differentially affect [Ca2+]i transients and proliferation of rat
ventricular myofibroblasts. Activation of the G1q/11-coupled P2Y4 receptor is the
main responsible for UTP-induced [Ca2+]i transients, which may result in ATP
release to the extracellular fluid and subsequent activation of P2Y11 receptors
116 PhD THESIS – MARIANA DE SOUSA CERTAL GOMES
linked to Gs proteins and adenylate cyclase/cyclicAMP/EPAC pathway. Besides
the expression of ADP-preferring P2Y1, P2Y12 and P2Y13 receptors has been
detected in fibroblasts isolated from adult rat ventricles, ADP-induced [Ca2+]i
transients are more likely mediated through the activation of P2Y4 receptors
coupled to the phospholipase C / IP3 pathway. Inhibition of TRP channels, as well
as disruption of lipid rafts microenvironment and PIP2 turnover, all affected the
plateau phase of ADP-induced [Ca2+]i response. More importantly, our results
show that long-term activation of P2Y2 and/or P2Y1 receptors by UTP and/or ADP,
respectively, increase fibroblast cells proliferation. Our findings also demonstrate
for the first time that the pro-fibrotic effects of nucleoside triphosphates (UTP and
ATP), but not ADP, may be counteracted by the activation of P2Y11 receptors.
Thus, we propose that the anti-fibrotic effect of P2Y11 receptors might be used as
a novel therapeutic target to prevent cardiac fibrosis.
PhD THESIS – MARIANA DE SOUSA CERTAL GOMES 117
CHAPTER 5. REFERENCES
118 PhD THESIS – MARIANA DE SOUSA CERTAL GOMES
Abbracchio M.P., Burnstock G., Verkhratsky A. and Zimmermann H. 2009.
Purinergic signalling in the nervous system: an overview. Trends Neurosci.
32(1):19-29.
Abbracchio, M.P., Burnstock, G., Boeynaems, J.M., Barnard, E.A., Boyer,
J.L., Kennedy, C., Knight, G.E., Fumagalli, M., Gachet, C., Jacobson, K.A. and
Weisman, G.A. 2006. International Union of Pharmacology LVIII: update on the
P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and
pathophysiology to therapy. Pharmacol Rev. 58:281-341.
Acharya A., Baek S.T., Huang G., Eskiocak B., Goetsch S., Sung C.Y.,
Banfi S., Sauer M.F., Olsen G.S., Duffield J.S., Olson E.N. and Tallquist M.D.
2012. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of
cardiac fibroblast progenitors. Development.139:2139–2149.
Adapala R.K., Thoppil R.J., Luther D.J., Paruchuri S., Meszaros J.G.,
Chiliam W.M. and Thodeti C.K. 2013. TRPV4 channels mediate cardiac fibroblast
differentiation by integrating mechanical and soluble signals. J Mol Cell Cardiol.
54:45-52.
Agocha, A.E. and Eghbali-Webb, M. 1997. A simple method for preparation
of cultured cardiac fibroblasts from adult human ventricular tissue. Mol Cell
Biochem. 172:195-8.
Alexander, S.P., Davenport, A.P., Kelly, E., Marrion, N., Peters, J.A.,
Benson, H.E., Faccenda, E., Pawson, A.J., Sharman, J.L., Southan, C. and
Davies, J.A. 2015. CGTP Collaborators. The Concise Guide to PHARMACOLOGY
2015/16: G protein-coupled receptors. Br J Pharmacol. 172:5744-869.
Alqallaf, S.M., Evans, B.A. and Kidd, E.J. 2009. Atypical P2X receptor
pharmacology in two human osteoblast-like cell lines. Br J Pharmacol.
156(7):1124-35.
Amisten, S., Melander, O., Wihlborg, A.K., Berglund, G. and Erlinge, D.
2007. Increased risk of acute myocardial infarction and elevated levels of C-
reactive protein in carriers of the Thr-87 variant of the ATP receptor P2Y11. Eur
Heart J. 28(1):13-8.
Anderson, K.R., Sutton, M.G., Lie, J.T. 1979. Histopathological types of
cardiac fibrosis in myocardial disease. J Pathol. 128(2):79-85.
Asazuma-Nakamura, Y., Dai, P., Harada, Y., Jiang, Y., Hamaoka, K. and
Takamatsu, T. 2009. Cx43 contributes to TGF-beta signaling to regulate
differentiation of cardiac fibroblasts into myofibroblasts. Exp Cell Res.
315(7):1190-9.
Balogh, J., Wihlborg, A.K., Isackson, H., Joshi, B.V., Jacobson, K.A., Arner,
A. and Erlinge, D. 2005. Phospholipase C and cAMP-dependent positive inotropic
PhD THESIS – MARIANA DE SOUSA CERTAL GOMES 119
effects of ATP in mouse cardiomyocytes via P2Y11-like receptors. J Mol Cell
Cardiol. 39(2):223-30.
Banerjee I., Fuseler J.W., Price R.L., Borg T.K. and Baudino T.A. 2007.
Determination of cell types and numbers during cardiac development in the
neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol. 293:H1883-
H1891.
Baudino, T.A., McFadden, A., Fix, C., Hastings, J., Price, R. and Borg, T.K.
2008. Cell patterning: interaction of cardiac myocytes and fibroblasts in three-
dimensional culture. Microsc Microanal. 14(2):117-25.
Berridge, M.J. and Irvine, R.F. 1989. Inositol phosphates and cell signalling.
Nature. 341:197-205.
Berridge, M.J. 2003. Cardiac calcium signalling. Biochem Soc Trans.
31:930-933.
Biernacka, A. and Frangogiannis, N.G. 2011. Aging and Cardiac Fibrosis.
Aging Dis. 2(2):158-173.
Bogdanov, Y. D., Wildman, S. S., Clements, M. P., King, B. F. and
Burnstock, G. 1998. Molecular cloning and characterization of rat P2Y4 nucleotide
receptor. Br J Pharmacol. 124:428-430.
Bohl, S., Wassmuth, R., Abdel-Aty, H., Rudolph, A., Messroghli, D., Dietz,
R. and Schulz-Menger, J. 2008. Delayed enhancement cardiac magnetic
resonance imaging reveals typical patterns of myocardial injury in patients with
various forms of non-ischemic heart disease. Int J Cardiovasc Imaging. 24:597–
607.
Borg, T.K., Rubin, K., Lundgren, E., Borg, K. and Obrink, B. 1984.
Recognition of extracellular matrix components by neonatal and adult cardiac
myocytes. Dev Biol. 104(1):86-96.
Bosman F.T. and Stamenkovic I. 2003. Functional structure and
composition of the extracellular matrix. J Pathol. 200(4):423-428.
Bours M.J., Swennen E.L., Di Virgilio F., Cronstein B.N. and Dagnelie P.C.
2006. Adenosine 5'-triphosphate and adenosine as endogenous signaling
molecules in immunity and inflammation. Pharmacol Ther. 112(2):358-404
Bouzegrhane, F. and Thibault, G. 2002. Is angiotensin a proliferative factor
of cardiac fibroblasts? Cardiovasc Res. 53(2):304-12.
Bragança, B., Oliveira-Monteiro, N., Ferreirinha, F., Lima, P.A., Faria, M.,
Fontes-Sousa, A.P. And Correia-de-Sá, P. 2016. Ion fluxes through KCa2 (SK)
and Cav1 (L-type) channels contribute to chronoselectivity of adenosine A1
receptor-mediated actions in spontaneously beating rat atria. Front Pharmacol.
7:45.
120 PhD THESIS – MARIANA DE SOUSA CERTAL GOMES
Bramich, N.J., Edwards, F.R. and Hirst, G.D. 1990. Sympathetic nerve
stimulation and applied transmitters on the sinus venosus of the toad. J Physiol.
429:349-375.
Braun, O.O., Lu, D., Aroonsakool, N. and Insel, P.A. 2010. Uridine
triphosphate (UTP) induces profibrotic responses in cardiac fibroblasts by
activation of P2Y2 receptors. J Mol Cell Cardiol. 49(3):362-9.
Brown, R.D., Ambler, S.K., Mitchell, M.D. and Long, C.S. 2005. The cardiac
fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev
Pharmacol Toxicol. 45:657-87.
Bujak, M. and Frangogiannis, N.G. 2007. The role of TGF-beta signaling in
myocardial infarction and cardiac remodeling. Cardiovasc Res. 74(2):184-195.
Burnstock, G. 1976. Do some nerve cells release more than one transmitter?
Neuroscience. 4:239-48.
Burnstock, G. 2006. Purinergic signalling. Br J Pharmacol. 147:S172-81.
Burnstock, G. 2007. Physiology and pathophysiology of purinergic
neurotransmission. Physiol Rev. 87:659-797.
Burnstock, G. 2012. Discovery of purinergic signaling, the initial resistance
and current explosion of interest. Br J Pharmacol. 167:238-55.
Burnstock, G. and Pelleg, A. 2015. Cardiac purinergic signalling in health
and disease. Purinergic Signal. 11(1):1-46.
Burnstock, G., Fredholm, B.B. and Verkhratsky, A. 2011. Adenosine and
ATP receptors in the brain. Curr Top Med Chem. 11:973-1011.
Calderone, A., Bel-Hadj, S., Drapeau, J., El-Helou, V., Gosselin, H.,
Clement, R. and Villeneuve, L. 2006. Scar myofibroblasts of the infarcted rat heart
express natriuretic peptides. J Cell Physiol. 207(1):165-173.
Calizo, R.C. And Scarlate, S. 2012. A role for G-proteins in directing G-
protein-coupled receptor-caveolae localization. Biochemistry. 51(47):9513-23.
Camelliti, P., Borg, T.K. and Kohl, P. 2005. Structural and functional
characterisation of cardiac fibroblasts. Cardiovasc Res. 65(1):40-51.
Cardoso, A.M., Schetinger, M.R., Correia-de-Sá, P. and Sévigny, J. 2015.
Impact of ectonucleotidases in autonomic nervous functions. Auton Neurosci.
191:25-38.
Carneiro, I., Timóteo, M.A., Silva, I., Vieira, C., Baldaia, C., Ferreirinha, F.,
Silva-Ramos, M. and Correia-de-Sá, P. 2014. Activation of P2Y6 receptors
increases the voiding frequency in anaesthetized rats by releasing ATP from the
bladder urothelium. Br J Pharmacol. 171(14):3404-19.
PhD THESIS – MARIANA DE SOUSA CERTAL GOMES 121
Certal, M., Vinhas, A., Pinheiro, A.R., Ferreirinha, F., Barros-Barbosa, A.R.,
Silva, I., Costa, M.A. and Correia-de-Sá, P. 2015. Calcium signaling and the novel
anti-proliferative effect of the UTP-sensitive P2Y11 receptor in rat cardiac
myofibroblasts. Cell Calcium. 58(5):518-33.
Chao, D. and Xia, Y. 2010. Ionic storm in hypoxic/ischemic stress: can
opioid receptors subside it? Prog Neurobiol. 90(4):439-70.
Chatelier, A., Mercier, A., Tremblier, B., Theriault, O., Moubarak, M.,
Benamer, N., Corbi, P., Bois, P., Chahine, M. and Faivre, J.F. 2012. A distinct de
novo expression of Nav1.5 sodium channels in human atrial fibroblasts
differentiated into myofibroblasts. J Physiol. 590(17):4307-19.
Chen, J.B., Liu, W.J., Che, H., Liu, J., Sun, H.Y. and Li, G.R. 2012.
Adenosine-5'-triphosphate up-regulates proliferation of human cardiac fibroblasts.
Br J Pharmacol. 166(3):1140-50.
Chen, S. and Li, S. 2012. The Na+/Ca2+ exchanger in cardiac
ischemia/reperfusion injury. Med Sci Monit. 18:RA161–RA165.
Cheng, J.P.X. and Nichols, B.J. 2015. Caveolae: One Function or Many?
Trends Cell Biol. 26:177–189.
Cheng, X., Jin, J., Hu, L., Shen, D., Dong, X.P., Samie, M.A., Knoff, J.,
Eisinger, B., Liu, M.L., Huang, S.M., Caterina, M.J., Dempsey, P., Michael, L.E.,
Dlugosz, A.A., Andrews, N.C., Clapham, D.E. and Xu, H. 2010. TRP Channel
Regulates EGFR Signaling in Hair Morphogenesis and Skin Barrier Formation.
Cell. 141:331-343.
Chhatriwala, M., Ravi, R.G., ., Boyer, J.L., Jacobson, K.A. and Harden, T.K.
2004. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor
versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint
of an ADP analog. J Pharmacol Exp Ther. 311(3):1038-43.
Christie, A., Sharma, V.K. and Sheu, S.S. 1992. Mechanism of extracellular
ATP-induced increase of cytosolic Ca2+ concentration in isolated rat ventricular
myocytes. J Physiol. 445:369-388.
Clemens, M.G. and Forrester, T. 1981. Appearance of adenosine
triphosphate in the coronary sinus effluent from isolated working rat heart in
response to hypoxia. J Physiol. 312:143-158.
Cohn, J.N., Ferrari, R. and Sharpe, N. 2000. Cardiac remodeling-concepts
and clinical implications: a consensus paper from an international forum on cardiac
remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll
Cardiol. 35(3):569-82.
Colgan S.P., Eltzschig H.K., Eckle T. and Thompson L.F. 2006.
Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal. 2(2):351-60.
122 PhD THESIS – MARIANA DE SOUSA CERTAL GOMES
Communi, D., Robaye, B. and Boeynaems, J.M. 1999. Pharmacological
characterization of the human P2Y11 receptor. Br J Pharmacol. 128(6):1199-206.
Costa, M.A., Barbosa, A., Neto, E., Sa-e-Sousa, A., Freitas, R., Neves, J.M.,
Magalhães-Cardoso, T., Ferreirinha, F. and Correia-de-Sá, P. 2011. On the role of
subtype selective adenosine receptor agonists during proliferation and osteogenic
differentiation of human primary bone marrow stromal cells. J Cell Physiol.
226(5):1353-66.
Cruikshank, S.J., Hopperstad, M., Younger, M., Connors, B.W., Spray, D.C.
and Srinivas, M. 2004. Potent block of Cx36 and Cx50 gap junction channels by
mefloquine. Proc Natl Acad Sci. 101(33):12364-9.
D’Ambrosi, N. and Volonté, C. 2013. Metabotropic purinergic receptors in
lipid membrane microdomains. Curr Med Chem. 20(1):56-63.
Davis, J. and Molkentin, J.D. 2014. Myofibroblasts: trust your heart and let
fate decide. J Mol Cell Cardiol. 70:9-18.
Davis, J., Burr, A.R., Davis, G.F., Birnbaumer, L. and Molkentin, J.D. 2012.
A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound
healing in vivo. Dev Cell. 23:705–715.
de Bakker, J.M., van Capelle, F.J., Janse, M.J., Tasseron, S., Vermeulen,
J.T., de Jonge, N. and Lahpor, J.R. 1996. Fractionated electrograms in dilated
cardiomyopathy: origin and relation to abnormal conduction. J Am Coll Cardiol.
27:1071–1078.
Dekkers, B.G., Racke, K. and Schmidt, M. 2013. Distinct PKA and Epac
compartmentalization in airway function and plasticity. Pharmacol Ther.
137(2):248-65.
Desmoulière, A., Redard, M., Darby, I. and Gabbiani, G. 1995. Apoptosis
mediates the decrease in cellularity during the transition between granulation
tissue and scar. Am J Pathol. 146(1):56-66.
Djerada, Z., Peyret, H., Dukic, S. and Millart, H. 2013. Extracellular NAADP
affords cardioprotection against ischemia and reperfusion injury and involves the
P2Y11-like receptor. Biochem Biophys Res Commun. 434(3):428-33.
Dolmatova E., Spagnol G., Boassa D., Baum J.R., Keith K., Ambrosi C.,
Kontaridis, M.I., Sorgen, P.L., Sosinsky, G.E. and Duffy, H.S. 2012.
Cardiomyocyte ATP release through pannexin 1 aids in early fibroblast activation.
Am J Physiol Heart Circ Physiol. 303(10):H1208-1218.
Drury A.N. and Szent-Györgyi A. 1929. The physiological activity of adenine
compounds with especial reference to their action upon the mammalian heart. J
Physiol. 68(3):213-37.
PhD THESIS – MARIANA DE SOUSA CERTAL GOMES 123
Du, J., Xie, J., Zhang, Z., Tsujikawa, H., Fusco, D. and Silverman, D. 2010.
TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation. Circ
Res. 106:992-1003.
Dubey, R.K., Gillespie, D.J. and Jackson, E.K. 1998. Adenosine inhibits
collagen and protein synthesis in cardiac fibroblasts role of A2B receptors.
Hypertension. 31:943-948.
Dubyak G.R. 1991. Signal transduction by P2-purinergic receptors for
extracellular ATP. Am J Respir Cell Mol Biol. 4(4):295-300.
Dubyak G.R. and el-Moatassim C. 1993. Signal transduction via P2-
purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol.
265:C577-606.
Eisenberg, L.M. and Markwald, R.R. 1995. Molecular regulation of
atrioventricular valvuloseptal morphogenesis. Circ Res. 77:1-6.
Epperson, S.A., Brunton, L.L., Ramirez-Sanchez, I. and Villarreal, F. 2009.
Adenosine receptors and second messenger signaling pathways in rat cardiac
fibroblasts. Am J Physiol. 296:C1171-1177.
Fan, D., Takawale, A., Lee, J. and Kassiri, Z. 2012. Cardiac fibroblasts,
fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue
Repair. 5(1):15.
Ferrari, D., Gambari, R., Idzko, M., Müller, T., Albanesi, C., Pastore, S., La
Manna, G., Robson, S.C. and Cronstein, B. 2016. Purinergic signaling in scarring.
FASEB J. 30(1):3-12.
Forrester, T. and Williams, C.A. 1977. Release of adenosine triphosphate
from isolated adult heart cells in response to hypoxia. J Physiol. 268(2):371-390.
Fredholm, B.B., Hedqvist, P., Lindstrom, K. and Wennmalm, M. 1982.
Release of nucleosides and nucleotides from the rabbit heart by sympathetic
nerve stimulation. Acta Physiol Scand. 116(3):285-295.
Fries, K.M., Blieden, T., Looney, R.J., Sempowski, G.D., Silvera, M.R.,
Willis, R.A. and Phipps, R.P. 1994. Evidence of fibroblast heterogeneity and the
role of fibroblast subpopulations in fibrosis. Clin Immunol Immunopathol.
72(3):283-92.
Froldi, G., Pandolfo, L., Chinellato, A., Ragazzi, E., Caparrotta, L. and
Fassina, G. 1994. Dual effect of ATP and UTP on rat atria: which types of
receptors are involved? Naunyn Schmiedebergs Arch Pharmacol. 349(4):381-386.
Froldi, G., Ragazzi, E. and Caparrotta, L. 2001. Do ATP and UTP involve
cGMP in positive inotropism on rat atria? Comp Biochem Physiol C Toxicol
Pharmacol. 128(2):265-74.
124 PhD THESIS – MARIANA DE SOUSA CERTAL GOMES
Froldi, G., Varani, K., Chinellato, A., Ragazzi, E., Caparrotta, L. and Borea,
P.A. 1997. P2X-purinoceptors in the heart: actions of ATP and UTP. Life Sci.
60(17):1419-1430.
Garbuzenko, E., Nagler, A., Pickholtz, D., Gillery, P., Reich, R., Maquart,
F.X. and Levi-Schaffer, F. 2002. Human mast cells stimulate fibroblast proliferation,
collagen synthesis and lattice contraction. A direct role for mast cells in skin
fibrosis. Clin Exp Allergy. 32:237–246.
Garcia-Marcos, M., Dehaye, J.P. and Marino, A. 2009. Membrane
compartments and purinergic signalling: the role of plasma membrane
microdomains in the modulation of P2XR-mediated signalling. FASEB J.
276(2):330-40.
Gendaszewska-Darmach, E. and Kucharska, M. 2011. Nucleotide receptors
as targets in the pharmacological enhancement of dermal wound healing.
Purinergic Signal. 7:193-206.
Gerasimovskaya, E.V., Ahmad, S., White, C.W., Jones, P.L., Carpenter,
T.C. and Stenmark, K.R. 2002. Extracellular ATP is an autocrine/paracrine
regulator of hypoxia-induced adventitial fibroblast growth. Signaling through
extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor. J Biol
Chem. 277(47):44638-50.
Gittenberger-de Groot, A.C., Vrancken Peeters, M.P., Mentink, M.M.,
Gourdie, R.G. and Poelmann, R.E. 1998. Epicardium-derived cells contribute a
novel population to the myocardial wall and the atrioventricular cushions. Circ Res.
82(10):1043-1052.
Goldsmith, E.C., Hoffman, A., Morales, M.O., Potts, J.D., Price, R.L.,
McFadden, A., Rice, M. and Borg, T.K. 2004. Organization of fibroblasts in the
heart. Dev Dyn. 230:787-794.
Goldsmith, E.C., Zhang, X., Watson, J., Hastings, J. and Potts, J.D. 2010.
The collagen receptor DDR2 is expressed during early cardiac development. Anat
Rec. 293(5):762-9.
Gordon, J.L. 1986. Extracellular ATP: effects, sources and fate. Biochem J.
233:309-319.
Gratton, J.P., Bernatchez, P. and Sessa, W.C. 2004. Caveolae and
caveolins in the cardiovascular system. Circ Res. 94(11):1408-17.
Grden, M., Podgorska, M., Kocbuch, K., Szutowicz, A. and Pawelczyk, T.
2006. Expression of adenosine receptors in cardiac fibroblasts as a function of
insulin and glucose level. Arch Biochem Biophys. 455(1):10-7.
Guinamard, R., Simard, C. and Del Negro, C. 2013. Flufenamic acid as an
ion channels modulator. Pharmacol Ther. 138:272-284.
PhD THESIS – MARIANA DE SOUSA CERTAL GOMES 125
Guo, J.L., Yu, Y., Jia, Y., Ma, Y.Z., Zhang, B.Y., Liu, P.Q., Chen, S.R. and
Jiang, J.M. 2014. Transient receptor potential melastatin 7 (TRPM7) contributes to
H2O2-induced cardiac fibrosis via mediating Ca2+ influx and extracellular signal-
regulated kinase 1/2 (ERK1/2) activation in cardiac fibroblasts. J Pharmacol Sci.
125(2):184-92.
Halkein, J., Tabruyn, S.P., Ricke-Hoch, M., Haghikia, A., Nguyen, N.Q.,
Scherr, M., Castermans, K., Malvaux, L., Lambert, V., Thiry, M., Sliwa, K., Noel, A.,
Martial, J.A., Hilfiker-Kleiner, D. and Struman, I. 2013. MicroRNA-146a is a
therapeutic target and biomarker for peripartum cardiomyopathy. J Clin
Invest.123(5):2143-2154.
Hanson, B.A. 1991. The effects of lithium on the phosphoinositides and
inositol phosphates of neurospora crassa. Exp. Mycol. 15:76-90.
Harada, M., Luo, X., Qi, X.Y., Tadevosyan, A., Maguy, A., Ordog,
B., Ledoux, J., Kato, T., Naud, P., Voigt, N., Shi, Y., Kamiya, K., Murohara, T.,
Kodama, I., Tardif, J.C., Schotten, U., Van Wagoner, D.R., Dobrev, D. and Nattel,
S. 2012. Transient receptor potential canonical‐3 channel‐dependent fibroblast
regulation in atrial fibrillation. Circulation. 126:2051–2064.
Harteneck, C. and Gollasch, M. 2011. Pharmacological modulation of
diacylglycerol-sensitive TRPC3/6/7 channels. Curr Pharm Biotechnol. 12:35-41.
Hattori, M. and Gouaux, E. 2012. Molecular mechanism of ATP binding and
ion channel activation in P2X receptors. Nature. 485(7397):207-212.
Henriksen, Z., Hiken, J.F., Steinberg, T.H. and Jorgensen, N.R. 2006. The
predominant mechanism of intercellular calcium wave propagation changes during
long-term culture of human osteoblast-like cells. Cell Calcium. 39(5):435-44.
Hergenreider, E., Heydt, S., Tréguer, K., Boettger, T., Horrevoets, A.J.,
Zeiher, A.M., Scheffer, M.P., Frangakis, A.S., Yin, X., Mayr, M., Braun, T., Urbich,
C., Boon, R.A. and Dimmeler, S. 2012. Atheroprotective communication between
endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol.
14(3):249-256.
Hinz, B., Phan, S.H., Thannickal, V.J., Galli, A., Bochaton-Piallat, M.L. and
Gabbiani, G. 2007. Myofibroblast function and origin. Am J Pathol. 170(6):1807-
1816.
Homolya, L., Steinberg, T.H. and Boucher, R.C. 2000. Cell to cell
communication in response to mechanical stress via bilateral release of ATP and
UTP in polarized epithelia. J Cell Biol. 150(6):1349-60.
Hu, H. and Sachs, F. 1997. Stretch-activated ion channels in the heart. J
Mol Cell Cardiol. 29(6):1511-1523.
Jarvis, M.D., Rademaker, M.T., Ellmers, L.J., Currie, M.J., McKenzie, J.L.,
Palmer, B.R., Frampton, C.M., Richards, A.M. and Cameron, V.A. 2006.
126 PhD THESIS – MARIANA DE SOUSA CERTAL GOMES
Comparison of infarct-derived and control ovine cardiac myofibroblasts in culture:
response to cytokines and natriuretic peptide receptor expression profiles. Am J
Physiol Heart Circ Physiol. 291(4):H1952-H1958.
Jasmin, J.F., Malhotra, S., Singh, D.M., Mercier, I., Rosenbaum, D.M. and
Lisanti, M.P. 2007. Caveolin-1 deficiency increases cerebral ischemic injury. Cir
Res. 100(5):721-9.
Jost, N., Nagy, N., Corici, C., Kohajda, Z., Horvath, A., Acsai, K., Biliczki, P.,
Levijoki, J., Pollesello, P., Koskelainen, T., Otsomaa, L., Toth, A., Papp, J.G.,
Varro, A. and Virag, L. 2013. ORM-10103, a novel specific inhibitor of the Na+/Ca2+
exchanger, decreases early and delayed afterdepolarizations in the canine heart.
Br J Pharmacol. 170(4):768-78.
Kai, H., Mori, T., Tokuda, K., Takayama, N., Tahara, N., Takemiya, K.,
Kudo, H., Sugi, Y., Fukui, D., Yasukawa, H., Kuwahara, F. and Imaizumi, T. 2006.
Pressure overload-induced transient oxidative stress mediates perivascular
inflammation and cardiac fibrosis through angiotensin II. Hypertens Res. 29:711-
718.
Kakkar, R. and Lee, R.T. 2011. Intramyocardial fibroblast myocyte
communication. Circ Res. 106(1):47-57.
Kamkin, A., Kiseleva, I., Isenberg, G., Wagner, K.D., Gunther, J., Theres,
H., Scholz H. 2003. Cardiac fibroblasts and the mechano-electric feedback
mechanism in healthy and diseased hearts. Prog Biophys Mol Biol. 82:111-120.
Kamkin, A., Kiseleva, I., Wagner, K.D., Lammerich, A., Bohm, J., Persson,
P.B. and Gunther, J. 1999. Mechanically induced potentials in fibroblasts from
human right atrium. Exp Physiol. 84(2):347-56.
Karamitsos, T.D., Francis, J.M., Myerson, S., Selvanayagam, J.B. and
Neubauer, S. 2009. The role of cardiovascular magnetic resonance imaging in
heart failure. J Am Coll Cardiol. 54:1407-1424.
Kawaguchi M., Takahashi M., Hata T., Kashima, Y., Usui, F., Morimoto,
H., Izawa, A., Takahashi, Y., Masumoto, J., Koyama, J., Hongo, M., Noda,
T., Nakayama, J., Sagara, J., Taniguchi, S. and Ikeda, U. 2011. Inflammasome
activation of cardiac fibroblasts is essential for myocardial ischemia/re-perfusion
injury. Circulation. 123:594–604.
Kegel, B., Braun, N., Heine, P., Maliszewski, C.R. and Zimmermann, H.
1997. An ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat
brain. Neuropharmacol. 36(9):1189-200.
Kehat, I. and Molkentin, J.D. 2010. Molecular pathways underlying cardiac
remodeling during pathophysiological stimulation. Circulation. 122(25):2727-35.
PhD THESIS – MARIANA DE SOUSA CERTAL GOMES 127
Kiseleva, I., Kamkin, A., Kohl, P. and Lab, M.J. 1996. Calcium and
mechanically induced potentials in fibroblasts of rat atrium. Cardiovasc Res.
32(1):98-111.
Ko, H., Carter, R.L., Cosyn, L., Petrelli, R., de Castro, S., Besada, P., Zhou,
Y., Cappellacci, L., Franchetti, P., Grifantini, M., Van Calenbergh, S., Harden, T.K.
and Jacobson, K.A. 2008. Synthesis and potency of novel uracil nucleotides and
derivatives as P2Y2 and P2Y6 receptor agonists. Bioorg Med Chem. 16(12):6319-
32.
Kohl, P. 2003. Heterogeneous cell coupling in the heart: An
electrophysiological role for fibroblasts. Circ Res. 93:381-383.
Kohl, P. and Noble, D. 1996. Mechanosensitive connective tissue: potential
influence on heart rhythm. Cardiovasc Res. 32(1):62-68.
Kohl, P., Camelliti, P., Burton, F.L. and Smith, G.L. 2005. Electrical coupling
of fibroblasts and myocytes: relevance for cardiac propagation. J Electrocardiol.
38:45-50.
Kong, P., Christia, P., Saxena, A., Su, Y. and Frangogiannis, N.G. 2013.
Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis.
Am J Physiol Heart Circ Physiol. 305:H1363–H1372.
Krenning, G., Zeisberg, E.M. and Kalluri, R. 2010. The origin of fibroblasts
and mechanism of cardiac fibrosis. J Cell Physiol. 225(3):631-637.
Kringelbach, T.M., Aslan, D., Novak, I., Schwarz, P. and Jorgensen, N.R.
2014. UTP-induced ATP release is a fine-tuned signalling pathway in osteocytes.
Purinergic Signal. 10(2): 337-47.
Kukulski, F., Lévesque, S.A., Lavoie, E.G., Lecka, J., Bigonnesse, F.,
Knowles, A.F., Robson, S.C., Kirley, T.L. and Sévigny, J. 2005. Comparative
hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. Purinergic Signal.
1(2):193-204.
Ladilov, Y., Haffner, S., Balser-Schafer, C., Maxeiner, H. and Piper, H.M.
1999. Cardioprotective effects of KB-R7943: a novel inhibitor of the reverse mode
of Na+/Ca2+ exchanger. Am J Physiol. 276:H1868-76.
Lane, E.B., Hogan, B.L., Kurkinen, M. and Garrels, J.I. 1983. Co-expression
of vimentin and cytokeratins in parietal endoderm cells of early mouse embryo.
Nature. 303:701–704.
Lazarowski, E.R., Boucher, R.C. and Harden, T.K. 2000. Constitutive
release of ATP and evidence for major contribution of ectonucleotide
pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide
concentrations. J Biol Chem. 275(40): 31061-31068.
128 PhD THESIS – MARIANA DE SOUSA CERTAL GOMES
Lazarowski, E.R., Boucher, R.C. and Harden, T.K. 2003. Mechanisms of
release of nucleotides and integration of their action as P2X- and P2Y-receptor
activating molecules. Mol Pharmacol. 64(4):785-795.
Le Douarin, N.M., Couly, G. and Creuzet, S.E. 2012. The neural crest is a
powerful regulator of pre-optic brain development. Dev Biol. 366(1):74-82.
Lekic, P.C., Pender, N. and McCulloch, C.A. 1997. Is fibroblast
heterogeneity relevant to the health, diseases, and treatments of periodontal
tissues? Crit Rev Oral Biol Med. 8(3):253-68.
Liang, W., McDonald, P., McManus, B., van Breemen, C. and Wang, X.
2008. P2Y2 receptor-mediated Ca2+ signaling and spontaneous Ca2+ releases in
human valvular myofibroblasts. Int Heart J. 49(2):221-36.
Lie-Venema, H., van den Akker, N.M., Bax, N.A., Winter, E.M., Maas, S.,
Kekarainen, T., Hoeben, R.C., de Ruiter, M.C. and Poelmann, R.E. 2007. Origin,
fate, and function of epicardium-derived cells (EPDCs) in normal and abnormal
cardiac development. Scientific World Journal. 7:1777-1798.
Lindner, D., Zietsch, C., Becher, P.M., Schulze, K., Schultheiss, H.P.,
Tschöpe, C. and Westermann, D. 2012. Differential expression of matrix
metalloproteases in human fibroblasts with different origins. Biochem Res Int.
875742.
Lu, D. and Insel, P. A. 2013. Hydrolysis of extracelular ATP by
ectonucleoside triphosphate diphosphohydrolase (ENTPD) establishes the set
point for fibrotic activity in cardiac fibroblasts. J Biol Chem. 288(26):19040-9.
Lu, D. and Insel, P.A. 2014. Cellular mechanisms of tissue fibrosis.
Purinergic signaling and response in fibroblasts and tissue fibrosis. Am J Physiol
Cell Physiol. 306(9):C779-88.
Lu, D., Soleymani, S., Madakshire, R. and Insel, P.A. 2012. ATP released
from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y2
receptors. FASEB J. 26(6):2580-91.
Mahmoudi, M., Willgoss, D., Cuttle, L., Yang, T., Pat, B., Winterford, C.,
Endre, Z., Johnson, D.W. and Gobé, G.C. 2003. In vivo and in vitro models
demonstrate a role for caveolin-1 in the pathogenesis of ischaemic acute renal
failure. J Pathol. 200(3):396-405.
Mahrholdt, H., Wagner, A., Judd, R.M., Sechtem, U., Kim and R.J. 2005.
Delayed enhancement cardiovascular magnetic resonance assessment of non-
ischaemic cardiomyopathies. Eur Heart J. 26:1461-1474.
Mamedova, L.K., Joshi, B.V., Gao, Z.G., von Kugelgen, I. and Jacobson,
K.A. 2004. Diisothiocyanate derivatives as potent, insurmountable antagonists of
P2Y6 nucleotide receptors. Biochem Pharmacol. 67(9):1763-70.
PhD THESIS – MARIANA DE SOUSA CERTAL GOMES 129
Manabe, I., Shindo, T. and Nagai, R. 2002. Gene expression in fibroblasts
and fibrosis: involvement in cardiac hypertrophy. Circ Res. 91(12):1103-1113.
Manner, J. 1999. Does the subepicardial mesenchyme contribute
myocardioblasts to the chick embryo heart? A quail-chick chimera study tracing
the fate of the epicardial primordium. Anat Rec. 255:212-226.
Manner, J., Pérez-Pomares, J.M., Macías, D., Muñoz-Chápuli, R. 2001.
The origin, formation, and developmental significance of the epicardium: a review.
Cells Tissues Organs.169:89-103.
Markwald, R.R., Fitzharris, T.P. and Manasek, F.J. 1977. Structural
development of endocardial cushions. Am J Anat. 148(1):85-119.
Martos, R., Baugh, J., Ledwidge, M., O'Loughlin, C., Conlon, C., Patle, A.,
Donnelly, S.C. and McDonald, K. 2007. Diastolic heart failure: evidence of
increased myocardial collagen turnover linked to diastolic dysfunction. Circulation.
115:888-895.
Maruoka, H., Jayasekara, M.P., Barrett, M.O., Franklin, D.A., de Castro, S.,
Kim, N., Costanzi, S., Harden, T.K. and Jacobson, K.A. 2011. Pyrimidine
nucleotides with 4-alkyloxyimino and terminal tetraphosphate delta-ester
modifications as selective agonists of the P2Y4 receptor. J Med Chem.
54(12):4018-33.
McGrath, J.C., Drummond, G.B., McLachlan, E.M., Kilkenny, C.,
Wainwright, C.L. 2010. Guidelines for reporting experiments involving animals: the
ARRIVE guidelines. Br J Pharmacol. 160:1573-6.
McIntosh, V.J. and Lasley, R.D. 2012. Adenosine receptor-mediated
cardioprotection: are all 4 subtypes required or redundant? J Cardiovasc
Pharmacol Ther. 17(1):21-33.
Meis, S., Hamacher, A., Hongwiset, D., Marzian, C., Wiese, M., Eckstein,
N., Royer, H.D., Communi, D., Boeynaems, J.M., Hausmann, R., Schmalzing, G.
and Kassack, M.U. 2010. NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-
carbonylimino-3,1-(4-methyl-phenylene)-car bonylimino))-bis(1,3-xylene-
alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11
agonist and stimulates release of interleukin-8 from human monocyte-derived
dendritic cells. J Pharmacol Exp Ther. 332(1):238-47.
Meldrum, L.A. and Burnstock, G. 1983. Evidence that ATP acts as a co-
transmitter with noradrenaline in sympathetic nerves supplying the guinea-pig vas
deferens. Eur J Pharmacol. 92(1-2):161-3.
Meszaros, J.G., Gonzalez, A.M., Endo-Mochizuki, Y., Villegas, S., Villarreal,
F. and Brunton, L.L. 2000. Identification of G protein-coupled signaling pathways
in cardiac fibroblasts: cross talk between Gq and Gs. Am J Physiol Cell Physiol.
278(1):C154-62.
130 PhD THESIS – MARIANA DE SOUSA CERTAL GOMES
Mikawa, T. and Gourdie, R.G. 1996. Pericardial mesoderm generates a
population of coronary smooth muscle cells migrating into the heart along with
ingrowth of the epicardial organ. Dev Biol. 174(2):221-232.
Miragoli, M., Gaudesius, G. and Rohr, S. 2006. Electrotonic modulation of
cardiac impulse conduction by myofibroblasts. Circ Res. 98(6):801-810.
Montell, C. 2005. The latest waves in calcium signaling. Cell. 122(2):157-
163.
Moore-Morris, T., Puceat, M. and Evans, S.M. 2014. Targeting cardiac
fibroblasts: the pressure is on. Cell Cycle. 13(17):2647-2648.
Morales, M.O., Price, R.L. and Goldsmith, E.C. 2005. Expression of
Discoidin Domain Receptor 2 (DDR2) in the developing heart. Microsc Microanal.
11(3):260-7.
Moreschi, I., Bruzzone, S., Bodrato, N., Usai, C., Guida, L., Nicholas, R.A.,
Kassack, M.U., Zocchi, E. and De Flora, A. 2008. NAADP+ is an agonist of the
human P2Y11 purinergic receptor. Cell Calcium. 43(4):344-55.
Moro, S., Gao, Z.G., Jacobson, K.A. and Spalluto, G. 2006 Progress in the
pursuit of therapeutic adenosine receptor antagonists. Med Res Rev. 26:131-159.
Nakayama, H., Wilkin, B.J., Bodi, I. and Molkentin, J.D. 2006. Calcineurin-
dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB
J. 20:1660-70.
Nebenfuhr, A., Ritzenthaler, C. and Robinson, D.G. 2002. Brefeldin A:
deciphering an enigmatic inhibitor of secretion. Plant Physiol. 130(3):1102-8.
Nilius, B. 2007. Transient receptor potential (TRP) cation channels:
rewarding unique proteins. Bull Mem Acad R Med Belg. 162(3-4):244-253.
Nishida, M., Onohara, N., Sato, Y., Suda, R., Ogushi, M., Tanabe, S., Inoue,
R., Mori, Y. and Kurose, H. 2007. Galpha12/13-mediated up-regulation of TRPC6
negatively regulates endothelin-1-induced cardiac myofibroblast formation and
collagen synthesis through nuclear factor of activated T cells activation. J Biol
Chem. 282:23117–28.
Noronha-Matos, J.B., Costa, M.A., Magalhães-Cardoso, M.T., Ferreirinha,
F., Pelletier, J., Freitas, R., Neves, J.M., Sevigny, J. and Correia-de-Sá, P. 2012.
Role of ecto-NTPDases on UDP-sensitive P2Y6 receptor activation during
osteogenic differentiation of primary bone marrow stromal cells from
postmenopausal women. J Cell Physiol. 227(6):2694-709.
Olivetti G., Abbi R., Quaini F., Kajstura J., Cheng W., Nitahara J.A., Quaini
E., Di Loreto C., Beltrami C.A., Krajewski S., Reed J.C. and Anversa P. 1997.
Apoptosis in the failing human heart. N Engl J Med. 336(16):1131-41.
PhD THESIS – MARIANA DE SOUSA CERTAL GOMES 131
Olson, E.R., Shamhart, P.E., Naugle, J.E. and Meszaros, J.G. 2008.
Angiotensin II-induced extracellular signal-regulated kinase ½ activation is
mediated by protein kinase Cδ and intracellular calcium in adult rat cardiac
fibroblasts. Hypertension. 51:704-711.
Panupinthu, N., Zhao, L., Possmayer, F., Ke, H.Z., Sims, S.M. and Dixon,
S.J. 2007. P2X7 nucleotide receptors mediate blebbing in osteoblasts through a
pathway involving lysophosphatidic acid. J Biol Chem. 282(5):3403-12.
Parekh, A.B. and Putney, J.W. Jr., 2005. Store-operated calcium channels.
Physiol Rev, 85(2):757-810.
Patergnani, S., Suski, J.M., Agnoletto, C., Bononi, A., Bonora, M., De
Marchi, E., Missiroli, S., Poletti, F. and Rimessi, A. 2011. Calcium signaling around
Mitochondria Associated Membranes (MAMs). Cell Commun Signal. 9:19.
Pearson, J.D. and Gordon, J.L. 1979. Vascular endothelial and smooth
muscle cells in culture selectively release adenine nucleotides. Nature. 281(5730):
384-386.
Pérez-Pomares, J.M. and Muñoz-Chápuli, J.M. 2002. Epithelial-
mesenchymal transitions: a mesodermal cell strategy for evolutive innovation in
metazoans. Anat Rec. 268:343-351.
Pham, T.M., Morris, J.B., Arthur, J.F., Post, G.R., Brown, J.H. and
Woodcock, E.A. 2003. UTP but not ATP causes hypertrophic growth in neonatal
rat cardiomyocytes. J Mol Cell Cardiol. 35:287–292.
Pinheiro, A.R., Paramos-de-Carvalho, D., Certal, M., Costa, C., Magalhães-
Cardoso, M.T., Ferreirinha, F., Costa, M.A. and Correia-de-Sá, P. 2013a.
Bradykinin-induced Ca2+ signaling in human subcutaneous fibroblasts involves
ATP release via hemichannels leading to P2Y12 receptors activation. Cell Commun
Signal. 11:70.
Pinheiro, A.R., Paramos-de-Carvalho, D., Certal, M., Costa, M.A., Costa, C.,
Magalhães-Cardoso, M.T., Ferreirinha, F., Sevigny, J. and Correia-de-Sá, P.
2013b. Histamine induces ATP release from human subcutaneous fibroblasts, via
pannexin-1 hemichannels, leading to Ca2+ mobilization and cell proliferation. J Biol
Chem. 288(38):27571-83.
Podrasky, E., Xu, D. and Liang, B.T. 1997. A novel phospholipase C- and
cAMP-independent positive inotropic mechanism via a P2 purinoceptor. Am J
Physiol. 273:H2380-2387.
Porter, K.E. and Turner, N.A. 2009. Cardiac fibroblasts: at the heart of
myocardial remodeling. Pharmacol Ther. 123(2):255-78.
Porter, K.E., Turner, N.A., O'Regan, D.J. and Ball, S.G. 2004. Tumor
necrosis factor α induces human atrial myofibroblast proliferation, invasion and
MMP-9 secretion: inhibition by simvastatin. Cardiovasc Res. 64:507-515.
132 PhD THESIS – MARIANA DE SOUSA CERTAL GOMES
Rajasekhar, P., Poole, D.P., Liedtke, W., Bunnett, N.W. and Veldhuis, N.A.
2015. P2Y1 Receptor Activation of the TRPV4 Ion Channel Enhances Purinergic
Signaling in Satellite Glial Cells. J Biol Chem. 290:29051-62.
Ralevic, V. and Burnstock, G. 1998. Receptors for purines and pyrimidines.
Pharmacol Rev. 50(3):413-492.
Ramires, F.J., Sun, Y. and Weber, K.T. 1998. Myocardial fibrosis
associated with aldosterone or angiotensin II administration: attenuation by
calcium channel blockade. J Mol Cell Cardiol. 30(3):475-483.
Ramsey, I.S., Delling, M. and Clapham, D.E. 2006. An introduction to TRP
channels. Annu Rev Physiol. 68:619-47.
Resende, R.R., Andrade, L.M., Oliveira, A.G., Guimarães, E.S.,
Guatimosim, S. and Leite, M.F. 2013. Nucleoplasmic calcium signaling and cell
proliferation: calcium signaling in the nucleus. Cell Commun Signal. 11(14):1-15.
Robson, S.C., Sevigny, J. and Zimmermann, H. 2006 The E-NTPDase
family of ectonucleotidases: Structure function relationships and
pathophysiological significance. Purinergic signal. 2:409-430
Rog-Zielinska E.A., Norris R.A., Kohl P. and Markwald R. 2016. The Living
Scar - Cardiac Fibroblasts and the Injured Heart. Trends Mol Med. 22(2):99-114.
Rohr, S. 2004. Role of gap junctions in the propagation of the cardiac action
potential. Cardiovasc Res. 62:309-322.
Rohr, S. 2011. Cardiac fibroblasts in cell culture systems: myofibroblasts all
along? J Cardiovasc Pharmacol. 57:389-99.
Runnels, L.W., Yue, L. and Clapham, D.E. 2002. The TRPM7 channel is
inactivated by PIP(2) hydrolysis. Nat Cell Biol. 4(5):329-36.
Sakaki, H., Tsukimoto, M., Harada, H., Moriyama, Y. and Kojima, S. 2013.
Autocrine regulation of macrophage activation via exocytosis of ATP and
activation of P2Y11 receptor. PLoS One. 8(4):59778.
Sasaki, I., Suzuki, M. And Hidaka, H. 2002. The novel and specific Rho-
kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-
homopiperazine as a probing molecule for Rho-kinase-involved pathway.
Pharmacol Ther. 93(2-39):225-232.
Schonfelder, U., Radestock, A., Elsner, P. and Hipler, U.C. 2006.
Cyclodextrin-induced apoptosis in human keratinocytes is caspase-8 dependent
and accompained by mitochondrial cytochrome c release. Exp Dermatol. 15:883-
90.
Schwiebert, E.M. 1999. ABC transporter-facilitated ATP conductive
transport. Am J Physiol. 276:C1-8.
PhD THESIS – MARIANA DE SOUSA CERTAL GOMES 133
Sengupta, P., Philip, F., and Scarlata, S. 2008. Caveolin-1 alters Ca2+
signal duration through specific interaction with the G{alpha}q family of G proteins.
J Cell Sci. 121:1363-1372.
Shah, K.B., Inoue, Y. and Mehra, M.R. 2006. Amyloidosis and the heart: a
comprehensive review. Arch Intern Med. 166:1805–1813.
Sharov, V.G., Sabbah, H.N., Shimoyama, H., Goussev, A.V., Lesh, M. and
Goldstein, S. 1996. Evidence of cardiocyte apoptosis in myocardium of dogs with
chronic heart failure. Am J Pathol. 148(1):141-9
Shinde, A.V. and Frangogiannis, N.G. 2014. Fibroblasts in myocardial
infarction: a role in inflammation and repair. J Mol Cell Cardiol. 70:74-82.
Shivakumar, K. and Kumaran, C. 2001. L-type calcium channel blockers
and EGTA enhance superoxide production in cardiac fibroblasts. J Mol Cell
Cardiol. 33(2):373-377.
Shryock, J.C. and Belardinelli, L. (1997). Adenosine and adenosine
receptors in the cardiovascular system: biochemistry, physiology, and
pharmacology. Am J Cardiol. 79(12A):2-10.
Sluijter, J.P.G., Verhage, V., Deddens, J.C., van den Akker, F. and
Doevendans, P.A. 2014. Microvesicles and exosomes for intracardiac
communication. Cardiovasc Res. 102(2):302-311.
Smith, C.L., Baek, S.T., Sung, C.Y. and Tallquist, M.D. 2011. Epicardial-
derived cell epithelial-to-mesenchymal transition and fate specification require
PDGF receptor signaling. Circ Res. 108:15–26.
Song, K., Nam, Y.J., Luo, X., Qi, X., Tan, W., Huang, G.N., Acharya, A.,
Smith, C.L., Tallquist, M.D., Neilson, E.G., Hill, J.A., Bassel-Duby, R. and Olson,
E.N. 2012. Heart repair by reprogramming non-myocytes with cardiac transcription
factors. Nature. 485(7400):599-604.
Souders, C.A., Bowers, S.L. and Baudino, T.A. 2009. Cardiac fibroblast: the
renaissance cell. Circ Res. 105(12):1164-1176.
Spach, M.S. and Boineau, J.P. 1997. Microfibrosis produces electrical load
variations due to loss of side-to-side cell connections: a major mechanism of
structural heart disease arrhythmias. Pacing Clin Electrophysiol. 20:397-413.
Sutton, M.G. and Sharpe, N. 2000. Left ventricular remodeling after
myocardial infarction: pathophysiology and therapy. Circulation. 101:2981-2988.
Tadevosyan, A., Maguy, A. and Ordog, B. 2012. Transient receptor
potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation.
Circulation. 126:2051-64.
Talasila, A., Germack, R. and Dickenson, J.M. 2009. Characterization of
P2Y receptor subtypes functionally expressed on neonatal rat cardiac
myofibroblasts. Br J Pharmacol. 158(1):339-53.
134 PhD THESIS – MARIANA DE SOUSA CERTAL GOMES
Tan, L.B., Jalil, J.E., Pick, R., Janicki, J.S. and Weber, K.Y. 1991. Cardiac
myocyte necrosis induced by angiotensin II. Circ Res. 69(5):1185-95.
Teiger, E., Than, V.D., Richard, L., Wisnewsky, C., Tea, B.S., Gaboury, L.,
Tremblay, J., Schwarts, K. and Hamet, P. 1996. Apoptosis in pressure overload-
induced hypertropht in the rat. J Clin Invest. 97(12):298-7.
Thastrup, O., Cullen, P.J., Drobak, B.K., Hanley, M.R. and Dawson, A.P.
1990. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by
specific inhibition of the endoplasmic reticulum Ca2+-ATPase. Proc Natl Acad Sci.
87(7):2466-70.
Thodeti, C.K., Paruchuri, S. and Meszaros, J.G. 2013. A TRP to cardiac
fibroblast differentiation. Channels (Austin). 7(3):211-4.
Thomsen, P., Roepstorff, K., Stahlhut, M. and van Deurs, B. 2002.
Caveolae are highly immobile plasma membrane microdomains, which are not
involved in constitutive endocytic trafficking. Mol Biol Cell. 13(1):238-50.
Tomasek, J.J., Gabbiani, G., Hinz, B., Chaponnier, C. and Brown, R.A.
2002. Myofibroblasts and mechano-regulation of connective tissue remodelling.
Nat Rev Mol Cell Biol. 3(5):349-363.
Travers, J.G., Kamal, F.A., Robbins, J., Yutzey, K.E., Blaxall, B.C. 2016.
Cardiac Fibrosis: The Fibroblast Awakens. Circ Res. 118(6):1021-1040.
Tullberg-Reinert, H. and Jundt, G. 1999. In situ measurement of collagen
synthesis by human bone cells with a sirius red-based colorimetric microassay:
effects of transforming growth factor beta-2 and ascorbic acid 2-phosphate.
Histochem Cell Biol. 112(4):271-6.
Turner N.A. and Porter K.E. 2013. Function and fate of myofibroblasts after
myocardial infarction. Fibrogenesis Tissue Repair. 6(1):5.
van den Borne S.W., Diez J., Blankesteijn W.M., Verjans J., Hofstra L. and
Narula, J. 2010. Myocardial remodeling after infarction: the role of myofibroblasts.
Nat Rev Cardiol. 7:30–37.
Vassort, G. 2001. Adenosine 5'-triphosphate: a P2-purinergic agonist in the
myocardium. Physiol Rev. 81(2):767-806.
Vial, C., Owen, P., Opie, L.H. and Posel, D. 1987. Significance of release of
adenosine triphosphate and adenosine induced by hypoxia or adrenaline in
perfused rat heart. J Mol Cell Cardiol. 19:187-197.
Villarreal, F., Epperson, S., Ramírez, I., Yamazaki, K. and Brunton, L. 2009.
Regulation of cardiac fibroblast collagen synthesis by adenosine: roles for EPAC
and PI3K. Am J Physiol Cell Physiol. 296:1178-1184.
PhD THESIS – MARIANA DE SOUSA CERTAL GOMES 135
Villarreal, F.J., Kim, N.N., Ungab, G.D., Printz, M.P. and Dillmann, W.H.
1993. Identification of functional angiotensin II receptors on rat cardiac fibroblasts.
Circulation. 88(6):2849-61.
Visconti, R.P. and Markwald, R.R. 2006. Recruitment of new cells into the
postnatal heart: potential modification of phenotype by periostin. Ann N Y Acad Sci.
1080:19-33.
Vogel, W., Gish, G. D., Alves, F. and Pawson, T. 1997. The discoidin
domain receptor tyrosine kinases are activated by collagen. Molecular Cell. 1:13-
23.
Volonté, C. and D’Ambrosi, N. 2009. Membrane compartments and
purinergic signalling: the purinome, a complex interplay among ligands, degrading
enzymes, receptors and transporters. FEBS J. 276(2):318-29.
von Kugelgen, I. 2006. Pharmacological profiles of cloned mammalian P2Y-
receptor subtypes. Pharmacol Ther. 110(3):415-32.
Wakeno, M., Minamino, T., Seguchi, O., Okazaki, H., Tsukamoto, O.,
Okada, K., Hirata, A., Fujita, M., Asanuma, H., Kim, J., Komamura, K., Takashima,
S., Mochizuki, N. and Kitakaze, M. 2006. Long-term stimulation of adenosine A2b
receptors begun after myocardial infarction prevents cardiac remodeling in rats.
Circulation. 114(18):1923-32.
Weber, K.T. 2000. Fibrosis and hypertensive heart disease. Curr Opin
Cardiol. 15(4):264-272.
Weber, K.T. and Brilla, C.G. 1991. Pathological hypertrophy and cardiac
interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation.
83:1849–1865.
Weber, K.T., Janicki, J.S., Shroff, S.G., Pick, R., Chen, R.M. and Bashey,
R.I. 1988. Collagen remodeling of the pressure-overloaded, hypertrophied
nonhuman primate myocardium. Circ Res. 62:757-765.
Weber, K.T., Pick, R., Silver, M.A., Moe, G.W., Janicki, J.S., Zucker, I.H.
and Armstrong, P.W. 1990. Fibrillar collagen and remodeling of dilated canine left
ventricle. Circulation. 82(4):1387-401.
White, P.J., Webb, T.E. and Boarder, M.R. 2003. Characterization of a
Ca2+ response to both UTP and ATP at human P2Y11 receptors: evidence for
agonist-specific signaling. Mol Pharmacol. 63(6):1356-63.
Wihlborg, A.K., Balogh, J., Wang, L., Borna, C., Dou, Y., Joshi, B.V.,
Lazarowski, E., Jacobson, K.A., Arner, A. and Erlinge, D. 2006. Positive inotropic
effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and
P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial
infarction. Circ Res. 98(7):970-6.
136 PhD THESIS – MARIANA DE SOUSA CERTAL GOMES
Williams, T.M. and Lisanti, M.P. 2004. The Caveolin genes: from cell
biology to medicine. Ann Med. 36(8):584-95.
Yegutkin, G.G. 2008. Nucleotide- and nucleoside-converting ectoenzymes:
Important modulators of purinergic signalling cascade. Biochim Biophys Acta.
1783(5):673-694.
Yitzhaki, S., Shainberg, A., Cheporko, Y., Vidne, B.A., Sagie, A., Jacobson,
K.A. and Hochhauser, E. 2006. Uridine-5'-triphosphate (UTP) reduces infarct size
and improves rat heart function after myocardial infarct. Biochem Pharmacol.
72(8):949-55.
Yue, Z., Zhang, Y., Xie. J., Jiang, J. and Yue, L. 2013. Transient Receptor
Potential (TRP) Channels and Cardiac Fibrosis. Curr Top Med Chem.13(3):270–
282.
Zak, R. 1974. Development and proliferative capacity of cardiac muscle
cells. Circ Res. 35:17–26.
Zarate, Y.A. and Hopkin, R.J. 2008. Fabry's disease. Lancet. 372:1427–
1435.
Zeisberg, E.M. and Kalluri, R. 2010. Origins of Cardiac Fibroblasts. Circ
Res. 107(11):1304–1312.
Zheng, J.S., Boluyt, M.O., Long, X., O’Neill, L., Lakatta, E.G. and Crow, M.T.
1996. Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of
neonatal cardiac myocytes. Circ Res. 78:525-535.
Zheng, J.S., O´Neill, L., Long, X., Webb, T.E., Barnard, E.A., Lakatta, E.G.
and Boluyt, M.O. 1998. Stimulation of P2Y receptors activates c-fos gene
expression and inhibits DNA synthesis in cultured cardiac fibroblasts. Cardiovasc
Res. 37(3):718-28.
Zhou, X. and Dobrev, D. 2012. Voltage-gated Na+ channels: novel players
in fibroblast-to-myofibroblast transition with a potential role in atrial
arrhythmogenesis? J Physiol. 590(20):4975.
Zimmermann, H. 2000. Extracellular metabolism of ATP and other
nucleotides. Naunyn Schmiedebergs Arch Pharmacol. 362:299-309.
